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Chapter 1 
Fluorescence based investigations of 
particulate drug delivery systems 
 -  
Introduction and Goals 
 
 
 

Introduction and Goals 
1. Particulate Drug Delivery Systems 
The term ‘particulate drug delivery system’ is not exactly defined; moreover, it is used in 
association with a wide range of different systems with pronounced structural differences 
(Fig. 1). They could be categorized based on their internal and external structure (e.g. 
dissolved/dispersed drug molecules, solid or fluid particulate character) as well as the 
apparent size of the individual delivery system. 
Fig. 1: Classification of particulate drug delivery systems 
Particulate drug carriers are intended for the controlled delivery of active substances and 
the enhancement of their therapeutic performance, by tailoring either the release profile 
from the carrier, the carriers’ biodistribution as well as the carrier uptake into certain 
tissues or cells [1-3]. They are used in oral, parenteral and also varying localized delivery 
applications (e.g. dermal, pulmonal, ocular or nasal) [1; 4-6]. From the huge variety of 
particulate systems the current overview will predominantly focus on solid micro- and 
nanoparticles based on organic compounds. 
Solid particulate carriers 
The most versatile group of carriers are the solid DDS. Based on organic materials, such 
as polymers or lipids, they are termed micro- or nanoparticles irrespective of their exact 
interior and exterior structure [7]. However, in most cases the micro-/nanoparticles are 
delivery systems, where the active ingredient is more or less homogenously distributed 
within the matrix material (either as solid solution or dispersed in individual crystals). The 
term ‘micro-’ or ‘nanosphere’ is thereby often used interchangeable, but would actually be 
restricted to strictly spherical systems. Particular systems (certain kind of subclass) are 
called ‘micro-’ or ‘nanocapsules’, where a single domain of an active ingredient is 
surrounded by the matrix material in a core-shell like structure [7] (Fig. 1). 
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Numerous scientific papers (including various reviews) deal with micro- and nanoparticles 
and their applications in different drug delivery approaches [3; 7-9]. Since the materials 
and methods used are quite similar for the preparation of both particle systems, the finally 
obtained size is predominantly determined by the applied process parameters such as the 
phase volume ratios or the homogenization of the intermediate emulsions. 
Commonly used matrix materials (Tab. 1) are either of natural or synthetic origin and the 
choice of material will predominantly depend on the desired properties of the final product, 
but also on the compatibility of the used material with the encapsulated drug substance as 
well as the preparation process.  
Tab. 1: Commonly used matrix materials for solid particles
Classification Examples  
Natural polymers Chitosan, sodium alginate, gelatine, albumine [10-17]
Synthetic biodegradable polymers  
Polyesters and derivatives Poly(lactic acid); poly(lactic acid-co-glycolic acid), 
poly(ε-caprolactone); copolymers and derivatives; 
poly(phosphor esters)  
[4; 18-22]
Polyanhydrides Poly (maleic acid), poly (fumaric anhydride-co-
isophthalmic anhydride) [23; 24]
Poly(phosphazenes) Polydichlorophosphazene, poly [(p-methyl-
phenoxy) (ethyl glycinato) phosphazene] [25; 26]
Others Poly (cyanoacrylate) [27; 28]
Synthetic non-biodegradable 
polymers
 
Acrylic polymers N-isopropylacrylamide; copolymers of methacrylic 
acid and ethacrylic acid 
[28-30]
Cellulose-based Hydroxypropylmethylcellulose; ethylcellulose [31; 32]
Lipids  
Esters of glycerol  Glycerol tripalmitate; glycerol trimyristate; glycerol 
behenate; glycerol monostearate [33-35]
Fatty acids Stearic acid; palmitic acid [35; 36]
 
The applied preparation process will not only determine the resulting particle size, but 
moreover the achieved entrapment and release characteristics of the prepared DDS. 
Numerous different preparation procedures are available, which are usually optimized on 
a certain drug – matrix combination for a desired release kinetic [37]. 
The most frequently used methods are emulsion-based solvent evaporation processes, 
which combine a variety of different preparation stages generally including the formation 
of either a single (O/W or W/O) or different multiple emulsions (W/O/W etc.), which again 
strongly depend on the characteristics of the used matrix material and the encapsulated 
active substance [7; 38; 39]. 
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Especially the applied emulsification technique (e.g. propeller or paddle stirrer, high shear 
homogenizer, high pressure homogenizer or ultrasound) will primarily determine the final 
particle size following the simple rule – the higher the applied shear stress the smaller the 
droplet and thus consequently the obtained particles, which is usually accompanied by a 
tightened particle size distribution [40-44]. Due to the variability and complexity of these 
technological procedures numerous factors affect the resulting particle properties (i.e. 
size, morphology, drug loading, internal drug distribution) and also the subsequent 
behaviour of the DDS (release, degradation). Some of the factors, described in literature, 
include: viscosity of the dissolved polymer phase (predominantly determined by molecular 
weight and concentration of the matrix material), initial loading with the active compound, 
the ratio of internal and external phase of the emulsion, the type and concentration of the 
used emulsion stabilizer in the external phase, the technique of solvent removal 
(determining the rate of solvent removal and the subsequent particles solidification) [35; 
38; 40; 45-50]. 
Alternatively phase separation methods are used for the preparation of polymeric particles 
and include the frequently used manufacturing procedures, coacervation [51] and 
nanoprecipitation [52]. The essential phase separation and thus the precipitation of the 
polymer could be ideally achieved by changes of the solution pH, the addition of 
multivalent electrolytes or the interaction with oppositely charged polymers in case of 
hydrophilic polymers [53-56] or by thoroughly mixing an organic polymer solution with an 
appropriate miscible polymer non-solvent [37; 57]. The here described impact factors are 
the used polymer type, the viscosity of the non-solvent, the ratio of non-solvent to the 
internal polymer solution, the order of mixing and, if applicable, the applied stirring rate 
[32; 57-60]. 
Numerous other preparation methods have been developed for other DDSs, including for 
example spray drying [61; 62] and spray congealing [33], salting out of polymer 
precipitates [63], processes based on supercritical fluids [34], the emulsion polymerization 
of individual monomers [64], breaking down of bigger aggregates (e.g. by jet-milling) [65] 
or various so-called printing methods based on small volume droplet generators known 
from commercial inkjet printers [66; 67]. 
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2. Imaging of Drug Delivery Systems 
In general imaging is frequently used during development and characterization of new 
drug delivery systems. Moreover the still raising impact also becomes apparent in a 
current issue of the European Journal of Pharmaceutics and Biopharmaceutics on 
“Imaging techniques in Drug Development” [68]. The editors highlighted imaging 
techniques, allowing spatial and temporal analyses, as tools for the drug development, 
which enable researchers to “see and measure and not just believe” [69]. 
Available analytical methods differ basically in their signal used for the detection. The 
most frequently used optical imaging techniques are generally based on the interaction of 
electromagnetic radiation with a certain sample, resulting in changes in light properties, 
which are detectable as image contrast. In conventional light microscopes this contrast 
arises from variations of phase, absorbance, scattering, reflection or refraction of light by 
the sample [70]. Despite several approaches for further contrast enhancement (e.g. phase 
contrast, darkfield illumination) some drawbacks still limit the application of light 
microscopy [70]:  
• Signal to background contrast often is quite low; 
• Mapping of certain functional or even structural aspects is usually difficult; 
• Lack of chemical specificity result in broad non-specific spectra. 
By introducing more specific photochemical probes such limitations could be overcome. 
On the one hand contrast is enhanced by an increased interaction of the probe with the 
excitation light and furthermore, using probes with desirable high affinity to certain 
structures allow the mapping of specific features or processes of interest.  
2.1 Principles of fluorescence 
In this context, fluorescence is by far the most commonly used and versatile probe signal, 
resulting from a multistep process – the radiative de-activation of the lowest electronically 
excited singlet state (Fig 2) [70; 71].  
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First excited 
singlet state S1
hνEX hνEM
Higher energy 
excited states
Lowest energy 
excited state
Ground state S0  
Fig. 2: Simplified Jablonski scheme illustrating the electron transitions during the fluorescence process  
By absorption of a certain quantum of energy (e.g. light of specific wavelength; hνEX) 
molecules are excited in their electronic state from the lowest present energy level, the 
ground state S0, to several excited singlet states, S1 levels. The absorbed energy is not 
retained by the molecules, but will be released within different time intervals. Immediately, 
non-radiative, rotational and vibrational, transitions occur to the lowest energy excited 
state. The following return into the ground state S0 is accompanied by the later emission 
of light (hνEM) of lower energy and therefore longer wavelengths then the light absorbed. 
This increase in the wavelength between absorbed and emitted light is the so-called 
Stoke’s shift of the used fluorophor [70]. 
2.2 Fluorescence imaging techniques 
There are numerous differing instruments described for fluorescence imaging. However, 
basically all are composed of only few fundamental components: (1) an excitation unit 
(e.g. incandescent lamps, lasers, LEDs), (2) a contrast enhancement unit (e.g. filters) and 
(3) a detection unit (e.g. photo-detectors, diode or CCD arrays) [70]. Based on their image 
acquisition mode most of the available imaging instruments could be classified in two 
groups:  
Wide-field fluorescence microscopy 
Wide-field microscopes are most frequently used for fluorescence imaging. A specimen is 
fully illuminated by light of a certain wavelength, normally generated using mercury or 
xenon lamps in combination with certain excitation filters. Emitted fluorescence light is 
collected from the sample across a large depth, including light from areas outside of the 
focal plane leading to a limited axial resolution, which is about 1 µm in a standard wide-
field instrument [72].  
 - 15 - 
Chapter 1 
Scanning fluorescence microscopy 
Scanning fluorescence microscopes comprises a variety of different instrumentations, all 
have in common that images are build-up in a scanning mode. By reducing the 
illumination aperture of a conventional microscope, excitation light is centred to a single 
point of the specimen. Both, excitation of the sample and collection of the fluorescence 
light occur successively for small single areas of the specimen. There are several 
scanning modes described in literature, including beam scanning, stage scanning or 
acusto-optical scanning; however, confocal laser scanning microscopy (CLSM) has by far 
the highest impact in biomedical research and characterization of pharmaceutical dosage 
forms [70].  
Since spatial resolution of a CLSM is increased only marginally compared to a 
conventional wide-field fluorescence microscope (by factor of 0.4 to 2), the apparent 
contrast enhancement is based on the exclusion of secondary fluorescence from out-of-
focus planes [73]. Moreover the achieved image resolution is still limited. Actually several 
approaches have been developed to “break the diffraction limit”, for example by 
multiphoton microscopy, near-field techniques, 4π-microscopy or stipulated-fluorescence-
depletion fluorescence microscopy all summarized by Patterson et al. [74]. 
Although the emitted light is the main primary detection signal there are several 
measurable parameters used to further characterize the occurring fluorescence process 
[70], e.g. 
• Fluorescence intensity 
• Emission or excitation spectra 
• Fluorescence lifetime 
• Polarization of the fluorescence light 
• Photobleaching and photoactivation 
• Fluorescence correlation. 
Thus, there are numerous different fluorescence based imaging techniques, which have 
been thoroughly reviewed and summarized elsewhere [70; 72; 73]. An overview about 
commonly used techniques is given in the table 2. 
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Tab. 2: Fluorescence imaging techniques – principles and applications [71; 72]
Technique Characteristics 
FRAP Fluorescence Recovery After Photobleaching 
- return of fluorescence signal in certain area of sample following photobleaching 
Æ mobility determination of fluorescence probes  
FLIP Fluorescence Loss In Photobleaching 
- fluorescence loss in the whole sample, following bleaching of specified area 
Æ structural analyses, mobility 
FRET Fluorescence Resonance Energy Transfer 
- energy transfer from an excited fluorophore (donor) to second fluorophore (acceptor) 
Æ analyses of molecular proximity and intermolecular interactions 
FLIM Fluorescence Lifetime Imaging 
- the lifetime of the excited state / decay of the fluorescence signal 
Æ analyses of molecular proximity (signal depends on local pH, ion concentration etc.) 
FCS-Imaging Fluorescence Correlation Spectroscopy Imaging 
- fluctuation in the fluorescence signal 
Æ analyses of molecular mobility, chemical reactions 
 
2.3 The fluorescence probe 
The presence of a photochemical active compound is generally essential for the 
fluorescence based analyses of particulate systems. Usually the fluorophore comprises a 
certain part of an organic molecule, which is able to absorb light of a certain wavelength 
and re-emit this energy as light with a different wavelength. Each fluorophore is 
characterized by specific excitation and emission spectra. Typically, resulting from the 
characteristics of the fluorescence process (Fig. 2) the maximum emission wavelength λem 
is slightly shifted into the red region of lower energy, compared to the maximum 
absorption wavelength λab. The brightness of a fluorescence dye is expressed by the so-
called fluorescence quantum yield, which represents the number of fluorescence photons 
emitted per absorbed excitation photons [75].  
For the characterization of particulate systems one can choose from a huge variety of 
different organic fluorophores, differing for example in their optical properties, 
photostability, lipophilicity or reactivity. Choosing the appropriate fluorescence probe is 
challenging but will be crucial for the success of an investigation. Several factors need to 
be considered comprising fundamentals such as: the information one is interested in, the 
composition and properties of the system to be investigated, the used imaging techniques 
and available instrumental conditions. Strongly depending on the intended application, 
there are several technical approaches for the introduction of the desired fluorescence 
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probe into the particulate DDS. The most comfortable way is the use of the intrinsic 
fluorescence of the encapsulated active pharmaceutical ingredient (API). However, since 
this is immediately linked to suitable optical properties of the API, this approach is usually 
applicable only in limited cases. Instead of the API most commonly organic fluorescence 
dyes are used. These could be either covalently conjugated to certain functional groups of 
the API, usually done in case of higher molecular weight drugs (e.g. proteins, peptides, 
DNA), co-encapsulated with the desired API or most frequently be used as model drugs, 
thus completely replacing the API. Besides the encapsulated compound also the matrix 
material can be varied in order to obtain a fluorescing system – either also by labelling of 
the matrix molecules with appropriate fluorophores or in single case by using matrix 
materials with intrinsic fluorescence. An additional opportunity offers the association of 
fluorescence labels with the surface of DDS, e.g. by biotin-streptavidin conjunction [76; 
77]. Examples for the above described possibilities are presented in table 3. 
Tab. 3: Approaches for introduction of fluorescence probes into particulate DDS
Technique Examples  
APIs with intrinsic fluorescence Minocyclin-HCl; riboflavin; topotecan; pheophorbide; 
dipyridamol 
[78-81] 
Organic fluorescence dye Fluorescein salts, coumarin-6; congo red, nile red, 
rhodamine dyes 
[54; 82-85]
Fluorescently labelled API FITC-petides/dextrans; RITC-lysozyme; TAMRA-ANP [11; 54;
 86; 87] 
Matrix materials with intrinsic fluorescence CEFB [88]
Fluorescently labelled matrix materials Rhodamine-DMPC; FITC-PAH; FITC-gelatine; Bodipy-
DOPA; CEFB-PLGA 
[54; 88-90] 
 
2.4 Application of fluorescence imaging  
Especially in the field of solid particulate DDS (nano- and microparticles) research without 
fluorescence imaging is hardly to imagine and numerous applications have been found in 
literature. State of the art is the characterization of systems subsequent to their 
preparation by CLSM analyses. Especially it is used to proof and visualize either the 
successful encapsulation [87; 91] or an applied surface coating and functionalization by 
conjugation with fluorescent compounds [76; 77; 92]. Furthermore it deals for mapping the 
APIs’ distribution within the DDS [15; 86; 89; 93] as well as structural composition of 
complex matrices or DDS [93; 94]. Internal drug distribution and matrix structure belong to 
the main determinants of drug release characteristics of a system [95; 96]. The correlation 
of individual release profiles and the fluorescence maps of the DDS allows the 
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comparison of impact for completely different preparation methods and varying 
preparation parameters and moreover increase the comprehension of apparent 
mechanisms [79; 97-99]. Thus the properties of DDS might be optimized and tailored for 
each specific application.  
Additionally fluorescence imaging is commonly applied for the characterization/elucidation 
of the DDS’s performance during their in-vitro or in-vivo application. Visualization and 
measuring of the mobility of fluorescing compounds, either originally encapsulated in the 
matrix or taken up from the enclosed medium, allows the characterization of release 
behaviour and mechanisms [78; 81; 100-102]. Microparticles’ degradation characteristics 
were investigated by mapping the development of internal pH distribution, the so-called 
microclimate pH [103-105], additionally allowing conclusions to be drawn on the stability of 
an encapsulated API. Investigation, especially of the nanoscaled systems, in cellular 
context is widely used for the determination of their properties in terms of drug targeting 
ability and/or toxicity. Using in-vitro cell culture systems, particle interaction with cells 
(frequently cancer cell lines) and their uptake into the cells as well as their intracellular 
tracking enable research to easily assess particles’ therapeutic capabilities and 
characterize the underlying uptake mechanisms [106-110]. Successful in-vivo targeting 
might be proofed subsequently by imaging of tissues isolated from animals following 
application of the DDS [110-113].  
Finally fluorescence imaging is also applied for in-vivo investigations of DDS. The 
investigation of each developed system in-vivo generally is essential, as the living 
organism is much more complex than any available in-vitro experimental set-up. Optical 
imaging offers a non-invasive method for evaluation and possibly even verification of the 
knowledge gained in the several in-vitro experiments. However, unfortunately application 
is challenging and limited especially by the interaction of the excitation as well as the 
emitted light with the surrounding tissue components. Strongly depending on the system 
and especially requiring an appropriate fluorescence probe, it allows the in-vivo tracking of 
nanoparticles following subcutaneous or intravenous administration in small animals 
(mice, rats). Most common application is the visualization of drug targeting – passive or 
active, drug release as well as the subsequent therapeutic efficacy of the system [86; 114-
117]. 
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3. Goals of the thesis 
Fluorescence imaging is ubiquitously used and irreplaceable in biomedical and 
pharmaceutical research. This outstanding position is especially founded on the numerous 
available detection techniques and therefore very versatile imaging capabilities. There is 
hardly any scientific question, which might not be addressed using fluorescence based 
analytics and where these investigations can significantly improve understanding of the 
underlying problems.  
Since only few APIs or matrix systems exhibit the necessary intrinsic fluorescence, the 
use of appropriate model compounds or the chemical modification of the API is 
indispensable. This can be seen as the main limitation of fluorescence imaging, as 
particulate systems are sensitive to almost every minute alteration of process parameters, 
which further complicates the interchangeable transfer of knowledge from one specific 
study to another. Especially the in-vivo performance, release and degradation behaviour 
of therapeutic systems, were shown to be highly sensitive to its composition, which might 
be already altered by varying excipients, preparation methods or even by only slightly 
differing preparation parameters. Basically a thorough knowledge of the DDS and its 
respective model system as well as their dependence on varying impact factors is 
essential to understand and transfer the results obtained from the imaging experiments.  
 
In this context the overall aim of this work, was the establishment of versatile particulate 
detection systems, capable for a variety of further applications, in particular the tracking of 
particles in-vitro or in-vivo, with special focus on the evaluation of potential impact factors 
on the particles’ characteristics.  
Based on a single preparation method, namely nanoprecipitation, a suitably sized 
nanoparticulate delivery system was established. To allow on-demand tailoring of specific 
particle properties for a particular application the influence of variations in single 
preparation parameters was investigated using plain particles prepared from different 
biodegradable polymers (Chapter 2). The application of the established particulate 
system for fluorescence imaging purposes further requires the introduction of a 
fluorescent label, which however might alter the processes during particle preparation and 
therefore the resulting particle properties. The impact of loading was evaluated using 
lipophilic organic fluorescent dyes as model compounds. Following thorough in-vitro 
characterization the in-vivo performance of different, fluorescently labelled systems was 
visualized by in-vivo small animal imaging (Chapter 3).  
In the second part of this thesis quantum dots, fluorescing semiconductor nanocrystals, 
should be established as additional fluorescent marker of particulate systems. With their 
bright and stable photoluminescence they were assumed to offer an attractive alternative 
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for commonly used organic fluorescence dyes and overcome their drawbacks (e.g. 
leakage from the matrix, photobleaching), which are problematic especially in case of 
long-term imaging applications. First of all CdSe nanocrystals, appropriate for in-vitro and 
in-vivo investigations, were synthesized using a simple one-step synthesis route. Several 
post-synthesis treatments were evaluated with respect to their potential to improve optical 
properties of the quantum dots and to enhance stability for further encapsulation 
(Chapter 4). Encapsulation of these CdSe quantum dots into polymeric nanoparticles 
using the prior established nanoprecipitation method was assumed to be well-suited to 
preserve the QDs optical properties due to the absence of mechanical high-shear 
processes and therefore allow the preparation of bright fluorescing, stable and 
monodisperse particles. The encapsulation process was investigated to elucidate critical 
steps, allowing further improvement of the particulate detection system (Chapter 5). 
Finally quantum dots were evaluated also as fluorescent label for larger polymeric 
microparticles. The impact of quantum dot properties and the matrix system on the overall 
characteristics of the microparticulate system and their potential use for imaging purposes 
was investigated (Chapter 6). 
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Nanoprecipitation 
 –  
Preparation of monodisperse 
 polymeric nanoparticles 
 
 

Monodisperse Polymeric Nanoparticles 
1. Introduction 
Despite enormous developments during the last 30 years [1-3], the field of nanoparticulate 
systems is still growing, understandable regarding their multiple applications including 
targeted and controlled drug delivery following parenteral, oral or local administration [4-6] 
as well as for different imaging purposes [7; 8]. Nowadays one can choose from a pool of 
different materials and preparation methods, tailoring the optimal preparation conditions 
and product properties for the intended application [2; 3]. 
Offering in general very desirable properties – biocompatibility and biodegradability – 
polymers based on poly-(lactic acid), including various copolymers and derivatives are the 
most commonly investigated building blocks [3]. However, also natural polymers, such as 
chitosan or sodium alginate, have been described [9; 10]. The varying already established 
preparation processes basically could be classified into two different groups [2]: using 
either the polymerization of monomers, which directly leads to the particulate systems, or 
alternatively the dispersion of already preformed polymers to particulates of nanometre 
size by appropriate dispersion techniques. The latter group contains several different 
procedures including emulsion-based solvent-evaporation methods, salting out of the 
used polymers or their nanoprecipitation, thoroughly reviewed elsewhere [2]. The chosen 
combination of the particle forming polymer, a certain preparation method and the applied 
process conditions obviously has an enormous impact on the resulting particle 
characteristics, including release behaviour, bio-distribution and tissue accumulation or 
cell-uptake [11]. Therefore a detailed knowledge of potential impact factors is generally 
essential in order to predict the fate of the developed drug delivery system.  
In the current work the technique of nanoprecipitation, first described by Fessi et al. [12], 
has been chosen as the desirable preparation method due to its characteristics, which 
allow an one-step preparation of small, nearly monodisperse particles [13], without the 
application of additional high-shear stress processes as for example microfluidization or 
ultrasound [14], which would further harm sensitive substances, like for example quantum 
dots.  
To provide a highly versatile system, suited for a wide range of applications several 
factors have been investigated with respect to their effect on the colloidal systems’ quality, 
predominantly determined by the achieved particle size and size distributions. The 
intended particle sizes for imaging applications were defined to be below 300 nm, which 
should provide sufficient diffusivity in the blood stream or within tissues of particles in 
subsequent in-vivo imaging applications. Aqueous as well as non-aqueous systems were 
established to allow also processing of hydrophilic or water–sensitive compounds by 
avoiding an aqueous phase. The chosen polymers were well-established for the 
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preparation of biodegradable particulate drug delivery systems [DDS] and differed in their 
lipophilicity, which should affect the surface properties of the resulting particles. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Synthesis and characterization of biodegradable copolymers 
Ethylene oxide (>98.8 %), potassium bis(trimethylsilyl) amide (0.5 M in toluene), 3,6-
dimethyl-1,4-dioxan [D,L-lactide], poly(ethylene glycol) monomethyl ether [mPEG2; 
MW=2000 Da], stannous 2-ethylhexanoate (>95 %) and trifluoro acetic anhydride [TFA] 
were obtained from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). 
Acetic acid (99 %) [glacial acid] was purchased from Merck (Merck KGaA, Darmstadt, 
Germany). Tetrahydrofuran [THF], diethyl ether, methylene chloride (p.a.), acetone (p.a.) 
were obtained at Acros (Acros Organics, Fischer Scientific GmbH, Nidderau, Germany). 
Chloroform [CHCl3] (HPLC grade) was provided by Carl ROTH (Carl ROTH GmbH, 
Karlsruhe, Germany). Deuterated chloroform [Chloroform-d1; CDCl3] was purchased from 
Deutero (Deutero GmbH, Kastellaun, Germany). 
2.1.2 Preparation and characterization of polymeric nanoparticles 
PLGA 75:25 (Resomer® 756) was obtained as kind gift of Boehringer Ingelheim 
(Boehringer Ingelheim AG, Biberach, Germany). Biodegradable copolymers PEG2PLAY 
and NH2PEG2PLAY (Y=20 or 40) were custom made following an established method as 
described. Pluronic® F68, sodium cholate hydrate (98 %), phosphotungstic acid (reagent 
grade) and poly(vinylalcohol) [PVA] (Mowiol 40-88) were obtained from Sigma-Aldrich 
(Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). Sodium dodecyl sulfate [SDS], 
sucrose and glucose were purchased from Merck (Merck KGaA, Darmstadt, Germany). 
Chloroform (p.a.) and acetone (p.a.) were obtained from Acros (Acros Organics, Fischer 
Scientific GmbH, Nidderau, Germany). Ethanol (p.a.) was provided from Merck (Merck 
KGaA, Darmstadt, Germany). 
2.1.3 Cell culture 
The L929 mouse fibroblast cell line and the CHO-K1 cell line (ATTC code No. CCL-61) 
were kind gifts from the Department of Pharmaceutical Chemistry, University of 
Regensburg. Fetal bovine serum [FBS] was purchased from Biochrom (Biochrom KG, 
Berlin, Germany). Trypsin-EDTA 0.25 % and Dulbecco’s phosphate buffered saline [PBS] 
were obtained from Invitrogen (Invitrogen GmbH, Karlsruhe, Germany). 3-[4,5-
Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide [MTT] was purchased from 
AppliChem (AppliChem GmbH Darmstadt, Germany). Eagle’s minimum essential medium 
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[EMEM] and nutrient mixture HAM’s F-12 were obtained from Sigma-Aldrich (Sigma-
Aldrich Chemie GmbH, Taufkirchen, Germany). Triton-X (p.a.) was obtained from Merck 
(Merck KGaA, Darmstadt, Germany). 
2.2 Methods 
2.2.1 Synthesis of diblock copolymer 
Synthesis of Poly(ethylene glycol)-mono amine (NH2-PEG2-OH) 
Poly(ethylene glycol)-mono amine with a molecular weight of 2,000 Da (2 kDa) was 
synthesized following a modified synthesis route, previously described by Tessmar et al. 
[15]. Briefly, 22 ml ethylene oxide (500.5 mmol) were dissolved in 150 ml THF (cooled at 
-79 °C). After slow addition of 22 ml of a 0.5 M potassium bis(trimethylsilyl)-amide solution 
in toluene (11 mmol), the mixture was stirred for 36 h. In the following the THF was 
evaporated using a rotary evaporator (Heidolph Instruments GmbH, Schwabach, 
Germany) and the solution was concentrated until a viscous polymer solution was 
obtained. For purification the product was dissolved in methylene chloride and precipitated 
in four portions of 500 ml diethyl ether. The precipitated polymer was dried under reduced 
pressure for at least 48 h. 
Synthesis of diblock copolymers mPEG2PLAY/ NH2PEG2PLAY (Y=20/ 40) 
Two kinds of diblock copolymers, each with two different molecular weights, were 
synthesized. The hydrophilic block consisted either of poly(ethylene glycol)-monomethyl 
ether [mPEG] or poly(ethylene glycol)-mono amine [NH2PEG] each with a molecular 
weight of 2 kDa. The second, lipophilic block consisted of a poly(lactic acid) [PLA] part, 
where Y refers to the molecular weight of the PLA block, which was either 20 kDa or 
40 kDa. The PLA part was attached to the PEG part by a ring-opening polymerization of 
D,L-dilactide using stannous 2-ethyl hexanoate as catalyst [16]. First of all, any trace 
amounts of water were removed from the educts. Therefore about 2 g of the PEG 
component were dissolved in 100 ml toluene in a three neck round bottom flask. Heated 
to reflux, 50 ml of toluene were distilled off using a water separator. The D,L-dilactide 
(20 g and 40 g, respectively) and further 100 ml toluene were added and again 50 ml 
solvent were distilled off. The final volume of toluene did not exceed 100 ml. After addition 
of 500 µl glacial acid and about 400 mg of the catalyst the mixture was refluxed for at least 
8 h under nitrogen atmosphere. Afterwards toluene was removed by repeated distillation 
with 200 ml methylene chloride and acetone using a rotary evaporator. Finally, the 
polymer dissolved in acetone was precipitated by slow dropwise addition to water. The 
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precipitate was separated, frozen at -80 °C and dried under vacuum. Until usage the 
polymers were kept under vacuum in a desiccator. 
2.2.2 Characterization of diblock copolymers 
To prove their successful synthesis, polymers have been characterized by determination 
of their molecular weight and thermal behaviour. Description of the used methods as well 
as the respective results will be presented in Appendix A. 
2.2.3 Preparation of polymeric nanoparticles  
Polymeric nanoparticles were prepared following a modified nanoprecipitation method 
(also called solvent displacement) first described by Fessi et al. [12], using a lipophilic 
organic solvent for the polymer and an excess of an external phase, which is a 
non-solvent for the polymer, but miscible with the polymer-solvent. Two differing 
procedures were established to enable the use for a broad spectrum of encapsulated 
substances: (A) a non-aqueous procedure with chloroform as polymer-solvent and 
ethanol as external phase (non-solvent) and (B) an aqueous system composed of 
acetone and water, respectively. Generally 10 ml of a 1 % solution of the polymer in the 
respective solvent was added dropwise to 40 ml of the external phase, partially containing 
additional stabilizers, with a drop-rate of about 2 ml per minute. The organic solvent was 
then allowed to evaporate over the required time, either avoiding agitation in case of the 
non-aqueous system or under permanent stirring with about 550 rpm. In case of the 
non-aqueous system the ethanol was afterwards removed by dialysis using a Nadir® 
dialysis membrane (cut-off of 10 to 20 kDa; Carl ROTH GmbH, Karlsruhe, Germany). 
Ethanol was exchanged by an aqueous solution of 0.1 % Pluronic F68. 
From the aqueous dispersions the particles were recovered by centrifugation (12,500 g, at 
least 30 min, 10 °C; Avanti JE centrifuge; Beckman Coulter GmbH, Krefeld, Germany), 
re-dispersed in a solution of an appropriate protectant and subsequently freeze-dried. 
Variations of preparation process 
Based on the above described standard process several parameters were varied to 
determine their impact on the properties and quality of the resulting nanoparticles. An 
overview of the applied variations is given in table 1. 
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Tab. 1: Summarized variations of the standard preparation process 
Process factor Investigated conditions Standard 
Concentration of polymer in solution 0.01–2 % 1 % 
Ratio of volumes of solvent to non-solvent  1:2; 1:4; 1:8 1:4 
Concentration of Pluronic  F68 in non-solvent 0.1– 0.5 % 0.5 % 
Type of stabilizer in non-solvent Pluronic F68 
Sodium dodecyl sulfate  
Sodium cholate 
Pluronic F68 
 
2.2.4 Freeze – thawing / freeze-drying experiments 
The effect of four different cryo/lyo-protectants, described in literature [17; 18], on the 
stability of the freeze-dried dispersions of polymeric nanoparticles was investigated at 
varying concentrations. Sucrose and glucose were used at concentrations of 0.5, 5.0, 10 
and 20 %; Pluronic F68 in concentrations of 0.1, 0.5, 1.0 and 1.5 % and additionally PVA 
in concentrations of 1.0, 1.5 and 2.5 %.  
Following centrifugation (2.2.3) nanoparticles were re-dispersed in about 10 ml of the 
protectant solution. 3 ml of each dispersion were transferred into glass vials and frozen 
either at -196 °C over 1 h, -80 °C over 24 h or -20 °C over 48 h. In the following, frozen 
samples were either thawed at room temperature to assess the particle protection during 
the freezing process or lyophilised using a lab-scale freeze-dryer (Martin Christ 
Gefriertrocknungsanlagen, Osterode am Harz, Germany). The minimum shelve 
temperature at the beginning was set to -40 °C. Sublimation lasted at least 4 days at 
vacuum pressure of 0.125 mbar and a shelve temperature of 15 °C. Dried samples were 
subsequently sealed and stored until re-dispersion in the same volume of water. 
Particle stability during freezing and freeze-drying was determined based on particle sizes 
and polydispersity indices [PI] prior and after freezing as well as after re-dispersion 
following lyophilisation. Results are presented either as directly measured particle size or 
as ratio of the obtained sizes (and PIs) determined after re-suspension and prior freezing, 
where a ratio of 1 indicated highest possible stability [19]. 
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2.2.5 Determination of particle size 
Photon correlation spectroscopy  
Commonly photon correlation spectroscopy [PCS] was used to determine the 
hydrodynamic diameters and polydispersity indices of the prepared nanoparticles usually 
dispersed in 5 % sucrose solution. Measurements were performed at 20 °C with a 
Zetasizer 3000 A (Malvern Instruments Inc., Herrenberg, Germany). Results are 
presented as mean and relative standard deviation of three independent measurements. 
The measurements were performed in different dispersion media, depending on the 
process step or the exact process conditions used. As PCS measurements are strongly 
influenced by the properties of dispersion media [20], refractive index and viscosity of 
each medium used was determined and results are summarized in Appendix B.  
Transmission electron microscopy  
Transmission electron microscopic [TEM] images (2.2.7) were used to determine the 
apparent diameter of the polymeric particles. Size was determined by manually measuring 
the diameter of 100 particles, for each sample. Results are presented as mean and 
relative standard deviation.  
2.2.6 Determination of zeta potential 
Zeta potential of nanoparticles, dispersed in water (pH ~6.7) was determined based on so-
called laser Doppler electrophoresis using a Zetasizer 3000 A (Malvern Instruments Inc., 
Herrenberg, Germany). Measurements were performed at 20 °C. 
2.2.7 Morphology of polymeric nanoparticles 
The morphology of nanoparticles was imaged by transmission electron microscopy. 
Samples were prepared by dropping diluted aqueous dispersions on 3.05 mm 
formvar/carbon coated copper grids (300 mesh) followed by negatively staining with 
phosphotungstic acid (2 % in water) for 30 s and subsequent drying under vacuum. 
Images were taken using a Zeiss EM C/CR (Carl Zeiss AG, Jena, Germany) with 60 kV 
operating voltage. 
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2.2.8 Cell culture 
The L929 cells and CHO cells were cultured in EMEM and nutrient mixture HAM’s F12, 
respectively, both supplemented with 10 % FBS. Standard cell culture conditions were 
37°C, 95 % relative humidity and 5 % CO2. Growth medium was changed every third day. 
2.2.9 Biocompatibility of polymeric nanoparticles  
Biocompatibility of prepared particulate systems was investigated following an established 
procedure using the colorimetric MTT assay for quantitative assessment [21]. Acute 
toxicity of nanoparticles was assessed in a direct contact test [22]. Test dispersions of the 
particles were prepared by serial dilution with the respective cell culture medium, 
supplemented with 10 % FBS. 
After seeding in a 96-well plate cells were grown to 80 to 90 % confluence. Medium was 
removed and the test samples (n=4, each concentration) were added. A solution of 
Triton X (0.5 % in PBS) was used as positive control (n=4), untreated cells with medium 
served as negative control (n=4) and blank values were obtained from medium without 
cells. After incubation at standard conditions for 4 h supernatants were aspirated and cells 
were washed once with PBS to remove any residuals. MTT solution (0.625 mg/ml in 
medium + 10 % FBS) was added and again cells were incubated for 4 h at standard 
conditions under exclusion of light. The water-soluble MTT is then converted into an 
insoluble formazan dye  by mitochondrial dehydrogenase only present in still living cells 
(Fig. 1) [23]. 
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Fig. 1: Conversion of MTT to its insoluble formazan
Thereafter the excess MTT solution was removed and a solution of SDS (10 % in PBS) 
was added for cell lysis and dissolution of the precipitated formazan crystals over 24 h at 
room temperature under exclusion of light.  
Subsequently, the formazan concentration was determined by measuring the optical 
density [OD] using an automatic microplate reader (TiterTek Plus; Friedrich S. Bartolomey 
Labortechnik, Germany) at 550 nm with a background correction at 630 nm. Cytotoxicity 
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was expressed as cell viability [%] of the treated cells relative to the untreated (negative 
control) calculated based on the following equation: 
 
%100*[%]
controllnegativeOD
cellstestOD
viabilitycell =  (1)
 
All data were expressed as mean (N=4) and relative standard deviation. Statistic 
significance was assessed by one-way analysis of variances (ANOVA) in conjunction with 
Tukey’s studentized range test using SigmaStat software. 
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3. Results 
Nanoparticles are highly sensitive towards polymer degradation or aggregation during 
storage in aqueous dispersions. The transfer of the colloidal system into a storable dry 
form was achieved by lyophilisation. The results of development of a reproducible 
freeze-drying procedure ensuring conservation of nanoparticles properties will be 
presented in the first part, since all following particle characterizations (e.g. size 
measurements) during evaluation of several impact factors were performed following 
freeze-drying and re-dispersion.  
3.1 Stabilization of colloidal systems during freeze-drying 
The impact of different protectants on the stability of polymeric nanoparticles during 
freezing and subsequent freeze-drying was thoroughly assessed using the PLGA 
particles, prepared via the non-aqueous system. A complete series of the obtained 
results, i.e. particle size prior freezing, after freezing at three different conditions and after 
re-dispersion following freeze-drying is exemplary presented for sucrose (Fig. 2). Results 
were generally found to be independent of the applied freezing conditions. No stabilization 
at all was obtained in pure, un-stabilized particle dispersions (values at 0 %) and 
aggregation could be easily detected by visual examination of the samples after thawing 
or re-suspension. Amounts, as low as 0.5 %, were sufficient for all protectants during 
freezing. However, aggregation of particles still occurred during subsequent freeze-drying, 
with the worst results obtained for the freezing temperature of -196 °C. For concentrations 
ranging between 5 and 20 %, no noteworthy changes either in mean particles sizes or in 
the obtained size distributions, indicated by the polydispersity indices of the 
measurements, were determined. 
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Fig. 2: Particle sizes [nm] and polydispersity indices of PLGA nanoparticles, prepared with non-aqueous 
system (+0.5 % F68) and stabilized with increasing concentrations of sucrose frozen at -196 °C (over 1 h), 
-80 °C (over 24 h) or -20 °C (over 48 h) 
For all the further used protectants, the overall stability of the nanoparticles, is 
summarized using the respective ratios of mean particle sizes and PIs after freeze-drying 
to prior freezing (Fig. 3). Glucose stabilization generally gave results comparable to those 
of sucrose, with a sufficient effect at concentrations between 5 to 20 % independent of the 
applied freezing temperature.
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Fig. 3: Ratios of particle sizes and polydispersity indices of PLGA nanoparticles stabilized using different 
protectants (glucose, Pluronic F68 and PVA determined after and before freeze-drying 
In case of the surfactant Pluronic F68 the highest impact of the applied freezing 
temperature was found. While stable particle formulations were obtained even with the 
lower concentration of 0.5 % at a freezing temperature of -196 °C, 1 % was necessary in 
case of -80 °C and highest amounts were required at lowest freezing temperature. PVA 
overall showed the best particle stability at all concentrations used, independent of the 
used freezing step.  
The time required for a quantitative re-dispersion of the lyophilisates (except apparent 
aggregates) also served as quality parameter and results are given in table 2. 
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Tab. 2: Re-dispersion times of lyophilisates containing increasing amounts of varying stabilizers 
Sucrose Glucose Pluronic F68 PVA 
0.5 % < 30 s 0.5 % < 30 s 0.1 % < 30 s 1 % < 2 h 
5 % < 1 min 5 % < 1 min 0.5 % < 30 s 1.5 % < 2 h 
10 % < 1 min 10 % < 1 min 1 % < 30 s 2.5 % > 3 h 
20 % < 5 min 20 % < 1 min 1.5 % < 1 min   
 
Except for some occurring aggregates all lyophilisates could be quantitatively re-
dispersed. However, the re-dispersion time was affected by the type of stabilizer and took 
up to several hours in case of PVA.  
Subsequently the stability of nanoparticles prepared from the different diblock copolymers 
during the freeze-drying process was investigated exemplarily using 5 % sucrose as 
stabilizer and was found to be overall very high, indicated by the obtained size ratios near 
to one (Fig. 4). Only in case of the amine group containing polymer the size distribution 
became broader during drying, if frozen at -196 °C.
0.0
2.5
5.0
7.5
10.0
12.5
15.0   -20 °C  -80 °C
  -196 °C
NH 2
PEG 2
PLA 2
0
PEG 2
PLA 4
0
NH 2
PEG 2
PLA 4
0
R
at
io
 p
ar
tic
le
 s
iz
es
PEG 2
PLA 2
0
0.0
2.5
5.0
7.5
10.0
12.5
15.0
R
atio polydispersity indices
 
Fig. 4: Ratios of particle sizes and polydispersity indices of polymeric nanoparticles prepared of different 
copolymers stabilized with 5 % sucrose determined after and before freeze-drying  
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3.2 The nanoprecipitation process – Investigation of process 
conditions 
3.2.1 Impact of precipitation system 
The impact of the used precipitation system (non-aqueous or aqueous) should be 
investigated originally based on the described standard conditions. However, it was 
observed, that the preparation in non-aqueous environment failed in case of the diblock 
copolymers, if the external phase was supplemented with Pluronic F68, which was 
essential in case of PLGA. Therefore all precipitations of diblock copolymers in ethanol 
were performed in absence of any stabilizer. 
The properties of the obtained particles, displayed by their particles size and size 
distribution, were found to strongly depend on the used polymers and moreover the used 
precipitation system (Fig. 5). Regarding the single polymers, particle sizes differed 
significantly between both preparation systems. 
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Fig. 5: Comparison of particle sizes [nm] and polydispersity indices of polymeric nanoparticles prepared via 
nanoprecipitation either using an aqueous or non-aqueous precipitation system  
PLGA particles were almost unaffected by the used solvent – non-solvent system. Indeed, 
in case of the copolymers behaviour differed depending on the absence or presence of 
the amine group. While methoxy-PEG-derivatives, independent of their molecular weight, 
are characterized by a pronounced increase in the measured particles size when 
changing the solvent system to anhydrous, the results are the opposite in case of the 
amine-derivative. Here, particles prepared in the aqueous system are clearly bigger than 
in the non-aqueous system. Although PIs were generally low in most cases, which 
indicates narrow size distributions, the results obtained using the hydrous preparation 
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system were comparably bad and overall the higher values were determined for the 
NH2PEG2PLAY based particles. 
Since the general trend of the copolymers was found to be independent of their molecular 
weight, further investigations were done with only one polymer group, namely the 
mPEG2PLA20 and NH2PEG2PLA20 derivatives. 
3.2.2 Impact of polymer concentration 
The polymer concentration in a fixed volume of organic solvent was found to strongly 
influence the resulting particle size only in case of the PLGA and mPEG2PLA20 particles, 
where increasing polymer concentrations led to increasing particle sizes, independent of 
the used precipitation system (Fig. 6). 
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Fig. 6: Particle sizes [nm] and polydispersity indices of polymeric nanoparticles using decreasing polymer 
concentrations using aqueous system (ratio 1:4); in case of PLGA particles results for non-aqueous system 
are presented additionally 
In contrast, the size of NH2PEG2PLA20 particles seemed to be almost not affected by the 
used polymer concentration in the organic phase, only the highest concentration led to a 
significant increase in size. The impact on size distributions was found to be more 
pronounced if the hydrous system was used, with an irregular increase in PI in case of 
lowest polymer concentrations, and overall broader distributions for the NH2PEG2PLA20 
based particles. 
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3.2.3 Impact of ratio of volumes of polymer solution to external phase 
With constant polymer concentrations in the organic phase, the ratios of polymer solution 
and external phase were varied by adding increasing volumes of polymer solution to a 
constant volume of external phase. Overall, the effect was comparably low (Fig. 7). No 
changes could be determined in case of mPEG2PLA20, whereas PLGA particles are 
characterized by a slight increase in size when a volume ratio of 1:2 and the anhydrous 
system was used for precipitation. The results found for NH2PEG2PLA20 were differing 
with highest particle size in case of a ratio of 1:4 and similar values for both other ratios. 
Size distributions generally seemed to be slightly broader with decreasing ratios. 
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Fig. 7: Particle sizes [nm] and polydispersity indices of polymeric nanoparticles using decreasing ratios of 
polymer solution (internal phase) to external phase prepared using aqueous system; in case of PLGA particles 
results for non-aqueous system are presented additionally 
3.2.4 Impact of stabilizer 
The impact of the stabilizer addition to the external phase was investigated by varying 
either the stabilizer type at similar concentrations or the concentrations of one stabilizer, 
namely Pluronic F68, which was chosen as standard, prior to any investigation (Fig. 8). All 
investigations were exclusively performed using the aqueous system, since presence of 
alternative surfactants (other than Pluronic F68) in the external phase was found to cause 
complete aggregation during the evaporation in case of the anhydrous system and 
furthermore the other used stabilizers were not sufficiently soluble in ethanol. Regarding 
the different investigated stabilizer types, trends in the results were almost independent of 
the used polymer. However, their impact on mPEG2PLA20 particles was almost negligible 
(Fig. 8, left). Smallest particles were obtained using sodium cholate, but accompanied of 
comparable high polydispersity indices. Lowest PIs, indicating narrow size distributions, 
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could be observed in case of Pluronic F68. Quality of particles prepared in presence of 
SDS was characterized by high particle sizes and broad size distributions. 
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Fig. 8: Particle sizes [nm] and polydispersity indices of polymeric nanoparticles prepared using the aqueous 
system (1 % polymer; ratio 1:8) - (left) with different types of stabilizer in the external phase (all at 0.5 %); 
(right) with different concentrations of Pluronic F68 in the external phase; arrows indicate failure in 
preparation of stable nanoparticles 
The effect of varying concentrations of Pluronic F68 generally differed between the 
lipophilic PLGA and the amphiphilic diblock copolymers (Fig. 8, right). For preparation of 
PLGA nanoparticles a stabilizer concentration of 0.5 % in the aqueous external phase was 
essential, otherwise aggregation occurred already during the precipitation step. In case of 
all PEG containing copolymers (mPEG, NH2PEG), a stable nanoprecipitation was possible 
in surfactant-free environment. Indeed, particle size was higher than in presence of any of 
the used amounts of Pluronic F68. Again, the impact was more pronounced in case of the 
NH2PEG-derivative. 
3.2.5 Measurement of zeta potential 
The zeta potential is a commonly used parameter to characterize particle surfaces. 
However, as the measured results differed strongly for the different polymers and 
preparation procedures and often very broad signal distributions were observed exact 
evaluation is complicated, wherefore only the main trends are schematically presented 
(Fig. 9). At first, measured potential was in the negative range in all cases. PLGA 
exhibited by far lowest surface potentials only less affected by changes in the preparation 
procedure. In contrast both PEG containing copolymers were characterized by overall 
higher zeta potentials and no influence of the amine group could be observed. However, 
different process parameters caused more pronounced changes.  
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Fig. 9: Schematic demonstration of the position of nanoparticles zeta potential, depending on polymer and 
exact preparation conditions 
3.2.6 Morphology of nanoparticles – impact of precipitation system 
Nanoparticles prepared by nanoprecipitation appeared round shaped and smooth, 
independent of the used polymer type (Fig. 10). In case of the diblock copolymers also 
the precipitation method did not significantly alter the appearance of particles in TEM, 
indicated by the comparison of NH2PEG2PLA20 prepared using non-aqueous (Fig. 10, C) 
or aqueous route (Fig. 10, D). 
A
 
B
 
C
 
D
 
Fig. 10: TEM images of polymeric nanoparticles (A) PLGA in aqueous system (B) PEG2PLA20 in aqueous 
system, (C) NH2PEG2PLA20 in aqueous system and (D) NH2PEG2PLA20 in non-aqueous; particles negatively 
stained with phosphotungstic acid; magnification: 8000x; scale bars correspond to 250 nm 
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3.2.7 Measuring particle size – impact of analytical method 
For the above mentioned investigations PCS measurements have been used as standard 
method to determine particles size and size distributions. Results obtained were 
compared to a further, different method using TEM images. Generally particle sizes 
determined with TEM are smaller than the respective values of the PCS investigation 
(Fig. 11). 
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Fig. 11: Particle sizes [nm] of polymeric nanoparticles either measured with PCS (mean ± SD of three 
measurements) or determined based on TEM images (mean ± SD of 100 particles) 
However, the most pronounced differences were found in case of the NH2PEG2PLA20 
particles. Moreover, the extents of differences depend on the used precipitation system. 
After preparation following the aqueous route particle sizes obtained by PCS were nearly 
twice as high as the respective results of the images analysis. In contrast to PCS results, 
TEM based particle sizes were almost equal for both types of diblock copolymers in both 
preparation methods. 
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3.2.8 Biocompatibility of polymeric nanoparticles 
Cytotoxicity of various types of nanoparticles has been tested in L929 and CHO cells. The 
results are exemplarily presented for the single batches and, independent of the polymer 
type, no significant toxicity was detected in both cell lines (Fig. 12). 
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Fig. 12: Viability of L929 and CHO cells after incubation (4 h) with nanoparticles prepared from different 
biodegradable polymers, using the aqueous system (1 % polymer; ratio 1:8); star indicate significant toxicity 
compared to the respective negative control (p<0.05) 
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4. Discussion 
4.1 Stabilization of colloidal formulations during freeze-drying 
As nanoparticulate systems gain more and more attention either as targeted DDS or for 
imaging purposes [3; 24], the storage of these colloidal systems until application is of 
rising importance in order to prevent physical instabilities due to particle aggregation of 
even fusion. Furthermore the hydrolysis of the matrix forming biodegradable polymer, or, 
in case of loaded nanoparticles, the leakage of encapsulated drug substance has to be 
prevented in an aqueous environment [17-19]. Lyophilisation was described as 
appropriate method to convert nanoparticle dispersions into long-term storable 
formulations preserving their quality. Since nanoparticles are exposed to several stress 
factors [24] and tend to aggregate during freezing and/or lyophilisation, impeding a 
quantitative reconstitution [19; 25; 26], the development of a suitable freeze-drying 
method was an essential step of this work. Sufficient stabilization of particle dispersions 
during freezing and desiccation could be achieved by addition of several protectants. 
Commonly the used stabilizers described in literature were several sugars or sugar 
alcohols and polymeric substances like PVA, PEG, gelatine or Pluronic F68 [17; 25-27]. 
However, the choice of the most appropriate substance strongly depends on the 
properties of the investigated nanoparticulate system and therefore has to be a case by 
case decision. Four frequently used protectants, each in several typical concentrations, 
were investigated regarding their effect on PLGA nanoparticles prepared by 
nanoprecipitation. As expected the supplementation of additional stabilizers was essential, 
since no un-stabilized sample was stable already during freezing. Generally all four 
substances (sucrose, glucose, Pluronic F68 and PVA) were found to sufficiently stabilize 
the system, but with different appropriate concentrations (Fig. 1 and Fig. 2). Besides the 
overall stability of the formulation, displayed by the ratios of size and PI of the product 
after and prior lyophilisation, the decision for an adequate substance depended on 
additional further aspects. Therefore, single results for particles of one batch are 
compared after dispersion in water or aqueous solutions of either sucrose (5 %), glucose 
(5 %), Pluronic F68 (1%) or PVA (1 %), reflecting the general behaviour of the 
investigated stabilizers on the resulting particle sizes (Tab. 3).  
 - 51 - 
Chapter 2 
Tab. 3: Single results of particle sizes and polydispersity indices of nanoparticles in different dispersion media 
Dispersion medium Particle size (± SD) / nm PI (± SD) 
Water 122.6 (2.7) 0.102 (0.013) 
Sucrose 5 % 117.7 (2.3) 0.105 (0.003) 
Glucose 5 % 120.7 (0.9) 0.117 (0.176) 
Pluronic F68 1 % 140.3 (3.2) 0.119 ( 0.016) 
PVA  1 % 152.9 (2.3) 0.487 ( 0.012) 
 
In case of both polymeric compounds (Pluronic F68 and PVA), an increase in the particle 
size following dispersion was observed, which can occur due to the adsorption of the 
macromolecules on the particles surface with a subsequent increase of the particles 
hydrodynamic diameters. Moreover the used PVA solutions exhibit comparable high 
viscosities (3.3 to 11.8 mPas), which could also interfere with the accuracy of the PCS 
measurements, leading to deviations of the polydispersity indices. Additionally the longest 
re-dispersion time of several hours are required, not desirable during application (Tab. 2). 
Additionally, the reproducibility was low in case of the non-ionic surfactant Pluronic F68, 
indicated by high standard deviations; especially for the polydispersity index (Fig. 3). 
Comparing the results of both sugar components generally similar stabilization capacity 
was observed. However, both differed strongly in stability or quality of the resulting 
lyophilisate (Fig. 13). 
  
Fig. 13: Images of PLGA nanoparticles after freeze-drying (freezing at -196 °C) stabilized with (A) sucrose 
and (B) glucose; each picture displays series starting with the highest concentration in left to the un-stabilized 
sample in the right 
All samples containing glucose were extremely hygroscopic (Fig. 13, B), resulting in a 
pronounced uptake of water within several minutes directly after finishing the 
freeze-drying process. Considering all mentioned observations, and since the effect of 
freezing temperature was found to be almost negligible, standard conditions for all 
preparations were defined as: 5 % sucrose and freezing at -196 °C for one hour. These 
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conditions furthermore were proved to be appropriate also for the stabilization of particles 
prepared from the other polymers used during this work (Fig. 4). 
4.2 The nanoprecipitation process – Investigation of process 
conditions 
During the development of DDS, the establishment of optimal process conditions 
generally requires the knowledge factors of potentially influencing the resulting product. 
This may be even more important in case of the herein used nanoprecipitation method, as 
particles sizes and size distributions are determined without the application of additional 
high-shear stress processes like microfluidization or ultrasound [14], but only depend on 
the chosen additives and process conditions, like solvent ratios or polymer concentrations. 
Despite the widespread use of this preparation method and several thorough 
investigations, the exact mechanistic background of the precipitation process is not 
conclusively elucidated [14; 28]. To simplify the process, it could be divided in two 
essential steps: During the addition of the organic polymer solution to a miscible 
non-solvent a spontaneous diffusion of the organic solvent into the non-solvent (eventually 
accompanied also by a certain flux of the non-solvent into the organic polymer phase) will 
lead to interfacial turbulences resulting in an immediate dispersion of polymer rich small 
sized nanodroplets. In intimate contact with the non-solvent the polymer precipitation is 
initiated and the final solidification is completed by a slow evaporation of the organic 
solvent [14; 29]. The main prerequisite is the application of an appropriate solvent 
combination of an organic phase with good solubility properties for the used polymer and 
on the other hand an external phase, which needs to be miscible with the organic solvent 
and essentially a non-solvent for the polymer [13]. Various combined systems are 
possible and have been already investigated [13; 30; 31], whereas water is the most 
commonly used external phase. In the current work two very different systems have been 
chosen. Besides the most frequently used combination of acetone and water, a anhydrous 
system should be additionally established, allowing the processing of highly water-soluble 
or water – sensitive compounds [32; 33]. Chloroform and ethanol were chosen based on 
the most promising results of initial screening experiments with several alternative 
combinations, like for example methylene chloride/ethanol, chloroform/ethanol and 
chloroform/heptane. Generally both systems were found to be appropriate for the 
nanoprecipitation of the three investigated polymers. Concluding from the above 
described experiments, the basic feature of nanoprecipitation – small particles with a 
narrow size distribution [13] – was fulfilled for most preparations, which is reflected by 
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particle sizes below 250 nm and PI values rarely exceeding 0.15, whereas values below 
0.1 are commonly obtained for nearly monodisperse particle collectives [20; 34]. 
However, using ethanol as external phase raised some problems, leading to deviations in 
the preparation process (see 2.2.3). In ethanolic environment soft polymer 
nanoprecipitates were formed and any further agitation during the evaporation of 
chloroform was found to provoke uncontrolled aggregation. Moreover a further dialysis 
step is required to remove the ethanol and transfer the particles into an aqueous 
environment, leading to the final solidification of the particles, which then allows their 
recovery via centrifugation.  
Numerous factors already have been described to influence the resulting particles’ 
properties - size, size distribution as well as the encapsulation efficiency and release 
characteristics for drug-loaded particles. Only few of them have been investigated in the 
current work, but single impact factors were found to differ in their degree of effect 
predominantly depending on both, the used polymer type and also the solvent – 
non-solvent system. 
The exact composition of the used solvent – non-solvent system has been reported to 
strongly determine the particles properties (e.g. size and size distribution). However, 
comparison of the results from the different preparation procedures indicate that the 
general rule – the lower the polarity of the non-solvent (expressed by its dielectric 
constant ε0), the higher the particle size [13; 30] – is not generally applicable for all 
polymers, except for particles made of mPEG2PLAY. While PLGA particles did hardly differ 
in size, NH2PEG2PLAY based NPs behave the other way round, yielding bigger particles in 
the more polar water (ε0=80.1 [13]) compared to ethanol (ε0=24.6 [13]). Moreover, despite 
its structural similarity to the mPEG2PLAY copolymers, this polymer type generally seems 
to exhibit a different behaviour (Fig. 5-8), which also will be discussed later. 
Since the particle sizes were reported to be influenced also by the rate of diffusion of the 
solvent into the surrounding non-solvent [13], the impact of the used polymer as well as its 
concentration in the internal phase could significantly contribute to the viscosity of this 
organic polymer solution and consequently also the diffusion and exchange of the solvent 
[13; 35]. Considering the results of the aqueous system (Fig. 5), particle sizes increase at 
same polymer concentration with increasing molecular weight [MW] of the polymer, which 
obviously influences the solution’s viscosity [36]: mPEG2PLA20 (MWexp=24 kDa) < 
mPEG2PLA40 (MWexp=45 kDa) << PLGA (Resomer® 756, MW=76-110 kDa [37]). While 
the impact of MW interestingly changed with exchanging the solvent – non-solvent 
system, the effect of polymer concentration was found to be independent of the used 
precipitation conditions (Fig. 6). Besides the viscosity mediated effect, the polymer 
concentration also determines the number of particle forming polymer molecules 
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(so-called aggregation number) and therefore the resulting particle size, which was 
thoroughly investigated for the similar mPEG5PLA45 copolymers [35; 38].  
Adjusting the polymer concentration between 2 and 0.1 % allows tailoring of particle sizes 
ranging between 220 nm and 50 nm. A further increase in concentration leads to the 
formation of irregular aggregates instead of defined particles. However, the decrease of 
particle size also reduces the quality of the particle collective, displayed by an erratic 
increase of the obtained PIs (Fig. 6). This might be due to the very low number of polymer 
molecules in solution, which is expected to move freely with very low interactions with 
each other. During the precipitation the distribution of the solvent in the external phase will 
take place almost immediately leading to an aggregation of neighbouring molecules, 
whose number may be absolutely arbitrary, thereof increasing the particle polydispersity. 
Interestingly this phenomenon could not be observed in the non-aqueous system, where 
the much slower solidification process may lead to a unification of the size distribution with 
time. 
As diffusion processes are predominantly gradient driven, the volume ratios of solvent and 
non-solvent were expected to contribute significantly to particle size [13; 39], which indeed 
could be proven for the PLGA particles only, with a higher impact in the non-aqueous 
system. A decreased particles size of about 70 to 80 nm could be observed if the external 
phase was provided in four- or eight-fold excess (Fig. 7).  
The addition of a stabilizer to the external phase was found to be essential in case of 
PLGA independent of the used system, in order to prevent the agglomeration or 
coalescence of the precipitate during solvent evaporation. In contrast, both PEG-PLA 
based systems were able to form stable dispersions also in absence of any surfactant, a 
characteristic behaviour of the amphiphilic diblock copolymers  in polar solvents [38; 40]. 
The interaction of the hydrophilic PEG part with the surrounding environment can result in 
a predominant orientation of the PEG blocks to the aggregate surface, surrounding a PLA 
rich core. The resulting structure could also be described as micellar like [38] with the 
PEG chains providing a steric hindrance for the aggregation of the particles. The higher 
zeta potential of PEG-PLA based particles compared to those based on PLGA (Fig. 9) 
commonly proves the existence of less charged PEGylated surfaces [6; 41; 42]. 
Interestingly the surface potential of diblock copolymers decreased if the precipitation 
system was changed from the aqueous to the non-aqueous, which might indicate a 
reduced interaction of the PEG chains with the ethanol compared to water.  
Unexpected was the failure of the nanoparticle formation in the non-aqueous environment 
in presence of only small amounts of Pluronic F68, which again might be explained by the 
changed hardening behaviour in ethanol. First of all, the non-ionic surfactant could 
interfere with the characteristic surface orientation of the PEG since it takes over the 
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surface stabilizing effect and the shielding to the polar environment, leading to a 
subsequent enrichment of PEG within the PLA core. Its well known plasticising properties 
[14; 43]  accompanied by the softening of the particles due to the influx of ethanol could 
lead to a coalescence of the precipitate and finally to the formation of polymer films at the 
bottom of the beaker.  
However, the addition of varying concentrations of Pluronic F68 did not alter the particle 
size obtained of PEG2PLA20 in the aqueous solvent system (Fig. 8, right), which is in line 
with information from literature [41].  
The exchange of the stabilizer type also alters particles sizes and size distributions 
(Fig. 8, left); but no clear trend could be determined as the negatively charged 
substances – SDS and sodium cholate – behave very contrary. Since both, in addition, 
resulted in a significant broadening of the size distribution, they were excluded as 
appropriate candidates for the desired nanoprecipitation system. 
Besides the frequently used biodegradable PLGA and mPEG-PLA polymers 
nanoprecipitation was also investigated using amine group terminated PEG-PLA 
polymers. The basic idea behind was the preparation of amine group bearing 
biodegradable nanoparticles to offer a system, which allows for example targeted 
transport or cellular interaction/uptake via the attachment of suitable ligands [44]. 
Therefore the impact of the amine group on the preparation processes was investigated 
as well. Surprisingly, the particle properties (e.g. size and size distribution) of the 
structural very similar mPEG2PLAY and NH2PEG2PLAY displayed partially pronounced 
differences or even contrary behaviour, which was observed, comparing the different 
solvent – non-solvent systems (Fig. 5), the polymer concentrations (Fig. 6), the volume 
ratios (Fig. 7) as well as the used stabilization system (Fig. 8). However, the 
morphological analysis of the prepared particles could not prove the preceding differences 
in the sizes (Fig. 10). Moreover, a TEM-based size analysis of several particles (Fig. 11) 
instead verified the assumed similarity between mPEG2PLAY and its amine derivative, as 
both showed almost same sizes. Indeed it can be concluded, that the observed 
differences between both polymer types appear to depend on the size determination 
method, where the different PEG derivatives seem to interfere with the analytical principle 
of PCS. The commonly used method for nanoparticle size determination, PCS, usually 
determines the so-called hydrodynamic diameter of particles, which obviously is sensitive 
to interactions of functional groups, e.g. amines, with the surrounding aqueous 
environment. In contrast, an image-based analysis provides an exact diameter, which in 
this case excludes the free diffusion of the contrast agent used for negative staining and 
which usually is slightly smaller than the corresponding PCS size [20; 45; 46]. In case of 
PEGylated nanoparticles it should also be considered, that the brush-like arrangement of 
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the PEG chains will predominantly affect the size in liquid dispersion, due to interactions 
with the polar media (PCS), and not in dried state (conventional TEM). The drying process 
could lead to a much thinner PEG film on the particle surface. Keeping in mind that the 
interaction with the surrounding environment will also influence the thickness of the 
attached water layer, the increased apparent particle size would be more reasonable for 
the hydrophilic, possibly charged primary amine end groups compared to the hydrophobic 
methoxy groups. Although no differences were observed in the surface potential (see 
3.2.5), which can be attributed to the additional water layer on the particles, further 
levelling occurring charges on the particle surfaces. In consequence, the observed 
reduction of the hydrodynamic diameter of NH2PEG2PLA20 particles in the anhydrous 
solvent system suggests a decreased interaction of the NH2–group with ethanol, which 
subsequently could also lead to an altered surface arrangement of the NH2PEG. The 
amine groups are probably not oriented straight away from the particle core, decreasing 
the interactions with the final aqueous dispersion also during PCS measurement. 
Although this phenomenon could not be completely elucidated based on the available 
information, the obtained results should sensibilise to a careful interpretation of particle 
size measurements, especially in case of nanoparticles, which show pronounced 
differences in their size dependent behaviour [20]. 
4.3 Particle cytotoxicity 
Finally, the cytotoxicity of the obtained nanoparticles was tested in different cell types to 
demonstrate the suitability of the prepared biodegradable nanoparticle system for 
applications as DDS or imaging tool. Although the results are only presented for a 
selected number of particle types (Fig. 12), all tested batches were found to be highly 
biocompatible, as significant toxicity appeared only in small number of experiment with 
individual samples, indicating no general impact of the particles tested. 
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5. Summary and Conclusion 
Nanoprecipitation was found to be a well-suited simple method for the preparation of 
nearly monodisperse polymeric nanoparticles from three different polymer types. By 
varying factors such as polymers’ molecular weight, polymer concentration and, to certain 
extent, also the ratio of solvent and non-solvent volumes tailoring of particle size within a 
size range of 50 to 250 nm was achieved. Depending on the used polymer type quite 
similar sizes were obtained in an aqueous and also a non-aqueous procedure, which was 
in contrast to already described investigations, but can be attributed to surface stabilizing 
effects of amphiphilic polymers. Therefore the established methods should be applicable 
for the encapsulation of both, lipophilic as well as highly water-soluble or water-sensitive 
compounds considering the same impact factors. Despite the successful establishment of 
an universal nanoprecipitation procedure, the current findings also reveal some limitations 
of the used analytical procedures for the particle size determination and the nanoparticle 
surface characteristics, especially obvious in case of the used diblock copolymers. Since 
the applied methods – PCS and electrophoretic mobility – are the most commonly used 
methods for nanoparticles characterization, these results should also sensibilise towards a 
critical interpretation of size measurements, which are in particular essential as in-vivo or 
in-vitro nanoparticle behaviour is strongly influenced by their apparent size as well as their 
zeta potential. 
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1. Introduction 
Fluorescence imaging using nanoparticulate systems is done either for diagnostic or 
detection purposes [1; 2] or during investigation and evaluation of the characteristic 
distribution behaviour of their respective drug loaded equivalents [3; 4]. Introduction of an 
appropriately detectable label is a prerequisite and could be done either by encapsulation 
of fluorescently labelled drug molecules [5; 6], the application of fluorescing matrix 
materials [7; 8] or by co-encapsulation of organic fluorescence dyes. The last method is 
the most frequently used one due to the ease of preparation and eventually the parallel 
applicability of unmodified drug molecules or the mere exchange of the labelling 
substance for the drug substance. Commonly used organic fluorophores reported in 
literature are for example coumarin 6, rhodamine 6G or Nile red, which are mainly chosen 
due to their fluorescence or solubility properties [9-13]. In general, the choice of an 
appropriate fluorescent label depends on the used particulate system, the indented 
application and the objective of the study as well as the used detection system. 
In the current work Nile red has been chosen initially as desirable fluorescent probe due to 
several characteristics. By reason of its good solubility in organic solvents [14] and the 
very lipophilic nature, it was expected to allow an easy encapsulation into lipophilic and 
amphiphilic polymers with a high loading capacity, consequently leading to bright 
fluorescing particles. Various applications have been reported using Nile red as lipophilic 
fluorescent probe either as free dye (e.g. for direct staining of lipidic intracellular cell 
components [15; 16]) or in encapsulated form for in-vitro investigations in cell-culture [11; 
17; 18] as well as isolated tissues [3; 19; 20]. With similar emission characteristics like 
other in-vivo applied fluorescent labels (e.g. CdSe quantum dots [21]) in-vivo applications 
of Nile red loaded nanoparticles may also be possible, which would make them a versatile 
and easily applicable tool. 
Using the previously established nanoprecipitation system (Chapter 2), Nile red was 
encapsulated into several different biodegradable polymers, dealing as fluorescent probe 
and furthermore as lipophilic model drug. Impact of particle loading was investigated to 
identify possible alterations in the particle properties due to performed substance 
encapsulation. The applicability of different Nile red loaded nanoparticles was evaluated 
by imaging their behaviour in cellular context as well as after intravenous (i.v.) 
administration in nude mice. Finally the obtained in-vivo results were assessed by 
comparison with an additional fluorescence labelled system with longer emission 
wavelength in the near-infrared region. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Preparation and characterization of nanoparticles 
PLGA 75:25 (Resomer® 756) was obtained as kind gift from Boehringer Ingelheim 
(Boehringer Ingelheim AG, Biberach, Germany). Biodegradable copolymers PEG2PLAY 
and NH2PEG2PLAY (Y=20 and 40) were custom made following an established method as 
described in chapter 2. Nile red (nile blue A oxazone) and Pluronic® F68 were obtained 
from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). 1,1'-
Dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide [DiR] was purchased from 
Invitrogen (Invitrogen GmbH, Karlsruhe, Germany). Sucrose and ethanol (p.a.) were 
purchased from Merck (Merck KGaA, Darmstadt, Germany). Chloroform (p.a.) and 
acetone (p.a.) were obtained from Acros (Acros organics, Fischer scientific GmbH, 
Nidderau, Germany).  
2.1.2 Cell culture 
The CHO-K1 cell line (ATTC code No. CCL-61), the L929 mouse fibroblasts and the 
MCF-7 human breast cancer cell lines were kind gifts of the Department of 
Pharmaceutical Chemistry, University of Regensburg. Fetal bovine serum [FBS] was 
purchased from Biochrom (Biochrom KG, Berlin, Germany). Trypsin-EDTA 0.25 %, 
Dulbecco’s phosphate buffered saline [PBS] and Leibowitz medium L-15 were obtained 
from Invitrogen (Invitrogen GmbH, Karlsruhe, Germany). 3-[4,5-Dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide [MTT] was purchased from AppliChem (AppliChem GmbH, 
Darmstadt, Germany). Monobasic sodium carbonate [Na2HCO3], HAM’s F-12 and Eagle’s 
minimum essential medium [EMEM] were obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemie GmbH, Taufkirchen, Germany). Sodium pyruvate was purchased from Serva 
(Serva Electrophoresis GmbH, Heidelberg, Germany). Triton-X (p.a.) was obtained from 
Merck (Merck KGaA, Darmstadt, Germany). 
2.1.3 In-vivo imaging 
Female hairless and immune competent SHK1-hr mice were obtained from Charles River 
(Charles River Laboratories Inc., Sulzfeld, Germany). 
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2.2 Methods 
2.2.1 Preparation of fluorescing nanoparticles 
Polymeric nanoparticles were prepared following modified nanoprecipitation methods [22] 
in detail established and discussed in chapter 2. Depending on the intended application, 
either the aqueous or the non-aqueous preparation route was used. Generally, a 1 % 
solution of the polymer was prepared in an organic solvent (either acetone or chloroform) 
and an aliquot of a stock solution of the fluorescent marker (either Nile red or DiR) in the 
same solvent was added (the amount was dependent on the intended loading). The final 
volume of the organic phase was generally adjusted to 5 ml. Afterwards this polymer 
solution was added dropwise to 40 ml of the external phase with an immediate formation 
of particles. The external phase differed depending on the used polymer solvent – ethanol 
in case of chloroform (non-aqueous system) and water in case of acetone (aqueous 
system). Afterwards the organic solvent was allowed to evaporate, followed by extended 
dialysis against an aqueous solution of Pluronic F68 (0.1 %) in case of the non-aqueous 
precipitation system. Recovery of the nanoparticles from the aqueous particle dispersions 
was performed via centrifugation (12,500 g, for at least 30 min, 10 °C; Avanti JE 
highspeed centrifuge; Beckman Coulter GmbH, Krefeld, Germany) and finally re-
dispersion in 5 % sucrose. Microparticles and artefacts were removed via filtration 
(< 1 µm). Subsequently nanoparticles were freeze-dried using a lab-scale freeze-dryer 
(Martin Christ Gefriertrocknungsanlagen, Osterode am Harz, Germany). The used 
preparation parameters will be given, as required. 
2.2.2 Determination of particle concentration 
Concentration of nanoparticles in dispersion was usually estimated semiquantitatively 
based on the solid content in an aliquot of the particle dispersions. For the determination 
one aliquot (usually 500 to 1000 µl) of the final dispersion was centrifuged (15,000 g, 
45 min, 10 °C) and the residual sediment was freeze-dried and weighed to determine the 
particle content. 
2.2.3 Fluorescence spectroscopic analysis  
Fluorescence spectra of the marker substances (in organic stock solutions) and the final 
particles (dispersed in aqueous solutions) were measured using a LS 55 
spectrophotometer (PerkinElmer, Waltham, USA), equipped with a red-sensitive R928 
photomultiplier in case of the DiR loaded samples. The measurement parameters differed 
depending on the used fluorescence label, as summarized in table 1. 
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Tab. 1: Instrumental settings for in-vitro fluorescence measurements
Marker Excitation wavelength / 
nm 
Spectrum range /
nm
Detector voltage / 
V 
Nile red 512 530-700 750 
DiR 750 775-900  750 
 
To allow a comparison of different particle batches, the measured intensities were 
subsequently normalized on the pre-determined particle concentration. 
2.2.4 Determination of particle size 
Photon correlation spectroscopy [PCS] was used to determine the hydrodynamic 
diameters and polydispersity indices of the prepared nanoparticles, usually dispersed in 
5 % sucrose. Measurements were performed at 20 °C with a Zetasizer 3000 A (Malvern 
Instruments Inc., Herrenberg, Germany). Results are presented as mean and relative 
standard deviation of three independent measurements. 
2.2.5 Determination of zeta potential 
Zeta potential of nanoparticles, dispersed in water (pH ~6.7) was determined based on so-
called laser Doppler electrophoresis using a Zetasizer 3000 A (Malvern Instruments Inc., 
Herrenberg, Germany). Measurements were performed at 20 °C and results are given as 
mean and relative standard deviation of six independent measurements. 
2.2.6 Cell culture 
The CHO cells were cultured in HAM’s F-12 nutrient mixture, supplemented with 10 % 
FBS. The L929 cell line was cultured in EMEM medium supplemented with 10 % FBS. 
The MCF-7 cells were cultured in EMEM medium supplemented with 5 % FBS. Standard 
cell culture conditions were 37 °C, 95 % relative humidity and 5 % CO2. Growth medium 
was changed every third day. 
2.2.7 Determination of biocompatibility 
Investigation of biocompatibility followed an established procedure [23] using the 
colorimetric MTT assay for quantitative assessment. Acute toxicity of nanoparticles was 
investigated using a direct contact test. Three different cell lines were used, the CHO cells 
(animal derived endothelial cell line), the L929 cells (animal derived fibroblast cell line) 
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and a human cancer cell line, the MCF-7 cells. The general parameters of the assay in 
detail have been given in chapter 2. 
All data were expressed as mean (N=4) and relative standard deviation. Statistic 
significance was assessed by one-way analysis of variances (ANOVA) in conjunction with 
Tukey’s studentized range test using SigmaStat software. 
2.2.8 Imaging of cellular uptake of fluorescently labelled nanoparticles 
Cellular uptake of fluorescently labelled nanoparticles was investigated using MCF-7 cell 
line. Cells were seeded in an 8-well Lab-Tek™ Chambered Coverglass (Nunc, Thermo 
Fisher Scientific, Langenselbold, Germany) with an initial density of 5,000 cells per well 
and grown for 48 h under standard cell culture conditions (given in 2.2.6). Dispersions of 
Nile red loaded particles were prepared by re-suspending the lyophilisate with Leibowitz 
medium and the particle concentration was adjusted to 0.2 mg/ml. After aspiration of the 
supernatant from the seeded cells, 150 µl of the each dispersion was added to one 
chamber, followed by incubation for 30 min at standard cell culture conditions under light 
exclusion. Cellular uptake was documented by confocal laser scanning microscopy 
[CLSM] using a Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning 
device (Carl Zeiss Co. Ltd., Germany). The inverted microscope was equipped with a 
Plan-Apochromate 63x objective. Samples were excited with a 514 nm argon laser and 
fluorescence was detected with a 560 to 615 nm bandpass filter. To attribute for the 
varying fluorescence properties of the used particle batches and to allow a 
semiquantitative comparison of the results, images recorded at equivalent microscopic 
settings were subsequently normalized on the initial fluorescence intensity of the prepared 
particles by image contrast enhancement. 
2.2.9 In-vivo imaging of fluorescently labelled nanoparticles 
The in-vivo behaviour of two differently fluorescently labelled particle types was 
investigated following intravenous administration in nude, female SKH1-hr mice (25 to 
30 g body weight). The in-vivo experiments generally complied with the standards for the 
use of animal subjects as stated in the guideline from the animal care and use committee 
of the Martin Luther University, Halle-Wittenberg, Germany. All mice were housed under 
controlled conditions (12 h light/dark schedule at 24 °C). During the imaging process the 
mice were placed on a 35 °C temperature controlled heating plate to prevent cooling out 
under the anaesthesia. The used narcotic system was an inhalation anaesthesia system 
with a gas mixture of isofluorane/oxygen with an initial flow of 4 % isofluorane (3.0 L/min 
O2) and a steady state flow of 1.8 % isofluorane (1.5 L/min O2). Following re-dispersion of 
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an aliquot (nanoparticles lyophilisate in purified water) the dispersion was isotonized with 
sorbitol and about 100 µl of the dispersion were slowly injected into the tail vein. 
Measuring and imaging of the particles fluorescence signal in-vivo was performed with a 
MaestroTM in-vivo fluorescence imaging system (Cambridge Research & Instrumentation, 
Woburn, MA), equipped with a Cermax®-type 300 Watt Xenon lamp with 5600 K. 
Experimental settings differed slightly depending on the used fluorescence dye (Tab. 2). 
Tab. 2: Instrumental settings for in-vivo fluorescence measurements
Particulate system Excitation filter / 
nm 
Emission filter /
nm
Spectral range /
nm
Exposure time /
ms 
PLGA/Nile red 503-555 Long-pass 580 550-800 1000 
PEG2PLA20/DiR 710-760 Long-pass 800 780-950 800 
 
The reference spectra were obtained from aqueous dispersions of dye loaded 
nanoparticles and the in-vivo background spectra were determined using an untreated 
mouse. Analysis and image generation was performed using the Maestro software 
supplied with the instrument (version 2.10). The stepwise generation of a representative 
unmixed picture is demonstrated in figure 1. In a first step fluorescence signals of the 
mice were recorded in 10 nm steps over the whole spectral range (Tab. 2). This series is 
composed to the so-called cube image. Unmixing of these cubes was done by allocating 
the signal of each pixel either to the background or the desired fluorescent probe. The 
obtained corresponding images were subsequently saved in monochrome format. The 
generated greyscale fluorescence images are then displayed using an intensity weighted 
colour system, where high fluorescence concentrations are displayed in dark red and low 
fluorescence intensity in blue. In between there is an incremental colour gradient from red 
to blue. 
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Cube image Background signal 
Signal of fluorescent 
 probe 
Overlay of background   
and intensity weight  
coloured fluorescence  
image 
 
 
 
     
Fig. 1: In-vivo fluorescence images displayed the step-wise picture analysis procedure  
To allow the comparison and evaluation of the time-dependent processes of particle 
distribution, fluorescence intensities of the obtained images at different time-points after 
NP administration (p.a.) were normalized on the maximum intensity of all pictures. Results 
will be presented using these so-called compare images. 
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3. Results 
Fluorescently labelled nanoparticles were prepared using different biodegradable 
polymers. Factors potentially influencing the particles properties (e.g. polymer type, 
precipitation system and loading) were investigated for the Nile red loaded particles. Both, 
Nile red and DiR loaded nanoparticles were used as fluorescing marker system either in 
cellular context or for small animal imaging. 
3.1 Nile red loaded nanoparticles – PLGA 
3.1.1 Effect of Nile red loading 
Following the non-aqueous precipitation method, loading of the lipophilic PLGA 
nanoparticles with the lipophilic fluorescence dye Nile red was successful over a wide 
loading range, from 0.05 % up to about 2.5 % dye per polymer weight (Fig. 2, left). Only 
in case of highest intended loading with 5 % preparation failed due to particles’ 
flocculation during dialysis.
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Fig. 2: PLGA nanoparticles prepared by nanoprecipitation using ethanol and chloroform, loaded with 
increasing amounts of Nile red – (left) development of maximum fluorescence intensity; (right) development 
of mean particle sizes [nm] and polydispersity index; arrows indicate a failure in particle preparation 
Fluorescence intensities were found to increase steadily with increasing Nile red loadings 
up to 0.3 % and then kept constant with further increase of added dye. Additionally, also 
the maximum emission wavelength shifted from 590 nm to about 608 nm with increasing 
loadings of Nile red. However, neither the mean particle sizes nor the size distributions, 
indicated by the PI of the particles, were affected by the different amounts of added dye 
molecules (Fig. 2, right). 
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3.1.2 Effect of the nanoprecipitation system 
In case of the PLGA particles, only a limited impact of the precipitation system on the 
properties of the obtained particles was found (Fig. 3). Both systems resulted in particles, 
with fluorescence intensities far below the values expected based on the intensity of the 
used organic stock solution. Furthermore, even a constant fluorescence for different 
loadings was found in case of the aqueous precipitation system (Fig. 3, left).
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Fig. 3: PLGA particles prepared by nanoprecipitation using differing systems, loaded with increasing amounts 
of Nile red – (left) development of maximum fluorescence intensity; (right) development of mean particle 
sizes [nm] and polydispersity index 
Particle sizes again were almost independent of the absolute dye loading and the 
precipitation system. The obtained polydispersity indices indicate very small, nearly 
monodisperse size distributions (Fig. 3, right). 
3.2 Nile red loaded nanoparticles – diblock copolymers 
The impact of different process parameters on the properties of particles prepared from 
PEG containing diblock copolymers was exemplarily demonstrated using PEG2PLA40, as 
the effects were found to be similar for all used amphiphilic diblock copolymers. 
Comparable to the results obtained with PLGA, fluorescence intensities of particles were 
far below the expected values, independent of the used precipitation system (Fig. 4, left). 
However, the impact of the absolute loading was found to be higher for the amphiphilic 
polymers, since intensity steadily increased with higher loadings (Fig. 4, right). 
Additionally, the obtained fluorescence intensities, achieved using the non-aqueous 
system, were generally lower than the respective values of the aqueous system. 
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Fig. 4: PEG2PLA40 particles prepared by nanoprecipitation using differing systems, loaded with increasing 
amounts of Nile red – (left) development of maximum fluorescence intensity normalized on theoretical 
maximum value; (right) development of maximum fluorescence intensity normalized on real maximum value 
Particle sizes were predominantly affected by the used precipitation system (Fig. 5). 
Independent of the Nile red loading particles, prepared by the aqueous route were about 
100 nm in diameter. In contrast, the non-aqueous procedure led to clearly higher particle 
sizes, above 200 nm, which additionally slightly increased with increasing dye load. 
Indeed, both processes resulted in still very narrow size distributions, indicated by PIs 
below 0.1. 
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Fig. 5: Mean particle sizes [nm] and polydispersity indices of PEG2PLA40 particles loaded with increasing 
amounts of Nile red prepared by nanoprecipitation using different systems 
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3.3 Biocompatibility of fluorescently labelled nanoparticles  
Biocompatibility of fluorescently loaded nanoparticles was tested using different cell lines. 
Prior to application, tests were usually performed using L929 and CHO cells. Independent 
of the dye loading (either with Nile red or DiR), cytotoxicity generally was found to be very 
low, which is expressed by high relative cell viabilities around 100 %.  
In case of PLGA particles, loaded with increasing amounts of Nile red (Fig. 6), only the 
batch with 2.5 % loading showed a significant toxicity in CHO cells at the highest 
concentration (Fig. 6, right). 
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Fig. 6: Viability of (left) L929 cells and (right) CHO cells after incubation (4 h) with PLGA nanoparticles loaded 
with increasing amounts of Nile red, prepared via the non-aqueous system; star indicate significant toxicity 
compared to the respective negative control (p<0.05); legend applicable for both diagrams 
Since MCF-7 cells were used for the cellular uptake studies, cytotoxicity in this cell line 
was also tested for the used particles (all loaded with 0.15 % Nile red). Statistically 
different toxicity was found only in for highest concentrations of PEG2PLA20 particles with 
still remaining viability over 85 % (Fig. 7). 
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Fig. 7: Viability of MCF-7 cells after incubation (4 h) with nanoparticles prepared of different polymers loaded 
with 0.15 % Nile red; star indicates significant toxicity compared to the respective negative control (p<0.05) 
PEG2PLA40 particles, loaded with 1 % DiR and prepared following the aqueous procedure, 
which have been used for the small animal imaging, also caused statistically significant 
toxicity (again with remaining viability still above 80 %) in CHO cells but not in L929 cells 
(Fig. 8). 
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Fig. 8: Viability of L929 cells and CHO cells after incubation (4 h) with PEG2PLA40 nanoparticles loaded with 
1 % DiR, prepared via the aqueous precipitation route; star indicates significantly reduced viability compared 
to the respective negative control (p<0.05) 
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3.4 Imaging of cellular uptake 
The behaviour of nanoparticles prepared from different biodegradable polymers was 
investigated by imaging their cellular uptake in MCF-7 cells. The used particles differed in 
their polymer matrix, but also in basic particle properties, such as size and fluorescence 
intensity, as summarized in table 3. 
Tab. 3: Properties of Nile red loaded particles used for cellular uptake experiments
Polymer Precipitation 
system 
Initial loading / 
 
% 
Fluorescence 
intensity 
Mean particle 
size (± SD) / 
nm 
Zeta potential 
(± SD ) / 
 mV 
PLGA Chloroform/ ethanol 0.15 323 123.3 (0.6) -53.2 (0.9) 
PEG2PLA20 Acetone/water 0.15 304 79.6 (0.3) -25 (2.1) 
NH2PEG2PLA20
Chloroform/ 
ethanol 0.15 132 123.7 (0.7) -41 (1.7) 
PEG2PLA40 Acetone/water 0.15 683 99.5 (0.6) -32 (5.3) 
NH2PEG2PLA40
Chloroform/ 
ethanol 0.15 110 101.2 (0.2) -40 (1.7) 
 
Polydispersity indices for all used particles were well below 0.1, indicating overall very 
small size distributions. 
Originally obtained CLSM images have been normalized on the fluorescence intensity of 
the used particle batch to contribute the mentioned differing optical properties and to allow 
an estimation of the particle immanent factors affecting the results of the interaction of 
particles with the cells. Indicated by the thereof obtained different intensities in the 
pictures, extent of intracellular accumulation of the fluorescence differed depending on the 
used polymer type (Fig. 9). 
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Fig. 9: CLSM images of MCF-7 cells after incubation (30 min) with Nile red loaded particles prepared of (A) 
PLGA; (B) PEG2PLA20, (C) NH2PEG2PLA20, (D) PEG2PLA40 and (E) NH2PEG2PLA40; inserts represent 
corresponding brightfield images; scale bars correspond to 20 µm 
Based on optical evaluation, highest intensities were found for cells incubated with 
PEG2PLA20 and NH2PEG2PLA20 particles, followed by PLGA nanoparticles and lowest 
values appeared in case of PEG2PLA40 and NH2PEG2PLA40. Overall no fluorescence was 
apparent in the cell nuclei (dark round areas within the cells). However, the cellular 
membranes between neighbouring cells seem to be clearly stained for all used polymers. 
3.5 In-vivo imaging  
Small animal imaging was performed after i.v. injection of the particles suspended in 
isotonic dispersions. Basically two different particle systems were compared – PLGA 
particles loaded with 0.3 % Nile red (mean particle size of 135 nm) and PEG2PLA40 
particles loaded with 1 % DiR (mean particle size of 150 nm). Time-dependent distribution 
behaviour was investigated by repeated imaging over a certain time and the obtained 
results are presented as compare images, obtained as described in 2.2.9. 
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Following the intravenous application fluorescence signal of Nile red was rapidly 
distributed within the whole animal body (Fig. 10) and starts to accumulate predominantly 
in the gall bladder. Within 15 and 37 min after injection fluorescence intensity in gall 
bladder reached almost maximum values, followed by an accumulation in the urinary 
bladder. 55 min after injection Nile red signal is detectable in urinary bladder only.  
 6 min p.a.  15 min p.a.  37 min p.a.  55 min p.a.  
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Fig. 10: In-vivo fluorescence images of nude female mice at certain time points after i.v. administration (p.a.) 
of PLGA nanoparticles loaded with 0.3 % Nile red; arrows indicate distinct organs: (a) gall bladder and (b) 
urinary bladder 
In case of the DiR loaded PEG2PLA40 particles differing result were obtained (Fig. 11). 
Following an initial rapid distribution phase, accumulation, apparent within 7 min after 
injection, is almost restricted to the liver during the first 40 min and then fluorescence 
could be also detected in the spleen. Nevertheless, circulating particles could be detected 
even 24 h after injection in regions outside spleen and liver, indicated by the blue staining 
of the animal’s body. 
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Fig. 11: In-vivo fluorescence images of female nude mice at certain time points after i.v. administration (p.a.) 
of PEG2PLA40 nanoparticles loaded with 1 % DiR; arrows indicate distinct organs: (a) liver and (b) spleen 
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4. Discussion 
Nanoparticles gain more and more attention in biomedical applications and are also 
widely used for imaging applications, either for diagnostic purposes or as model systems 
to visualize the distribution of their respective drug loaded equivalents.  
The main focus of this chapter was the evaluation of the established nanoparticulate 
system with respect to a potential application for fluorescence imaging purposes. 
Focussed on plain particles several impact factors already have been thoroughly 
investigated to allow tailoring of suitable particles with desired properties (chapter 2). 
However, also the encapsulation of different dye compounds could alter the particles 
properties and obviously needs to be evaluated before each application. Respective 
fluorescence labelling of particles was done by encapsulation of the lipophilic fluorescent 
dye Nile red, and various dye loadings were investigated with respect to their impact on 
the particles properties and for identification of optimal conditions for in-vitro and in-vivo 
imaging.  
Generally, the encapsulation of the lipophilic Nile red was successful in all used polymers 
and almost independent of the used solvent – non-solvent system. However, the 
properties of the obtained particles differed depending on the applied preparation 
conditions. First of all, the effect of Nile red loading on particle size was almost negligible 
over a wide range of concentrations (Fig. 2, right; Fig. 3, right; Fig. 5). The differences 
observed using different polymers and varying precipitation systems (Fig. 3, right; Fig. 5) 
were almost equal to the behaviour of unloaded nanoparticles, as presented in chapter 2. 
In general the effect of substance load on particles size varied due to the properties of the 
used compound, the matrix material and also the chosen preparation method [24-27]. 
Indeed, the initial absolute drug load is usually not among the main factors influencing the 
resulting particles size. This could deal as indication for a very homogenous distribution of 
the lipophilic Nile red dye within the used polymeric matrices already in the polymer 
solution due to intense interactions between the polymer and the dye. Principally it could 
be expected that nanoparticles with encapsulated compounds, which are well dissolved in 
the polymer matrix, are less affected by increased loadings compared to systems 
containing particulate substances in solid state, which obviously require a higher space 
during the particle formation.  
In this context also the encapsulation efficiency of the dye needs to be considered, which 
obviously determines the particles fluorescence intensity, and therefore might deal as 
indicator for the amount of encapsulated dye. At first, it is remarkable that the overall 
fluorescence intensities of Nile red loaded particles are far below the values expected 
from comparisons with organic stock solutions containing equal concentrations of the dye 
(Fig. 3, left; Fig. 4, left). This would mean overall very bad encapsulation efficiencies of 
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about only 3 % in the best case, which was unexpected considering the lipophilic nature of 
both the dye and the matrix polymer. Additionally, at least the used aqueous 
nanoprecipitation method has been reported to be well-suited for the processing of 
lipophilic substances [22; 27; 28]. Indeed, the low fluorescence intensities following the 
encapsulation might be attributed to a quenching of the solid polymer matrix as well as a 
“self”-quenching of neighbouring dye molecules due to the high loading density [29-31]. 
Considering both of these possible effects, the determined intensities could hardly be 
used as measure for the absolute amount of encapsulated compound. However, an 
estimation of relative values is still possible, allowing the comparison of different batches 
and particle types. The results obtained also show a differing behaviour of lipophilic PLGA 
and the amphiphilic copolymers. While PLGA matrices seem to be dye saturated, if the 
initial loading exceeds 0.3 % (Fig. 2, left; Fig. 3, left), and no further increase in 
fluorescence intensity could be observed. The loading and the resulting fluorescence 
intensity increased in case of the PEG2PLA40 particles with theoretical loadings up to 
2.5 % without reaching a plateau of the fluorescence. Comparing the absolute measured 
intensities it was found that the overall highest values were reached for PEG2PLA40 
particles prepared by the aqueous solvent – non-solvent system (Tab. 4). However, this 
does not necessarily mean that also the highest dye amounts are encapsulated in these 
particles, since the various polymeric matrices could significantly differ in their optical 
behaviour. 
Tab. 4: Mean fluorescence intensities (± SD) of Nile red loaded nanoparticles in aqueous dispersion (1 mg/ml)
PLGA PEG2PLA40
Chloroform/ethanol Chloroform/ethanol Acetone/water 
0.6 % 1 % 2.5 % 0.6 % 1 % 2.5 % 0.6 % 1 % 2.5 % 
873.37 
(22.25) 
781.88 
(11.90) 
695.70 
(33.55)  
232.17 
(2.18) 
385.35 
(5.8) 
622.68 
(32.08) 
614.00 
(39.31) 
1011.78 
(18.08) 
1366.70 
(80.33) 
 
Considering the absolute values, encapsulation efficiency and resulting fluorescence 
intensity is not only affected by the polymer type, but moreover also by the used solvent 
non-solvent system. The decrease in intensity in the non-aqueous environment could be 
attributed to the higher solubility of Nile red in the ethanolic external phase, leading to a 
pronounced dye loss from precipitated particles during the evaporation of chloroform. This 
is in line with reports on a nearly 1000fold increase in Nile red’s solubility by changing the 
dissolution medium from aqueous to organic (i.e. acetone) [14]. Interestingly this effect 
was much higher in case of the amphiphilic copolymers, as the intensities of differently 
loaded PLGA based particles prepared in the different solvent – non-solvent systems 
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showed only minute differences (Fig. 3, left). This additional impact of the polymer matrix 
may be explained by the softer and more sponge-like structure of the diblock copolymer 
nanoparticles, already discussed in chapter 2. It allows the penetration of ethanol and 
subsequent enhanced dissolution of dye from the particles, leading to a higher loss of 
fluorescence in the non-aqueous system.  
Although only a limited part of the different process steps was investigated, the obtained 
results clearly demonstrate the complex nature of the nano-encapsulation processes, 
whose results are a product of numerous interactions, for example between dye and 
matrix materials as well as between dye and the different solvents or liquids used. Usually 
such factors have to be thoroughly investigated in case of drug loaded systems in order to 
successfully optimize the results for each investigated drug compound. Furthermore, such 
factors also will have to be considered, if an appropriate model system for imaging 
purposes is requested. Here an optimal transfer of the imaging results would ideally 
require identical properties of both the original drug loaded particles and the investigated 
dye loaded model systems. 
Despite the high variability in the resulting particle fluorescence, the particles with initial 
loadings ranging between 0.15 and 0.6 % were found to be sufficiently bright for all 
intended imaging purposes, which were subsequently performed with individual batches. 
Additionally, all investigated batches demonstrated a high biocompatibility of the Nile red 
loaded nanoparticles in various tested cell types (Fig. 6; Fig. 7) independent of used 
matrix, the loading or the applied solvent – non-solvent system, which obviously allows 
their universal use as imaging tool in various cellular contexts. 
The performance of the polymeric nanoparticles in cellular context was investigated using 
a human breast cancer cell line, MCF-7 cells, which is a well-established system for 
evaluation of the efficiency of various antitumor drugs and their respective delivery 
systems, including various nanoparticulate formulations [10; 32-34]. Uptake of the 
nanoparticles prepared from differing matrix materials by MCF-7 cells has been already 
reported [32-35] and could also be demonstrated for all five polymer types investigated 
herein. The batches were chosen with respect to the obtained particle size based on PCS 
measurements, which should be around 100 nm for all polymers, which explains the 
different used preparation procedures (Tab. 3). This approach should minimize additional 
effects of differing particles sizes and only the impact of particle nature or polymer type 
should be observed. Following the incubation of cells with the different Nile red loaded 
nanoparticles (for 30 min), the dye fluorescence could be detected for all polymers. It was 
localized within the cytoplasm or in the region of the cellular membranes (Fig. 9). The 
fluorescence observed in the cytoplasm was attributed to individual or aggregated 
nanoparticles and the observed intensities differed largely depending on the particle types 
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(complete in-vitro properties are summarized in table 3). Observed differences in the 
normalized fluorescence intensity could not be allocated to one certain factor, as the 
particles taken up to the highest extent, were prepared from PEG2PLA20 and 
NH2PEG2PLA20 and these particles differed in two properties, their particle size (about 
40 nm) as well as their zeta potential (about 10 mV). 
Various investigations about factors influencing the cellular uptake of drug loaded 
nanoparticles can be found in literature [36-41]. The there discussed key parameters 
include the particle size, the surface charge and the surface decoration with other 
coatings (e.g. the amount of stabilizers and/or targeting sequences). In summary it could 
be said that the here observed particle behaviour could hardly be attributed to one specific 
factor, moreover several parameters were responsible to varying extents. 
Focussing on the impact of zeta potential, it was reported to be more important for smaller 
particles (comparing 250 nm and 100 nm species) [42], whereas further studies also 
reported almost no impact of the zeta potential [33]. Focussing on the particle size, usually 
smaller particles are taken up to a higher extent, however, the differences between the 
investigated sizes were usually more prominent comparing particles with sizes of 150 nm 
and several micrometer [37; 41; 43]. Also the molecular weight of the surface decorating 
PEG block in case of PEGylated nanoparticles was found to change the specific cellular 
response in certain cell types [44], but this is not applicable for the current results, where 
only one PEG type (2 kDa) was investigated. Additionally, it has to be mentioned that both 
used types of diblock copolymers probably differ significantly in the PEG surface density, 
which is indicated by their zeta potentials. This effect has to be attributed to differing 
preparation methods, which were used in order to prepare similar sized particles. In line 
with the discussion in chapter 2 and as mentioned above, the NH2PEG2PLAY based 
particles (prepared with the non-aqueous route) were found to exhibit an even more 
negative surface potential than the respective mPEG-derivatives (prepared via the 
aqueous procedure). This could deal as an indication for a reduced interaction of the 
NH2PEG with the ethanolic environment, which consequently did not favour the outward 
orientation of the PEG chains, leading to a reduced shielding of the negative zeta 
potential.  
Overall it was demonstrated that the cellular uptake is a very complex process and its 
elucidation still is in the focus of ongoing research. Furthermore, the limited results 
presented herein allow no thorough discussion of all obvious impact factors, which would 
necessitate a more comprehensive investigation of cellular uptake for different polymer 
types and also preparation methods as performed in chapter 2 for the particles sizes and 
fluorescence properties, which is obviously out of the scope of this work. 
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As mentioned above also the cell membranes were strongly fluorescing (Fig. 9), which 
could eventually be attributed to a high density of nanoparticles in the outer region of the 
cytoplasm. However, a very recently published work also used Nile red for the 
investigation of the in-vitro transfer of lipophilic compounds between different lipid 
particles [45]. Considering that similar phenomena are rather likely to occur also in cellular 
context, this would lead to a pronounced accumulation of the free dye in the double layer 
of the lipid cell membrane, which additionally hampers the discussion of the uptake 
results.  
The limitations of the dye Nile red as marker substance for imaging of drug delivery 
systems became even more obvious by the results obtained from in-vivo imaging 
(Fig. 10). Generally the Nile red fluorescence was initially very well distributed within 
mouse body following i.v. administration of the PLGA nanoparticles. However, since a 
significant release of the fluorescence dye was already observed in-vitro, it is questionable 
whether the obtained signal could be attributed to the Nile red loaded nanoparticles or to 
released dye molecules in lipophilic cellular contexts or tissues. Both have to be critically 
discussed in the following. 
First of all the time-dependent distribution of the in-vivo fluorescence signal in circulation 
is comparable to other investigations of polymeric nanoparticles with unmodified surfaces 
[46-48]. Additionally Nile red is almost exclusively fluorescing in lipophilic environments 
[14] Therefore, at the first glance, the fraction of the detected fluorescence might be very 
well attributed to Nile red still incorporated in lipophilic PLGA particles. In that case, the 
very fast elimination of fluorescence, occurring within 1 h after administration, could be 
attributed to an strong activation of the reticuloendothelial system [RES] following 
opsonisation of the unmodified (‘naked’) particles [46]. However, there are two main 
factors/observations weakening this assumption: the spectral properties of the 
fluorescence signal and the observed fluorescence’ body distribution. At first, the Nile red 
fluorescence spectrum extracted from in-vivo data is not similar to the respective in-vitro 
curves (Fig. 12). This indicates an alteration of the dye loaded particles or a leakage of 
the dye to different lipophilic areas, since Nile red is known for its pronounced 
solvatochromatic properties with changing fluorescence depending on the hydrophobicity 
of its environment [14]. Additionally the observed blue-shift of the maximum emission 
wavelength (Δλem ~ 20 nm) complicates the separation of measured fluorescence from the 
background signal, which obviously further hampers the image processing. 
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Fig. 12: Normalized fluorescence spectra of Nile red loaded PLGA nanoparticles measured either in-vitro or 
in-vivo  
As mentioned above also the observed tissue distribution of the fluorescence has to be 
taken into consideration for the final evaluation. Obviously there is pronounced 
accumulation of the fluorescence also in the bladder. Keeping in mind the renal filtration 
threshold [49], an accumulation of solid PLGA particles (sizes above 100 nm) will be 
rather unlikely. Therefore the results might also indicate a significant dye loss during the 
investigation, which becomes either bound to endogenous substances with significant 
renal filtration or the dye even gets metabolized.  
Additionally, it is very remarkable that no fluorescence at all could be detected in the liver 
or spleen (Fig. 10), which is in contrast to the above mentioned participation of the RES in 
the elimination of unmodified particles [46]. However, the observed lack of particle 
accumulation in the liver can also be attributed to other hurdles for the detection. 
Considering the Nile red fluorescence spectrum, it is very likely that the particles could not 
be visualized as the main fluorescence will be absorbed by the extraordinary high 
amounts of haemoglobin present in these RES organs, which exhibit their maximum 
absorption in the spectral range of Nile red’s λem (Fig. 13). Overall, this discussion points 
out the numerous of factors, which need to be considered during the development of 
appropriate imaging systems and furthermore show the limited applicability of Nile red as 
fluorescence marker for in-vivo investigations. 
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Fig. 13: Wavelength dependent absorption coefficient of haemoglobin (Hb), oxyhaemoglobin (HbO2) and 
water; demonstration of the near-infrared window appropriate for in-vivo imaging [50] 
In general the alternatively used near infrared [NIR] light is much better suited for the non-
invasive in-vivo imaging, furthermore allowing also the imaging of deeper tissue regions 
(>500 µm) [50]. Therefore the second nanoparticulate system was loaded with DiR as 
lipophilic marker, exhibiting a λem of about 788 nm. For this dye the partition between 
lipophilic phases, as observed with Nile red, was expected to occur to a much lower 
extent. For example, due to the higher lipophilicity of the DiR (logPNile red ~5 [16]; logPDiR 
~18 [51]) a transfer between lipophilic areas with bridging of hydrophilic barriers should be 
rather unlikely and additionally no shift in the λem was detectable during the experiment, 
when comparing the DiR spectra obtained either in-vivo or in-vitro (data not shown). 
PEG2PLA40 particles loaded with 1 % DiR were successfully used to demonstrate an in-
vivo particle distribution and their improved fluorescence properties even allowed the 
visualization of individual blood vessels near the animal’s skin during the first 4 h following 
i.v. injection (Fig. 14). 
 
Fig. 14: Inverted grey-scale fluorescence image of a female nude mouse 30 min p.a. of DiR loaded 
PEG2PLA40 nanoparticles; dark regions indicate areas with high fluorescence intensity 
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The time-dependent results differed significantly from the above described Nile red 
observations (Fig. 11). Following a fast distribution phase a pronounced accumulation 
could be observed in the liver, which was somehow surprising as particles with a PEG 
layer on the surfaces have been reported to reduce the activation of RES due to a 
reduced opsonisation, leading to reduced liver uptake, although this can be never 
completely avoided [44; 46; 52]. Nevertheless, a typical increase in circulation time 
compared to uncoated particles, could be observed by a significant fluorescence in the 
circulation (outside the liver) also 24 h after administration of the particles. This 
inconsistence may be attributed to an inhomogeneous PEG distribution on the particles 
surfaces, here particles with only partial and imperfect coating would be identified by the 
RES and eliminated immediately [53] and the perfectly coated ones would be able to 
circulate up to several days. An identification of the surface coating or a separation of the 
different particle species would obviously be of utmost importance here to elucidate the 
observed differences between the eliminated and long circulating particles species. 
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5. Summary and Conclusion 
The previously established nanoprecipitation method was successfully applied for the 
encapsulation of two lipophilic organic fluorescence dyes in order to provide fluorescing 
nanoparticles. Dealing as a lipophilic label or model drug, Nile red was found to have only 
limited impact on the resulting particle size or surface characteristics, as the obtained 
particles were quite similar to unloaded control particles. This probably indicates a 
homogenous distribution of the dye or even its complete dissolution in the polymer matrix.  
Although the adjustment of the fluorescence intensity with varying dye loading was limited 
to a certain extent, the nanoparticles, in general were found to be suitable for different 
imaging purposes. However, several observed drawbacks might limit their common 
applicability: A “bleeding” of dye, leading to a decrease in signal intensity, accompanied 
by a transfer to other surrounding lipophilic areas hampers an image based allocation of 
the obtained fluorescence signal to the investigated nanoparticulate system. During 
in-vivo imaging applications, moreover, the fluorescence of Nile red might be quenched by 
endogenous compounds, like haemoglobin, wherefore an assessment of the 
nanoparticle’s fate would be rather unreliable. 
These dye inherent limitations were successfully overcome by exchanging Nile red for the 
even more lipophilic near-infrared dye DiR. The DiR loaded nanoparticles proved to be an 
ideal tool, especially for in-vivo applications, allowing the imaging of whole body particle 
distributions as well as the imaging of deeper tissue regions. 
Application of the nanoprecipitation method for the encapsulation of other compounds, 
either marker or drug substances, will require a careful assessment and in general the 
investigation of particles’ properties in each single case, as the complex interaction of 
matrix material, the precipitation system and the encapsulated compound will always 
determine the properties of the final product. In case of the DiR particles the impact of the 
processing factors were assumed to be very similar to Nile red as both exhibit comparable 
solubilities. 
Fluorescence labelling of nanoparticles by nanoprecipitation could be easily achieved and 
the results obtained in cell culture and during in-vivo imaging generally demonstrate their 
potential for the evaluation of different nanoparticulate systems. Indeed, the interpretation 
of the obtained results will be strongly dependent on the choice of an appropriate label, 
which is especially apparent from the results for the Nile red labelled systems.  
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 Synthesis and Characterization of CdSe Quantum Dots 
1. Introduction 
Quantum dots, semiconductor nanocrystals in sizes ranging from 3 to 15 nm, are 
characterized by their unique optical properties resulting from the so-called quantum 
confinement [1; 2]. Their composition and size tuneable, bright fluorescence accompanied 
by narrow emission spectra, broad absorbance spectra and high quantum yields made 
them desirable fluorescent probes, which outclass organic fluorescence dyes also due to 
their high photostability [3; 4]. Besides their application in optoelectronic devices or lasers 
[5-7] tremendous work has been done establishing their use as stable and secure 
fluorescence labels in bio-imaging or diagnostics, which can also be attributed to their 
particulate character that allows the attachment of several, also differing, ligands to a 
single fluorophor [8-12]. Various types of such nanocrystals are available differing in 
composition, shape or surface characteristics, all determining their exact properties and 
subsequent potential applications (Fig. 1).
Fig. 1: Overview about light emitting properties of differently composed quantum dots and respective area of 
application [13] 
In the present work CdSe quantum dots have been chosen, as they are easy to 
synthesize with maximum emission wavelengths spanning a broad range of the visible 
spectrum. Therefore they could allow detection with commonly available fluorescence and 
confocal laser scanning microscopes applied for in-vitro investigations [9; 14], but 
furthermore might also be used for in-vivo small animal imaging [15; 16], which is only 
limited by the tissue interaction of the exciting and the emitted light [17; 18]. Besides 
focusing on the reproducible synthesis and purification of the CdSe quantum dots with 
emission wavelengths above 600 nm, also possibilities for the further stabilization or even 
increase of their initial photoluminescence [PL] properties have been investigated. This 
was essential since their application as particulate labels requires further processing 
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steps, including mechanical stress to the crystal surface or encapsulation into optical 
denser materials, which most likely will be at the expense of their initial 
photoluminescence and therefore reducing the later achievable detection limits. Several 
approaches to improve the luminescence stability have been described in literature. The 
most commonly used one, is the on-growth of an additional inorganic shell of a wide-band 
gap semiconductor, usually ZnS, on the primary CdSe core [19]. However, in the current 
work first attempts using these core/shell systems failed during initial screening 
experiments due to the immanent complexity of the two step synthesis, wherefore further 
effort was spent on modifying simple CdSe quantum dots with additional organic capping 
ligands, which should also ease the subsequent encapsulation of the inorganic 
nanocrystals in the polymeric particles due to a better interaction with the polymeric 
matrix. By using capping ligands with a hydrophilic character [20-22] this is an usually 
done process to obtain water dispersible quantum dots or allow the further attachment of 
targeting ligands [13; 23]. Herein the performed ligand exchange experiments were 
focussed on mainly lipophilic coating agents since the prepared CdSe quantum dots are 
later encapsulated into lipophilic or at least amphiphilic polymer matrices. Using an 
established synthesis route, CdSe quantum dots were investigated and modified to 
identify the most promising candidates allowing further processing. 
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2. Materials and Methods 
2.1 Materials 
Cadmiumoxide [CdO] (99.99+ %), anhydrous cadmium chloride, elemental selenium 
(99.5 %, 100 mesh), oleic acid (techn.), trioctylphosphine [TOP] (90 %), octadecene 
(90 %), 2-mercaptoethanol, allylamine (>99 %), dodecylamine (>98 %) and oleylamine 
(70 %) were obtained from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Taufkirchen, 
Germany). Chloroform (p.a.), hexane (p.a.) and acetone (p.a.) were obtained from Acros 
(Acros Organics, Fischer scientific GmbH, Nidderau, Germany). Ethanol (p.a.), methanol 
(p.a.), isopropanol (p.a.) and nitric acid (65 %) were provided from Merck (Merck KGaA, 
Darmstadt, Germany). 
2.2 Methods 
2.2.1 Synthesis of CdSe Quantum Dots 
Unmodified CdSe quantum dots were synthesized according a simple organometallic 
route described in literature using precursor solutions of Cd and Se in hot, coordinating 
organic solvents [24-26]. 
The Se-precursor was prepared by mixing 16 mg (0.203 mmol) Se powder with 0.72 ml 
TOP under agitation until a clear colourless solution was obtained. For the second, the 
Cd-precursor 51 mg (0.397 mmol) CdO, 20 ml octadecene and 2 ml oleic acid were mixed 
in a three neck flask. Under N2 atmosphere the mixture was heated up to 230 °C using a 
heating mantle with controller (Isopad TD 2000; Tyco Thermal Controls GmbH, 
Heidelberg, Germany) until all substances were dissolved. Afterwards the Se–TOP was 
injected at once to initiate the CdSe crystal nucleation, temperature of the heating mantle 
was decreased to 220 °C and crystals were allowed to grow for certain time, 60 min 
standard, and then finally cooled down to room temperature. 
Crystal growth kinetic was monitored by determination of their sizes (derived from their 
absorption wavelengths) as well as the quantum yields [QY] every 5 min during synthesis. 
2.2.2 Coating of CdSe Quantum Dots 
After their synthesis original CdSe quantum dots were treated with several organic 
ligands. By comparing different ligands, described in literature [19; 27; 28], standard 
coating conditions were determined with respect to each kind of coating, namely the 
coating temperature and the duration of coating, as summarized in table 1.  
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Tab. 1: Lipophilic ligands and applied conditions used for coating of CdSe Quantum Dots 
Ligand Temperature Atmosphere 
Max. coating 
duration 
2-Mercaptoethanol  room temperature normal 24 h 
 OHSH  60 °C N2 24 h 
Allylamine  room temperature N2 24 h 
 
CH2
NH2 -- --  
Dodecylamine  room temperature N2 24 h 
 NH2CH3  85 °C N2 24 h 
Oleylamine  room temperature N2 24 h 
 NH2CH3  100 °C N2 24 h 
 
In brief, an aliquot of the unpurified CdSe dispersions derived from synthesis was put in a 
three neck flask. The five-fold volume of the respective ligand was added under N2 
atmosphere (if applicable). In the case of increased temperatures the systems were 
heated up to the desired temperature and temperature was kept over 24 h. Temperature 
was controlled using a heating mantle with controller. The coating process was monitored 
by determination of the quantum yields during the coating process.  
2.2.3 Purification of the Quantum Dot dispersion 
Prior to analysis or further application, the CdSe raw dispersions were purified, unless 
otherwise stated. Different literature described methods [29-31] were compared with 
respect to their effect on PL properties and recovery. An aliquot of the coated quantum dot 
raw dispersion was mixed with an at least 30-fold excess of a polar organic solvent (e.g. 
acetone, ethanol, isopropanol/methanol, methanol) to induce the precipitation of the 
lipophilic nanocrystals. Each solvent was tested either alone or in combination with the 
quantum dot compatible solvent hexane as stabilizer, according a procedure previously 
introduced at the Department of Pharmaceutical Technology. After centrifugation 
(10,000 g, 20 min, 10 °C) using a high-speed centrifuge (Avanti JE centrifuge; Beckman 
Coulter GmbH, Krefeld, Germany) the supernatant was discarded and the obtained 
sediment was re-dispersed in CHCl3 for all preparations. 
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2.2.4 Spectroscopic analysis 
All quantum dot batches were characterized regarding their absorbance, maximum 
emission wavelength λem and quantum yield prior and after their purification. 
Measurements were performed in chloroform dispersions using 1 cm path length quartz 
cuvettes. 
Absorbance spectra of the quantum dots (380 to 700 nm) were determined with a two-
beam spectrophotometer (UVIKON 941; Kontron Instruments, Germany). Fluorescence 
emission spectra were recorded using a LS 55 spectrophotometer (PerkinElmer, 
Waltham, USA) over the range of 500 to 700 nm with an excitation wavelength of 400 nm. 
The relative quantum yield Φ generally was determined by comparing wavelength 
integrated fluorescence intensity of an unknown sample to that of a well known standard 
[32]. The fluorescence standard used was oxazine 170 perchlorate in ethanolic solution 
(ΦSt = 0.6) [33]. Calculation was based on the following equation [33]:  
  
2
*** ⎟⎟⎠
⎞
⎜⎜⎝
⎛Φ=Φ
St
St
St
St n
n
F
F
A
A
; (1)
 
with the integrated area under the corrected fluorescence spectrum A, the fraction of light 
absorbed at excitation wavelength F (applied: 400 nm) and the refractive index n of the 
solvent or dispersion medium respectively. The subscript “St” denotes the values of the 
used fluorescence standard. Optical density of the investigated samples was set within 
the range of 0.01 to 0.1 to avoid inner filter effects. 
2.2.5 Determination of nanocrystals size and molar concentration 
Size and absorbance coefficient of uncoated and coated CdSe quantum dots in dispersion 
were determined based on the lowest energy excitonic peak at λa in their absorbance 
spectra (Fig. 2). 
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Fig. 2: Exemplary UV absorbance spectrum of CdSe quantum dots and definition of λa 
The relationship between the achieved particle diameter d and its λa, as well as the 
dependence of the absorbance coefficient εab on the particle sizes was reported in 
literature based on the evaluation of particles using TEM as well as absorbance 
spectroscopy. The following empirically derived equations are generally used for the 
calculation of the particle size and absorbance coefficient of CdSe quantum dots, 
respectively [34]: 
   
57.41)4277.0(
)106242.1()106575.2()106112.1( 233649
+
−∗+∗−∗= −−−
a
aaaCdSed
λ
λλλ (2)
  ; 56.2*5867 dab =ε (3)
 
with the mean diameter of CdSe quantum dots dCdSe [nm], the lowest energy excitonic 
peak λa [nm] and the decadic molar absorbance coefficient εab [L/mol*cm]. 
The subsequent molar concentration of CdSe quantum dots in dispersion was calculated 
based on Lambert Beer´s law using the determined absorbance coefficient and the 
measured absorbance of the samples [35]: 
  
d
Ac
ab *ε=
; (4)
 
with the absorbance of the sample A, the concentration of quantum dots in the sample 
c [mol/L], the length of penetrated medium d [cm] and decadic molar absorbance 
coefficient εab  [L/mol*cm]. 
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2.2.6 Calculation of theoretical – UV-based amount of Cd and Se 
Based on the mean size of the synthesized CdSe quantum dots determined using their 
characteristic UV absorbance (see 2.2.5) the molar amount of Cd and Se atoms per mol 
nanocrystals was calculated assuming their preferential crystallisation in the wurzite 
structure [24; 34], which is described by the typical elementary cell (a=b=4.298 Å, 
c=6.716 Å) containing four atoms of each element. 
2.2.7 Determination of real elemental Quantum Dot composition 
Inductively coupled plasma optical emission spectroscopy [ICP-OES] was used to 
determine absolute concentrations and elemental ratios of the quantum dot components 
(Cd and Se). Sample solutions were prepared by oxidative disintegration of the 
nanocrystals. An aliquot, between 50 and 200 µl, of the purified quantum dot dispersion 
was dried under atmosphere pressure at room temperature and disintegrated by addition 
of 500 µl nitric acid and 2 to 3 drops of ethanol. Subsequently, samples were diluted to 
10 ml using a volumetric flask. The final concentration of HNO3 was about 2 to 3 %.  
The standard solutions, prepared of cadmium chloride and selenium, contained 100 ppm, 
10 ppm and 1 ppm of Cd and Se in 2 to 3 % nitric acid. Measurements were performed 
using a Jobin Yvon 70 Plus (S+S) ICP-OE spectrophotometer (Horiba, Jobin Yvon, 
France) in the sequential analysis mode. Instrumental settings and element characteristics 
are given in tables 2 and 3.  
Tab. 2: Instrumental settings for ICP-OES measurements
Instrumental setting  
Plasma gas (temperature and flow rate) Argon (~8000 K; 10-20 L/min) 
Transport gas  Argon (0.6-1 L/min) 
Sample flow rate 1 ml/min 
 
Tab. 3: Element characteristics for ICP-OES measurements
Element Detection wavelength / nm Nominal detection limit / ppb 
Cadmium 226.502 23 
Selen  196.090 75 
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2.2.8 Investigation of Quantum Dot morphology 
The morphologic analysis of uncoated and coated CdSe quantum dots was done by 
transmission electron microscopy [TEM]. Samples were prepared by dropping diluted 
organic dispersions on 3.05 mm formvar/carbon coated copper grids (300 mesh) followed 
by drying under vacuum. Images were taken using a Zeiss EM C/CR (Carl Zeiss AG, 
Jena, Germany) with 60 kV operating voltage. 
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3. Results 
3.1 Synthesis and characterization of CdSe Quantum Dots 
CdSe quantum dots have been prepared following a simple organometallic route. 
Immediately after combination of both pre-cursor solutions nucleation of fluorescing 
crystals occurred indicated by the resulting absorption and emission properties of the 
synthesis mixture (30 s value) (Fig. 3). The following time of synthesis is characterized by 
a continuous red-shift in both, first excitonic peak (λa) and maximum emission 
wavelengths (λem), ranging from 509 and 527 nm, respectively, after 30 s, to 603 and 
617 nm after 90 min of synthesis duration.
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Fig. 3: Development of (left) normalized absorption and (right) fluorescence spectra during CdSe quantum 
dots synthesis over 90 min 
With increasing λem also the mean diameter d of the nanocrystals increased by continuous 
incorporation of both, Cd and Se, to the once nucleated crystals, indicated by the growing 
amounts of both elements per 0.1 mmol of disintegrated quantum dots over the synthesis 
duration (Fig. 4). Generally the ratio of Cd to Se is influenced by the synthesis route and 
herein the amount of incorporated Cd was always slightly higher, indicated by a Cd/Se 
ratio of at least 1.7 during the whole synthesis.
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Fig. 4: Development of (left) nanocrystals size [nm] with increasing maximum emission wavelength and 
(right) of elemental composition of CdSe quantum dots [mmol / 0.01 mmol QDs] during synthesis over 90 min 
Morphological investigations of the as prepared quantum dots, determined by TEM proved 
the formation of narrowly size distributed crystals (Fig. 5), which however, did not appear 
exactly round (dot-shaped).
    
Fig. 5: TEM images of CdSe quantum dots; magnification 63,000 x; scale bars correspond to 10 nm 
The optical properties of the quantum dots were displayed by their QY, which decreased 
from the initial maximum value of 16 % to about 9 % within 15 min and kept almost stable 
over the following 70 min of synthesis (Fig. 6). 
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Fig. 6: Development of quantum yield of CdSe quantum dots during synthesis over 90 min 
3.2 Purification of CdSe Quantum Dots 
Several solvents and solvent mixtures, as summarized in table 4, were compared 
especially with respect to their impact on QY (Fig. 7) and their precipitation efficiency 
(Fig. 8).  
Tab. 4: Organic liquids used for precipitation of CdSe quantum dots 
Method Solvent / Solvent mixture  
A Ethanol  
B Ethanol + Hexane (5:1)  
C Acetone  
D Acetone + Hexane (5:1)  
E Methanol  
F Methanol + Hexane (5:1)  
G Methanol/Isopropanol (75/25)  
H Methanol/Isopropanol + Hexane (5:1)  
 
To attribute for the already high initial QY variability of the different batches, the 
investigations were conducted using four different starting batches of CdSe quantum dots. 
Even following identical synthesis protocols without noticeable obvious failures (e.g. 
pronounced fluctuation in the nucleation- or growth temperature) the conducted QD 
synthesis is highly sensitive, resulting in batches with significant differences in quality. 
However, the general effects of the used purification method on the PL properties seem to 
be almost independent of the initial quality of the quantum dots (Fig. 7). Interestingly all 
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methanol containing precipitation mixtures resulted in the lowest QYs (E-F), whereas the 
highest QY stability was found for acetone both with and without the addition of hexane 
(C+O). For all investigated polar solvents, the addition of hexane generally led to slightly 
higher values of obtained QY. 
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Fig. 7: Influence of purification procedure on quantum yield of CdSe quantum dots; given as means (±SD) of 
four separately synthesized QD batches; explanation of different procedures represented by capital letters 
given in table 2  
The precipitation efficiency, herein dealing as a measure for the recovery of the initial 
amount of quantum dots after re-dispersion following purification (Fig. 8), on the other 
hand was found to be the best in case of the methanol based solvents, whereas only 
50 % or even 25 % were recovered in case of acetone based precipitation solvent 
mixtures. 
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Fig. 8: Recovery of CdSe quantum dots following purification with different procedures; explanation of different 
procedures represented by capital letters given in table 4 
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3.3 Lipophilic coating of CdSe Quantum Dots 
Surface modification of original CdSe quantum dots was performed by exchanging the 
surface ligands resulting from the synthesis either by several primary alkylamines differing 
in chain length or 2-mercaptoethanol under various conditions, as summarized in table 5.  
Tab. 5: Lipophilic coatings and coating conditions 
Method Conditions  
a Oleylamine/ room temperature  
b Oleylamine/ 100 °C  
c Dodecylamine/ 40 °C  
d Dodecylamine/ 85 °C  
e 2-Mercaptoethanol/ 60 °C  
f 2-Mercaptoethanol/ room temperature  
g Allylamine/ room temperature  
 
Using the identical CdSe starting batch the development of the QY was found to be 
strongly influenced by both the coating material and moreover the temperature 
(Fig. 9, left). 
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Fig. 9: Quantum yield of CdSe quantum dots (left) during coating with different lipophilic ligands and (right) its 
stability during purification using acetone/hexane; explanation of coating procedure represented by lowercase 
letters given in table 5 
The different procedures improved the initial PL properties in the following order: 
dodecylamine/ 40 °C > oleylamine/ 100 °C > dodecylamine/ 85 °C > oleylamine/ room 
temperature. No positive effect at all was found for allylamine and 2-mercaptoethanol. 
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Regardless of the initially achieved QY after coating, the following purification step again 
decreased the QY to about 15 % in the case of the oleylamine and dodecylamine 
derivatives, independent of the used coating procedure, which however still is a multiple of 
the pre-coating value of about 3 % (Fig. 9, right). Indeed, aborting the coating process 
during the first hour, which was characterized by the strongest increase in QY 
(Fig. 9, left), again led to a substantial loss of QY during purification. This then equates 
almost the pre-coating value (Fig. 10). 
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Fig. 10: Quantum yield of CdSe quantum dots during coating with oleylamine at 100 °C over 60 min and its 
respective stability during purification using acetone/hexane 
3.4 Quantification of CdSe Quantum Dots 
Basically there are two different methods to determine the concentration of quantum dots 
in dispersion. The molar concentration of quantum dots can be determined based on their 
absorbance spectrum, which includes the maximum absorption wavelength as well as the 
absorbance (see equation (3)). On the other hand it is possible to quantify the molar 
amounts of the quantum dot forming elements, herein Cd and Se, after disintegration of 
the nanocrystals, using ICP-OES. In order to answer the question of their relative 
proportion for different quantum dot species, the apparent Se concentration, as 
determined by ICP-OES, was compared to the theoretical molar concentration of Se, 
calculated from the respective nanocrystals’ light absorbance (Fig. 11). 
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Fig. 11: Relation between Se concentration based quantification of uncoated CdSe quantum dots using either 
UV-based or ICP-OES-based calculation dependent on quantum dot size; mathematical fits (solid and dashed 
line) inserted for explanation only 
As expected, the amount of Se steadily increases with increasing quantum dot diameter, 
but on the other hand the apparent concentration of Se is slightly lower than the 
theoretically expected one for crystal sizes of 4 to almost 5 nm and the observed 
differences are constant within this size range. With further increasing size, the ICP-OES 
results are characterized by a steady increase in Se amounts whereas the UV-based 
calculation followed an almost linear relation. 
In case of further surface modified quantum dots the relation between UV-based and 
ICP-OES-based Se concentrations was also investigated, but only starting from one 
single quantum dot batch, which consequently posses only one single average crystal 
size (Fig. 12). 
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Fig. 12: Relation between Se concentration based quantification of CdSe quantum dot using either UV-based 
or ICP-OES-based calculation – (left) after coating with different lipophilic ligands and (right) focused on 
oleylamine-coated quantum dots; explanation of coating procedure represented by lowercase letters given in 
table 5 
Except after coating with dodecylamine, which also showed the most pronounced impact 
on the earlier investigated PL properties, the same general trend (UV-based 
concentrations higher than the ICP-OES-based ones) was obtained, but here strongly 
varying absolute differences were observed. The initial ratio of “UV concentrations” to 
“ICP-OES concentrations” before coating of this batch has been about 3.5. Following 
coating the ratios range from 0.78 to 4 for the different investigated coating procedures. 
However, a good reproducibility was found for the afterwards commonly used coating 
scheme with oleylamine, which was conducted in triplicate. 
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4. Discussion 
Several synthesis procedures for fluorescing semiconductor nanocrystals have been 
described in literature, predominantly differing in the used pre-cursor substances, solvents 
or stabilizing ligands [24; 36-41]. However, independent of the used synthesis scheme 
they can be separated into two major steps: (1) nucleation and (2) growth of nanocrystals 
[42]. The continuous red-shift in both, the absorbance (λab) and maximum emission 
wavelengths (λem), (Fig. 3) act as a direct indicator for the typical size tuneable optical 
properties of quantum dots. Since both, the emission and the absorbance of CdSe 
quantum dots, span a broad range of the visible spectrum, changes of the emission and 
absorbance are observable by the formation of the yellow particle dispersion immediately 
after nucleation and thereafter a stepwise change to a deep–red colour of the dispersion. 
In parallel the formed particles also show a constant alteration of their fluorescence colour 
under excitation with UV-light to longer wavelengths as indicated in figure 13. 
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Fig. 13: Images of development of emission wavelength of CdSe quantum dots during synthesis under UV-
excitation at 355 nm; numbers indicate time points of sampling in minutes 
The resulting shape of the synthesized nanocrystals is predominantly driven by 
thermodynamic processes and thus understandably sensitive towards thermal or kinetic 
fluctuations [42; 43], wherefore the deviation in crystal morphology (Fig. 5) from the 
expected perfect dot-shape is not surprising. However, the shape of quantum dots on the 
other hand could have pronounced impact on the crystal quality also regarding the optical 
properties, which are for example also affected by defects in the quantum dot surfaces 
[43; 44]. The optical quality of the quantum dots is primarily defined by their quantum yield 
(also known as quantum efficiency), determining the radiative energy transition, 
represented by the amount of emitted light per amount of absorbed light [45]. In case of 
the CdSe quantum dots, QYs did not exceed 10 to 15 % during the whole synthesis 
(Fig. 6), which is in line with results previously described in literature [46].  
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Considering all characterized parameters, it is obvious that the most pronounced changes 
in composition and fluorescence occur during the first minutes of crystal growth. Within 
five minutes λem shifts about more than 50 nm into the red range and the diameter 
increases about one third of the initial size, which is also accompanied with increased 
elemental concentrations determined after crystals disintegration. However, in the 
following, initially measured QY of 16 % decreases steadily, which could be attributed to 
occurring surface defects of the growing crystals. Compared to that initial shift, changes in 
the following growth appear almost marginal and quantum dot properties seem to be 
almost fixed after the first 15 minutes of reaction. Focusing on the fluorescence intensity, 
the “best” quantum dots therefore would be available after only a few minutes of 
synthesis. However, for the optimal duration of the reaction the overall photoluminescence 
properties are crucial, of course including the QY but also the maximum emission 
wavelength λem, which should be as high as possible, to allow a detection also in cells, 
tissues or even small animals. Thus, CdSe batches have been prepared with a standard 
growth time of 60 min, essential to achieve the long emission wavelengths typical for 
bigger quantum dots, but consequently with lower overall QY. 
After synthesis quantum dots are dispersed in a mixture containing unreacted pre-cursors 
and several other organic compounds resulting from the synthesis. Prior to their further 
application purification is essential, preferable without too detrimental effect on the 
quantum dots’ PL properties. The investigated purification methods (Tab. 4) differed 
significantly regarding their impact on QY as well as their precipitation efficiency (Fig. 7; 
Fig. 8). Interestingly, all methanol containing precipitation mixtures, which are most 
commonly described in literature [30; 47] resulted in the lowest quantum yields (Fig. 7, E-
F), but the best precipitation efficiencies (Fig. 8, E-F). The obvious relationship between a 
method’s precipitation efficiency and the QY of the purified quantum dots can be 
explained, considering the mechanistic background of the purification process. The 
interactions of the polar solvent (added in excess) with the surface capping ligands (e.g. 
TOP, oleic acid) lead to a destabilization of the capping layer, followed by a temporary 
aggregation of the particles, which allows their centrifugation. Stronger interactions, as in 
the case of methanol therefore lead to strong destabilization and good precipitation, but, 
also to an increased surface destruction, demonstrated by the low obtained QY. In 
contrast, the most gentle purification methods, using pure acetone or acetone with 
hexane, are accompanied with only low precipitation efficiencies, indicating the limited 
interaction with the surface ligands. Unlike previously reported for CdTe-based quantum 
dots [44], no significant regeneration of the fluorescence could be observed during 
storage over 72 h following purification (Fig. 7).  
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Conclusively, none of the investigated methods fulfilled all desired properties, i.e. 
quantitative precipitation (and re-dispersion) and a maintained high quantum yield. 
Indeed, focusing on the PL would increase the loss of initial quantum dots by magnitudes, 
which is not desirable for the intended applications. Therefore, one has to compromise 
and choose the purification method depending on the intended application of the QDs. In 
the case of a QD characterization, if only less amounts are sufficient, method D (acetone 
+ hexane) will be used, whereas in the cases where more QDs are required (e.g. for 
encapsulation into polymeric particles) method B (ethanol + hexane) will be used, 
accepting a significantly reduced QY.  
Capping ligands, which are bound to the surface of nanocrystals, have been identified to 
be essential for their desired optical properties. By passivation of dangling lone pairs 
(partially coordinated surface atoms) they prevent a non-radiative energy loss and 
additionally they might play an active role in surface reconstitution [48]. Lots of effort 
already has been spent to investigate ligand effects either during synthesis [38] or during 
post-treatment ligand exchange experiments [27; 49; 50]. As discussed above the initial 
quantum yield of the custom-made CdSe quantum dots is already highly variable, hardly 
exceeds 10 to 15 % and furthermore is sensitive to post-preparative procedures, like for 
example purification. Surface passivation therefore would offer an attractive option to 
improve quantum dot stability and moreover, their photoluminescence properties. 
Considering the results obtained from coating with different primary alkylamines and 
2-mercaptoethanol no clear trends could be determined, neither regarding the alkyl chain 
length nor the applied coating temperature (Fig. 9). In general effects found in literature 
could not be confirmed for the here used system, except the obvious quenching of CdSe 
fluorescence by the thiol ligand, once established for stabilizing CdTe quantum dots [51]. 
Quite contrary to literature, no improvement at all was found for the short allylamine, 
which has been described to increase QY up to 50 % [47].  
The impact of the coating time can be easily understood considering that the coating 
procedures generally are described as dynamic processes [49]. Thus they need a certain 
time until their equilibrium state is reached, which however is not characterized by the 
highest increase in QY but moreover in the highest stability of the newly attached ligands 
towards removal during purification (Fig. 9, right; Fig. 10). Successful coating processes 
have been described to last between 12 to 96 h [27; 51]. Thus for particles used in further 
experiments coating times of at least 12 h were applied. The diversity of the obtained 
results and the information, derived from literature, which are also partially inconsistent, 
indicate that the involved processes during surface modification of quantum dots are still 
not completely elucidated. Numerous factors influencing either the coating process or the 
outcome have been identified, including – quantum dot type, size and concentration, initial 
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PL properties, original surface ligands and therefore the overall synthesis route, the 
proportion of crystals to ligand, the dispersing solvents, the coating temperature, length of 
the alkyl chain, type of amine (primary, secondary, tertiary), surface coverage or the 
ligand, and ligand’s classification regarding the Lewis acid-base theory [27; 38; 42; 50; 
51]. The establishment of an optimal coating procedure for all these factors actually 
seems to be a mostly empirical process, which is furthermore hampered by an 
unsatisfying reproducibility of the modification steps. 
For the further encapsulation experiments an exact knowledge of the current quantum dot 
concentration is essential as the PL properties of a fluorescent probe are strongly 
depending on their absolute concentration. The molar concentrations of quantum dots in 
dispersions are commonly determined based on their absorbance following an empirical 
relationship as introduced in 2.2.5, which was already described in literature for a certain 
type of quantum dots [34]. This relationship, obtained from TEM and spectroscopy 
studies, has also been used in this work, if the quality of different quantum dot batches 
should be determined or compared with each other. However, one has to keep in mind 
that this method it is not applicable in cases where the measurement of the absorbance 
spectra is not possible or where it might be disturbed by the presence of other light 
absorbing substances (e.g. when quantum dots are mixed with or encapsulated in other 
organic materials). In such cases it is only possible to quantify the amounts of the 
quantum dot forming chemical elements, herein Cd and Se, after disintegration of the 
particles and subsequent quantification using for example ICP-OES. During the later 
investigated encapsulation of the quantum dots (Chapters 5 and 6) both methods have 
been used: Prior to encapsulation the PL properties and the molar concentrations of CdSe 
in the stock solution were determined and the intended loading was calculated based on 
the non destructive UV measurements. In contrast, the effective loading (real amount of 
encapsulated nanocrystals) subsequently was determined based on the Se concentration 
measured by ICP-OES of an aliquot before and after encapsulation. 
Comparing the results of both methods, focusing on the Se concentration, there is an 
apparent deviation of the two concentrations (Fig. 11), which may be due to the restriction 
to the mean diameter of the nanocrystals in order to calculate the theoretical Se 
concentration. However, the used quantum dots are obviously not monodisperse and the 
actual broadness of the current size distribution can especially account for the deviation of 
the ICP-OES measurements, which even changes with the investigated particle sizes. 
Nevertheless the observed differences kept almost constant within the size range of 4 to 
almost 5 nm and therefore the results of the UV-measurements could still be used as 
reliable indicator of the quantum dot concentration during encapsulation into particles.  
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The evaluation of the relationship in case of different coatings of quantum dots was also 
essential, since the mentioned empirical equations (2.2.5; equations (2-4)) were initially 
used for the determination of molar concentrations of simple uncoated CdSe quantum 
dots without further processing and modifications. Since it was demonstrated earlier that 
coating and purification could dramatically change the optical properties of quantum dots 
(absorbance as well as emission), it is quite obvious, that using an absorbance based 
calculation for coated quantum dots could lead to more or less pronounced errors of 
calculated particle sizes and concentrations. A similar general trend (UV-based 
concentrations higher than ICP-OES-based ones) was obtained for most investigated 
coatings (Fig. 12). The strongly varying differences are understandable, but the available 
data are certainly not sufficient at all to discuss the individual effects of the coatings. 
Nevertheless, for the afterwards commonly used oleylamine coating the obtained ratio 
and also its reproducibility was very satisfying and this is why no further elucidation of the 
involved processes was performed. 
Generally the observed differences in the calculation can therefore be considered as 
constant and will not disturb the obtained absolute concentration values, since for the 
encapsulation efficacy always the ICP-OES measurements were directly compared and 
for comparisons of purifications procedures (etc.) always the same starting particle 
concentrations were directly compared in the subsequent experiments. 
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5. Summary and Conclusion 
Following a simple organometallic approach CdSe quantum dots with the desired 
maximum emission wavelengths λem of about 610 nm were successfully synthesized. 
While the obtained crystal size and composition are predominantly responsible for their 
λem, the surface properties (e.g. presence of crystal defects and attached surface ligands) 
were found to contribute significantly to the quantum dots optical quality, especially their 
quantum yield. Generally the PL of these nanocrystals was found to be highly sensitive 
towards deviations in the synthesis or generally towards all processes, which potentially 
lead to a destruction of their delicate surface structure. Besides a sufficient initial stability, 
especially the reproducibility of all preparation steps is essential with respect to a potential 
application of these QD as fluorescent marker substances. Therefore standardised 
methods were defined for the synthesis conditions, purification of the QD dispersions and 
furthermore a post-synthesis surface modification. Following the same synthesis protocol 
over 60 min, purification procedures differed depending on the intended application of the 
respective quantum dots. Characterization and comparison of different batches was done 
after precipitation with a mixture of acetone and hexane, which were found to be less 
aggressive to the crystal surface. However, due to a resulting low recovery of QDs this 
method was not appropriate in cases were larger amounts of purified crystals are 
required. For these applications the purification was done with a mixture of ethanol and 
hexane, taking into account the reduced optical quality of the obtained nanocrystals. 
An exchange of the original surface capping ligands, derived from the synthesis, for 
primary alkylamines (chain lengths of C12 or C18) led to an improvement of the initial QY by 
multiples. Moreover the PL stability of the obtained nanoparticles was also enhanced 
during aggressive process steps, like for example the purification. Coating with oleylamine 
at elevated temperatures was consequently used as standard coating method for further 
work using the CdSe quantum dots as particulate fluorescence markers.  
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Chapter 5 
Non-aqueous nanoprecipitation 
 –  
A promising technique for the 
encapsulation of lipophilic Quantum 
Dots? 
 
 Quantum Dot Loaded Fluorescing Nanoparticles 
1. Introduction 
The current research in life sciences using quantum dots as fluorescent markers has 
grown tremendously since these fluorescent nanocrystals, have been identified as 
promising tools for imaging applications, based on their extraordinary optical properties 
compared to the commonly used organic fluorescent dyes [1]. Actually, cellular 
diagnostics or molecular imaging would be hardly possible in some cases without the 
application of quantum dots.  
Bearing predominantly non-biocompatible, lipophilic organic ligands at their inorganic core 
surface and with the suitable optical properties, which are restricted to crystals in smallest 
nano-dimensions [2], usually a post-synthesis processing is required in order to increase 
their biocompatibility and allow their use in biological systems [3; 4]. Depending on the 
indented application there is a variety of modifications described in literature, which can 
be roughly separated into three main groups of processing techniques: (1) direct 
modification of single quantum dot surfaces by conjugation with biomolecules or polymers 
[5; 6], (2) embedding of quantum dots in micelles or liposomes [7; 8] or (3) their 
encapsulation into solid biocompatible matrices [9-11]. Such quantum dot conjugates 
have been widely used for in vitro cell-based assays [12], targeting and imaging of certain 
tissues [13], identification of different cell types [8; 14] or intracellular trafficking [15]. 
Furthermore they could also deal as an alternative to common organic fluorescence dyes 
frequently used during development and characterization of drug delivery systems. 
However, each here described modification of the quantum dots could lead to an 
alteration in their physicochemical and optical characteristics [3] and possibly results in a 
loss of their desired optical properties [16]. To gain a better understanding of available 
processing methods, essential for further optimization, occurring processes and critical 
parameters need to be characterized focused on one single system, which was the main 
intention of the current work. 
The encapsulation of quantum dots into solid polymeric matrices by so-called 
nanoprecipitation has been chosen since this is a simple method offering several 
advantages. Characterized by overall narrow size distributions, the particle size can be 
easily tailored by various factors, thoroughly discussed in chapter 2. Furthermore other 
commonly applied procedures in preparation of nanoparticles (e.g. solvent evaporation, 
polymerization [6; 9; 17]) use aggressive emulsification steps or require radicals or UV 
irradiation to initiate the polymerization of monomers of the matrix, which obviously limit 
their applicability to encapsulate sensitive substances. In comparison with this, 
nanoprecipitation appears as gentle method and therefore seems to be appropriate for the 
encapsulation of quantum dots, known to be very sensitive against their environment and 
different processing steps, in order to preserve their desired optical properties. 
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In the present work the applicability of the non-aqueous nanoprecipitation method for the 
encapsulation of lipophilic quantum dots was investigated. The impact of loading, 
properties of the quantum dot surface or matrix material was determined, primarily 
focusing on the resulting fluorescence properties of the obtained polymeric nanoparticles. 
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2. Materials and Methods 
2.1 Materials 
PLGA 75:25 (Resomer® 756) was a kind gift of Boehringer Ingelheim (Boehringer 
Ingelheim AG, Biberach, Germany). Biodegradable copolymers (mPEG2PLA40 and 
NH2PEG2PLA40) were synthesized following an established method as described in 
chapter 2. Unmodified CdSe quantum dots and oleylamine-coated (OA-coated) CdSe 
quantum dots were synthesized as described in chapter 4. QDot®800 were purchased 
from Molecular Probes (Invitrogen, Goettingen, Germany). Oxazine 170 perchlorate 
(95 %), Pluronic® F68, elemental selene (100 mesh) and anhydrous cadmium chloride 
(p.a.) were obtained from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Taufkirchen, 
Germany). Sucrose, ethanol (p.a.), methanol (p.a.), isopropanol (p.a.) and nitric acid 
(65 %) were purchased at Merck (Merck KGaA, Darmstadt, Germany). Chloroform (p.a.), 
hexane (p.a.) and acetone (p.a.) were obtained from Acros (Acros Organics, Fischer 
scientific GmbH, Nidderau, Germany).  
2.2 Methods 
2.2.1 Preparation and characterization of CdSe Quantum Dot stock 
dispersion 
Prior to encapsulation raw dispersions of custom-made CdSe quantum dots were purified 
following a procedure established in chapter 4. Briefly, an aliquot, usually 1 to 2 ml of the 
dispersion were mixed with a 30-fold excess of a mixture of ethanol and hexane (5:1), 
followed by centrifugation (10,000 g, 30 min, 10 °C; Avanti JE centrifuge; Beckman 
Coulter GmbH, Krefeld, Germany), discarding the supernatant and subsequent re-
dispersion of the sediment in chloroform. 
Photoluminescence [PL] properties and molar concentrations of nanocrystals were 
determined following methods described in chapter 4 (2.2.4 & 2.2.5). 
2.2.2 Preparation and characterization of the QDot® 800 stock dispersion 
The commercially available QDots® 800 were purified following the method recommended 
by the supplier. An aliquot of the QDot® raw dispersion was mixed with a 4-fold excess of 
a solvent mixture of methanol and isopropanol (ratio=3:1). After centrifugation (3,000 g, 
5 min, 10 °C) the supernatant was discarded and the sediment was re-dispersed in CHCl3. 
The molar concentration of the QDots® in the stock dispersion could not be calculated 
based on the commonly used UV absorption due to the unknown composition of the 
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particles, and therefore was estimated assuming a quantitative precipitation and re-
dispersion. PL properties basically were determined following the same procedure as for 
the CdSe quantum dots; however, with changed instrumental settings, for the 
measurement of the fluorescence emission spectra a red-sensitive R928 photomultiplier 
was additionally used. In contrary to custom-made quantum dots, QDot® 800 were excited 
at 460 nm and spectra were recorded over the range of 500 to 900 nm. 
2.2.3 Precipitation of Quantum Dot loaded nanoparticles 
Polymeric nanoparticles were prepared following a modified nanoprecipitation method 
[18], introduced in detail in chapter 2, using chloroform and ethanol as solvent – 
non-solvent system. If not otherwise stated the preparation followed the standard 
conditions described there. Briefly, a 1 % solution of the polymer (PLGA, mPEG2PLA40 or 
NH2PEG2PLA40) was prepared in CHCl3 and a respective amount of the quantum dot 
stock dispersion was added (depending on the determined quantum dot concentration 
and intended loading). The final volume of this organic phase was then adjusted to 5 ml. 
Afterwards this polymer solution was added dropwise to 40 ml of the non-solvent, while 
the formation of particles occurred immediately. Either pure ethanol or an ethanolic 
solution of Pluronic F68 (0.1 to 0.5 %) were used as external non-solvent phase. Avoiding 
further agitation of the particle dispersion, the CHCl3 was allowed to evaporate over at 
least three days at room temperature. The ethanol was subsequently removed via dialysis 
against water containing 0.1 % Pluronic F68 using a Nadir® dialysis membrane (cut-off of 
10-20 kDa; Carl ROTH GmbH, Karlsruhe, Germany). Recovery of the nanoparticles from 
the aqueous dispersion was performed by centrifugation (12,500 g, at least 30 min, 10 °C) 
and subsequent re-dispersion in 5 % sucrose solution. Formed microparticles and other 
artefacts were removed via filtration (< 1 µm). Subsequently, the nanoparticles were 
freeze-dried using a lab-scale freeze-dryer (Martin Christ Gefriertrocknungsanlagen, 
Osterode am Harz; Germany). 
Preparation of unloaded nanoparticles, dealing as negative control, followed same 
procedure except the addition of the quantum dots. 
2.2.4 Determination of particle concentration 
Analysis of the PL properties of the quantum dot loaded nanoparticles required knowledge 
about their concentration in dispersion, which usually was estimated semiquantitatively 
based on the solid content in a certain aliquot of dispersion, depending on the investigated 
production step. Within particle preparation, 0 % loss of material during the initial 
precipitation step was assumed, and the particle concentration was obtained from the 
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initial weight of polymer in relation to the actually apparent present volume of the particle 
dispersion. To determine the concentration in the final, purified, dispersion an aliquot 
(usually 500 to 1000 µl) was centrifuged (15,000 g, 45 min, 10 °C) and the residual 
sediment was freeze-dried and again weighed to obtain the solid content of the aliquot. 
2.2.5 Fluorescence spectroscopic analysis of the nanoparticles 
Fluorescence properties of quantum dot loaded nanoparticles were determined at different 
steps during particle preparation. Therefore fluorescence spectra (500 to 750 nm; 500 to 
900 nm) of the polymer particles either dispersed in ethanolic or aqueous solutions were 
measured using a LS 55 spectrophotometer (PerkinElmer, Waltham, USA), equipped with 
a red-sensitive R928 photomultiplier in the case of the QDot® 800 loaded samples, 
following excitation with either 488 nm or 460 nm and a photomultiplier voltage of 750 V. 
To allow comparison of different process steps or particle batches, measured intensities 
were subsequently normalized on the pre-determined particle concentration. 
2.2.6 Determination of particles loading with CdSe Quantum Dots  
Inductively coupled plasma optical emission spectrophotometry [ICP-OES] was used to 
determine the elemental concentrations of the quantum dot components Cd and Se. For 
sample preparation an aliquot of the final lyophilisate was disintegrated in 2 ml ethanol 
containing HNO3 (65 %). 50 to 100 µl of the initial organic quantum dot dispersion used in 
the respective experiment dealt as reference for the determination of the maximum 
achievable amounts of Cd and Se. Subsequently all samples were diluted up to 10 ml in a 
volumetric flask and the final concentration of HNO3 was about 2 to 3 %.  
The standard solutions, prepared of cadmium chloride and selenium, contained 100 ppm, 
10 ppm and 1 ppm of Cd and Se in 2 to 3 % HNO3. Measurements were performed using 
a Jobin Yvon 70 Plus (S+S) ICP-OE spectrophotometer (Horiba, Jobin Yvon, France) in 
the sequential analysis mode. Instrumental settings and element characteristics are given 
in chapter 4 (2.2.7). 
The CdSe loading of the nanoparticles was calculated based on the following equations: 
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with the real concentration of Se in the nanoparticles C(Se)real [nmol/mg], the molar 
amount of Se in degraded particles measured via ICP-OES M(Se)ICP-Sample [nmol], the 
weight of the particles used for the preparation of the ICP-sample mICP-Sample [mg], the 
theoretical required concentration of Se in the nanoparticles given at 100 % encapsulation 
C(Se)Initial [nmol/mg], the molar amount of Se in the QD-reference measured with ICP-
OES M(Se)QD-Reference [nmol], the multiple of the volume of the QD-reference used for 
encapsulation fQD-Reference and the weight of polymer used for particle preparation 
mPolymer [mg]. 
2.2.7 Determination of particle sizes 
Photon correlation spectroscopy [PCS] was used to determine the hydrodynamic 
diameters and polydispersity indices of the prepared nanoparticles usually dispersed in 
5 % sucrose. Measurements were performed at 20 °C with a Zetasizer 3000 A (Malvern 
Instruments Inc., Herrenberg; Germany). Results are presented as mean and relative 
standard deviation of three independent measurements. 
2.2.8 Morphologic analysis of Quantum Dot loaded nanoparticles 
The morphology of quantum dot loaded nanoparticles as well as the spatial distribution of 
quantum dots within the polymeric matrix was imaged by transmission electron 
microscopy [TEM]. Samples were prepared by dropping diluted aqueous dispersions on 
3.05 mm formvar/carbon coated copper grids (300 mesh) followed by negative staining 
with phosphotungstic acid (2 % in water) for 30 s and subsequent drying under vacuum. 
Images were taken using a Zeiss EM C/CR (Carl Zeiss AG, Jena, Germany) with 60 kV 
operating voltage. 
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3. Results 
The characterization of the quantum dot loaded nanoparticles was primarily focused on 
their photoluminescence properties, to prove their suitability as potential imaging systems. 
Besides the mere effect of quantum dot loading, also the optimization by using surface 
modified quantum dots as well as different matrix materials was investigated. Additionally, 
the results of the custom-made nanocrystals were compared with commercially available 
quantum dots (QDots® 800). 
3.1 PLGA based nanoparticles – the effect of loading 
The preparation of stable PLGA based nanoparticles was only possible by supplementing 
0.5 % Pluronic F68 to the ethanolic external phase, otherwise particles agglomeration 
occurred already during the precipitation process. PLGA particles were prepared with 
increasing amounts of initially added quantum dots over the range of 0.023 to 0.75 nmol 
per milligram of polymer. The quantum yield of the used quantum dot stock dispersions 
was about 3 %. Immediately following the precipitation, all quantum dot containing 
samples clearly showed a detectable fluorescence; however, no dependency on the initial 
loading with quantum dots was observed (Fig. 1, left). Considering all three main process 
stages (precipitation, dialysis and lyophilisation) a dramatic loss in the particles’ 
fluorescence could be observed for all batches with different amount of encapsulated 
quantum dot (Fig. 1, right) and similar trends were obtained in three control experiments. 
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Fig. 1: PLGA based nanoparticles with increasing loadings of uncoated CdSe quantum dots given in nmol/mg 
– (left) normalized fluorescence spectra taken immediately after nanoprecipitation; (right) development of 
fluorescence intensity during the whole preparation process (displayed by values of three fundamental 
preparation stages); arrow indicates failure in particle preparation; intensity of samples with equal particle 
concentrations (1 mg/ml) normalized on maximum fluorescence intensity 
The particles with loadings up to 0.1 nmol/mg were initially characterized by the highest 
luminescence intensities directly following precipitation. However, the final dispersion did 
not show any fluorescence at all. In contrast, the batches with lowest post-precipitation 
intensities were finally the only two exhibiting a detectable fluorescence of the final 
product, which however, was only a tenth of the initially observed value. Thus, the post-
precipitation value was not considered an adequate indicator for the properties of the final 
product. Interestingly, no particles could be obtained in the case of the highest intended 
quantum dot loading. Following a successful precipitation almost complete aggregation 
occurred within the first hours of evaporation. 
An increasing amount of encapsulated quantum dots was also found to affect the resulting 
size of the polymeric nanoparticles (Fig. 2). 
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Fig. 2: Particle sizes [nm] and polydispersity indices of PLGA nanoparticles with increasing loadings of 
uncoated CdSe quantum dots given in nmol/mg; arrow indicates failure of particle preparation 
Keeping almost the size of the unloaded control until a quantum dot loading of 
0.075 nmol/mg, the nanoparticle size escalated about almost 50 nm, followed by 
negligible further increase, when loading exceeded 0.1 nmol/mg of polymer. Indicated by 
overall very low polydispersity indices, all batches prepared have narrow size 
distributions. 
No significant impact of the quantum dot concentration on the encapsulation efficiency 
could be determined, which was found to range generally between 92 and 100 %. 
An overall increase in the number of encapsulated nanocrystals with increasing loading 
was further proved by TEM, exemplarily shown for loadings of 0.1 and 0.2 nmol/mg 
(Fig. 3). Quantum dots were found to be randomly distributed within the polymeric 
matrices.
A
  
B
  
Fig. 3: TEM images of PLGA based nanoparticles loaded with either (A) 0.1 nmol/mg uncoated CdSe 
quantum dots or (B) 0.2 nmol/mg uncoated CdSe quantum dots; arrows indicate single nanocrystals; scale 
bars correspond to 50 nm 
 - 131 - 
Chapter 5 
3.2 PLGA based nanoparticles – the effect of Quantum Dot 
coating 
Post-synthesis surface modification of CdSe quantum dots was found to partially increase 
their initial PL characteristics and is discussed to increase stability during further 
processing (Chapter 4). Therefor the fluorescence characteristics of PLGA nanoparticles 
loaded with increasing amounts of oleylamine-coated (OA-coated) CdSe quantum dots 
were compared to that obtained with uncoated quantum dots at the main process stages 
(Fig. 4). 
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Fig. 4: Normalized fluorescence intensity of PLGA nanoparticles loaded with increasing amounts of either 
uncoated CdSe or OA-coated CdSe quantum dots; intensity of samples with equal particle concentrations 
(1 mg/ml) normalized on maximum intensity; arrows indicate failures of particle preparation 
By far highest post-precipitation values were measured with particles containing the 
highest quantum dot loadings of 0.75 nmol/mg. However, independent of the surface 
properties of the encapsulated QDs, preparation finally failed in both cases due to polymer 
aggregation. For all other the loading also the within preparation intensities increased with 
increasing quantum dot loadings; however, again fluorescence of the final particle 
dispersions was very low. 
OA-coated CdSe also showed bigger effects on the polymeric nanoparticles size, which 
increased stepwise up to 230 nm in the case of the 0.3 nmol/mg of polymer loading 
(Fig. 5). Also for the surface modified quantum dots loaded nanoparticles polydispersity 
indices were very low, indicating a narrow size distribution. 
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Fig. 5: Particle sizes [nm] and polydispersity indices of PLGA nanoparticles loaded with increasing amounts of 
either uncoated or OA-coated CdSe quantum dots given in nmol/mg 
3.3 The effect of matrix material  
Three different materials, the lipophilic PLGA and two amphiphilic diblock copolymers 
(PEG2PLA40 and NH2PEG2PLA40) were used to investigate the possible impact of the 
matrix material on the final polymeric nanoparticles’ PL properties using similar initial 
loadings of both uncoated and OA-coated quantum dots. First of all it should be noted that 
the used precipitation systems differed depending on the applied polymer. While the 
addition of 0.5 % Pluronic F68 to the external phase was a pre-condition for precipitation 
in case of PLGA, no further stabilization is required in the case of the amphiphilic 
polymers. Moreover, the presence of even small amounts of the surfactant in the external 
phase (e.g. 0.1 %) led to stepwise aggregation of the precipitated polymer during the 
evaporation step. Thus particles made of PEG2PLA40 and NH2PEG2PLA40 were generally 
prepared using surfactant-free ethanol as external phase. 
The matrix forming polymer was found to have a pronounced effect on the optical quality 
of the prepared particles in case of both coated and uncoated quantum dots (Fig. 6, left). 
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Fig. 6: (left) Development of normalized (maximum) fluorescence intensity of nanoparticles loaded either with 
uncoated (dashed line) or OA-coated CdSe quantum dots (solid line) during evaporation phase; symbols 
represent the type of polymer used as matrix; stars indicate time-point of failure and abortion; (right) 
normalized fluorescence spectra of nanoparticles based on NH2PEG2PLA40 loaded with OA-coated CdSe 
quantum dots at various stages of the preparation process; initial loading with quantum dots was 
0.75 nmol/mg; intensity of samples with equal particle concentrations (1 mg/ml) 
As already demonstrated above no particles at all were obtained using PLGA loaded with 
uncoated CdSe quantum dots and aggregation or moreover a film formation also occurred 
during evaporation for PEG2PLA40 based batches independent of the used quantum dot 
type. Highest stability was found in case of NH2PEG2PLA40 based systems. The 
development of fluorescence spectra during the whole preparation process is exemplarily 
presented for NH2PEG2PLA40 loaded with OA-coated quantum dots (Fig. 6, right). 
NH2PEG2PLA40 particles loaded either with unmodified or OA-coated quantum dots 
remained fluorescing over the complete process (Fig. 7, left). However, only in case of 
the nanoparticles loaded OA-modified nanocrystals the fluorescence signal could be 
allocated to the typical quantum dot fluorescence (Fig. 7, right). 
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Fig. 7: (left) Development of fluorescence intensity of nanoparticles based on NH2PEG2PLA40 during the 
whole preparation process (displayed by values of four fundamental preparation stages); initial loading of 
either uncoated or OA-coated CdSe quantum dots was 0.75 nmol/mg, intensity of samples with equal particle 
concentrations (1 mg/ml) normalized on maximum intensity; (right) comparison of normalized fluorescence 
spectra recorded following lyophilisation and re-dispersion in water 
Compared to the negative control a pronounced increase in particle size was observed for 
such NH2PEG2PLA40 based particles if loaded with 0.75 nmol/mg, which were slightly 
higher if uncoated CdSe were encapsulated (Fig. 8, left). 
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Fig. 8: (left) Particle sizes [nm] and polydispersity indices of NH2PEG2PLA40 nanoparticles either unloaded or 
loaded with uncoated or OA-coated CdSe quantum dots respectively (initial loading 0.75 nmol/mg); (right) 
TEM image of NH2PEG2PLA40 nanoparticles loaded with OA-coated quantum dots, arrows indicate quantum 
dot clusters; scale bar corresponds to 50 nm 
Within the solid particles the OA-coated quantum dots were not further randomly 
distributed, as in case of PLGA particles with lower loadings, moreover crystals were 
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found to be arranged in cluster like structures and several clusters were apparent per 
nanoparticle (Fig. 8, right). 
3.4 Encapsulation of QDot® 800 
Commercially available quantum dots with an emission wavelength of about 790 nm were 
encapsulated to additionally offer an imaging tool with enhanced in-vivo detectability. 
PLGA was used as matrix material and the initial loading was estimated to be about 
0.02 nmol/mg. Following high initial maximum fluorescence intensity after precipitation, 
the values mainly decreased in two steps of the preparation process – during first hours of 
evaporation and during dialysis (Fig. 9). 
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Fig. 9: (left) Normalized fluorescence spectra and (right) development of maximum fluorescence intensity of 
PLGA nanoparticles loaded with QDot® 800 quantum dots during the whole preparation process; initial loading 
0.02 nmol/mg; intensity of samples with equal particle concentrations (1 mg/ml) normalized on maximum 
intensity 
The maximum fluorescence intensity of nanoparticles in final dispersion was only a tenth 
of the post-precipitation value, which is comparable to the results presented for the 
encapsulation of custom-made quantum dots. With a mean diameter of 150 nm the QDot® 
containing particles are similar sized as the unloaded control. 
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4. Discussion 
Nanoprecipitation generally serves as appropriate method for the preparation of polymeric 
nanoparticles. Varying process parameters were found to allow tailoring of particle sizes 
ranging from 50 to 300 nm with narrow size distributions. Compared to typically used 
solvent evaporation procedures [10; 14] no emulsification step (e.g. sonication) is required 
and due to the resulting lack of mechanical stress to the quantum dot surface, 
nanoprecipitation was expected to stabilize or moreover protect quantum dot 
photoluminescence properties during the encapsulation process. However, this expected 
behaviour could not be proved at all by the conducted experiments, most likely due to the 
effect of the used solvents and matrix materials on the surfaces of the encapsulated 
quantum dots.  
Principally, independent of the exact polymer/quantum dot system, nanoprecipitation was 
found to result in quantum dot loaded nanoparticles, whose final fluorescence intensities 
were multitudes below the values expected based on the initial PL of the used quantum 
dots. There is an apparent loss in the intensity signal throughout the whole preparation 
process (Fig. 1; Fig. 4; Fig. 6; Fig. 7; Fig. 9). Generally three critical steps could be 
identified and will be discussed in the following (1) the precipitation, (2) the evaporation of 
chloroform and (3) the final dialysis against water. 
The impact of precipitation was determined by comparing intensities of both, the pure 
organic quantum dot stock dispersion and the dispersions of nanoparticles, immediately 
after precipitation, providing equal quantum dot concentrations in both. Considering the 
initial QY of the organic stock preparation there was a loss in quantum dots fluorescence 
intensity of about 99.9 % during the precipitation step. For evaluation of the loaded 
nanoparticles the initial post-precipitation intensity was defined as 100 %. During 
evaporation over at least three days this post-precipitation intensity decreased by about 
50 to 90 %, followed by an almost negligible further loss of 5 to 10 % during final dialysis. 
Independent of the respective preparation stage there are very few reasons, which can 
provide an explanation of these phenomena. Since quantum dots have been reported to 
be sensitive to their environment [19-21] the loss in intensity is discussed to result 
predominantly from a destabilization or destruction of the quantum dot surface. This is 
supported by reports in literature whereupon a loss in QDs fluorescence intensity results 
of a depletion of surface ligands [13]. Both, the matrix polymer itself or the organic 
non-solvent ethanol, which also was found to gradually diffuse into the polymeric 
nanoparticles during chloroform evaporation (Chapter 2), can interact with the crystal 
surface or the surface capping ligands. This could lead either to a change in the spatial 
arrangement of the ligands or even their partial detachment. Additionally results also 
suggest that spontaneous solidifications of the particle matrix can cause mechanical 
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stress to the quantum dot surface, which also reduces their photoluminescence. Keeping 
in mind the extraordinary impact of surface integrity and ligands on the optical properties 
of the quantum dots [22], after all these negative effects are not surprising. In this context 
also an apparent quenching of the quantum dots fluorescence by the polymer matrix has 
to be considered. This phenomenon was even found to take place in solution, depending 
on both the polymer type and its applied concentration (Fig. 10). 
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Fig. 10: Relative maximum fluorescence intensity of CdSe quantum dots after addition of organic solutions 
containing different amounts of different biodegradable polymers  
For concentrations of 1 % as used for nanoparticles preparation in the present work 
already the dissolved polymers caused a decrease in fluorescence ranging between 50 
and 90 %. After precipitation, in the solid particle state, the impact can be expected to be 
even higher due to a locally much higher concentration of the polymer around the 
quantum dots and an also increased optical density of the solid polymer matrix as 
compared to the polymer solution. 
Based on PLGA as matrix polymer and unmodified quantum dots, several factors were 
investigated with respect to their impact/contribution on the fluorescence properties of the 
labelled nanoparticles. 
The preparation of stable fluorescing PLGA based nanoparticles generally was successful 
by increasing the quantum dot loading (Fig. 1), proved by overall high encapsulation 
efficiencies from 0.023 to 0.3 nmol/mg, and the nanocrystals were found randomly 
distributed (Fig. 3). The fluorescence intensities of these QD loaded PLGA nanoparticles, 
however, would hardly allow their application as an imaging tool. Indeed, a further 
increase in loading up to 0.75 nmol/mg was very limited since aggregation of the PLGA 
nanoparticles occurred immediately after precipitation. This effect might be due to space 
requirements of the nanocrystals dispersed in the polymeric matrix. During the 
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establishment of the nanoprecipitation, it was determined, that the here applied process 
parameters (non-aqueous system, 1 % PLGA, ratio of solvent and non-solvent phase of 
1:8) usually lead to particles smaller than 200 nm (Chapter 2). Considering the limited 
impact of the quantum dot loading on final size of PLGA particles (Fig. 2) and, in addition, 
the relative large space required by the nanocrystals determined in case of highly loaded 
NH2PEG2PLA40 particles (~280 nm) (Fig. 8, left) the loading capacity of PLGA particles is 
expected to be limited predominantly by spatial factors of the incorporated particulate 
substances. The larger amounts of solid crystals obviously lead to the formation of 
inhomogeneous polymer matrices with insufficient surface stabilization and subsequently 
the formation of precipitating polymer aggregates. 
In case of the PLGA particles, an exchange of the unmodified nanocrystals by oleylamine-
coated quantum dots, which were found to stabilize QDs optical properties (Chapter 4), 
could not level the overall impact of the preparation process on the fluorescence 
properties within the investigated loading range of 0.1 to 0.75 nmol/mg (Fig. 4). There is 
almost no protective effect of the OA ligand during precipitation. This is indicated by 
similar post-precipitation intensities of two particle batches containing QDs with initial QY 
(about 3 %) but different surface ligands (unmodified or OA-coated) (Fig. 4). The above 
discussed fluorescence quenching by the polymer (Fig. 10) also occurred in case of the 
OA-coated quantum dots (data not shown), but was slightly lower ranging between 60 and 
40 % for solutions containing 1 % polymer. Nevertheless results indicate similar sensitivity 
of the oleylamine ligand to rearrangement or detachment as the original ligands resulting 
from the synthesis. Following precipitation intensities firstly suggest an increased stability 
of the OA-coated quantum dots, indicated by enhanced within preparation values (“after 
dialysis”). Indeed this is afterwards levelled by a higher sensitivity towards the 
lyophilisation and the final product has no improved fluorescence intensities compared to 
particles prepared with uncoated CdSe.  
The particles sizes were found to be even more influenced by the surface properties of the 
encapsulated quantum dots than by the initial loading (Fig. 5). This may be due to the 
bigger surface ligand and additionally its interaction with the lipophilic PLGA, which may 
lead to matrices with a more spongy structure and therefore larger particles. 
The choice of the nanoparticle forming matrix material by far had the most pronounced 
impact on the nanoparticles, as indicated by the comparison of the lipophilic PLGA and 
the two amphiphilic diblock copolymers PEG2PLA40 and NH2PEG2PLA40 (Fig. 6). At first, 
as reported for PLGA particles also the preparation of PEG2PLA40 particles failed with the 
high QD loading of 0.75 nmol/mg. In contrast, the NH2PEG2PLA40 polymer resulted in 
stable particles with the best optical properties of all prepared systems, despite its 
similarity of the chemical structure (Fig. 7). Again also the space requirements of the 
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nanocrystals could contribute to the observed destabilization. However, contrary to the 
above discussed PLGA, PEG2PLA40 by far resulted in highest particle sizes if precipitated 
in the non-aqueous system (Chapter 2) and therefore could offer sufficient space. 
Moreover the differences between both types of diblock copolymers suggest a partition of 
the respective PEG part (either mPEG or NH2-PEG). In case of the mPEG2PLA40 an 
interaction of the PEG-block with the quantum dots generally is very likely as similar 
polymers already have been used for the surface modification of quantum dots [23]. A 
hence resulting preferential orientation of the PEG block to interior of the particle would 
lead to an inadequate surface decoration of the polymeric nanoparticles with PEG, which 
is essential as steric barrier for the forming nanoparticles [24], subsequently resulting in 
particle aggregation and coalescence. Indeed, considering this, it was surprising that the 
addition of further emulsion stabilizers (e.g. Pluronic F68) to the non-solvent phase as in 
the case of PLGA particles could not successfully prevent the aggregation of the forming 
PEG2PLA40 particles.  
A general similar destabilization of the polymer nanoparticles would be expected also in 
case of the NH2PEG2PLA40, especially since an interaction of other primary amines with 
quantum dots has been already demonstrated [25] (also see Chapter 4). The enhanced 
PL properties of the final dispersion (Fig. 7), compared to all other batches, may deal as 
additional proof for a crystal surface stabilizing activity of the amine group. Thus, a re-
orientation of the NH2-PEG to the particle interior would be expectable. Nevertheless no 
aggregation of the forming nanoparticles occurred for this polymer. This suggest that the 
number of amine groups interacting with the quantum dots are small enough to still ensure 
sufficient presence of NH2-PEG on nanoparticles surface, acting as steric barrier for the 
polymer particles. This might be explained with respect to the spatial distribution of 
quantum dots within the polymeric matrix with was found to be cluster-like (Fig. 8, right), 
assuming that only few crystals in the outer area of the clusters will interact with the amine 
groups. Overall the exact processes of particle stabilization could not be explained so far. 
In this context it should be noted that nanoprecipitation initially was successful in case of 
all three materials and aggregation and coalescence occurred only within several hours 
following preparation. This clearly suggests an initially sufficient steric stabilization of the 
nanoparticle surfaces. However, in contrast to the aqueous procedure particles 
precipitated in ethanol, as in the current case, were found to harden only incompletely 
after precipitation due to a continuously swelling and uptake of ethanol (Chapter 2). 
Therefore it may be possible that there is dynamic change in the initial polymer orientation 
which could lead to continuous destabilization of the particles. 
As mentioned above for the PLGA nanoparticles, also in case of the diblock copolymers 
the OA-coated quantum dots showed no superiority compared to the uncoated quantum 
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dots. The ratio in fluorescence of polymeric nanoparticles within preparation was found to 
be 0.35 which is almost the same as determined for the both used QD stock dispersions 
with initial QYs of 3.42 % and 10 % respectively. The positive effect on the fluorescence 
properties of the final product (Fig. 7) would then primarily be based on the initial higher 
quantum yield of the OA-coated quantum dots. 
Compared to the custom-made CdSe quantum dots commercially available nanocrystals 
were found to show pronounced differences in the PL properties of the prepared 
nanoparticles. Even with loadings as low as 0.02 nmol/mg, similar to the lowest 
investigated loading of the custom-made quantum dots, nanoparticles exhibit a low, but 
still detectable fluorescence. The generally similar profiles of signal loss following the 
precipitation (Fig. 1; Fig. 9) indicate comparable sensitivities of both quantum dot types. 
But several factors can contribute to the observed superiority of the commercial quantum 
dots over the custom-made nanocrystals. On the one hand QDots® 800 exhibit a higher 
initial quantum yield of more than 20 % (compared to 3 to 10 % in case of CdSe used 
within this work). Additionally a higher stability during the precipitation step was observed, 
since the post-precipitation intensity was only 5 % below the intensity of the stock solution 
containing same amounts of QDots®. In addition the conflicts of the polymers’ optical 
properties and the near-infrared emitting QDots® will be certainly different due to different 
absorption wavelengths. 
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5. Summary and Conclusion 
Basically the here investigated preparation of quantum dot loaded nanoparticles using the 
nanoprecipitation method provided a simple tool for the production of monodisperse 
fluorescently labelled nanoparticles, with high encapsulation efficiencies and only limited 
impact of the load on the resulting particle sizes. However, the finally achieved 
fluorescence intensities of the resulting polymeric nanoparticles actually would be 
insufficient for an application of the prepared particles for most imaging purposes. 
The investigation of the encapsulation process allowed the identification of main impact 
factors, which are essential for further optimization of this labelling procedure. Since the 
overall achieved high encapsulation efficiencies of quantum dots confirm the assumption 
of an effective fluorescence label, only the complex interference of the used quantum dots 
with the used solvents and polymeric matrices, together with the particle formation steps, 
can be made responsible for the poor optical properties of the final products. Namely 
three critical process steps have been identified, whereas the biggest impact was found 
during initial evaporation phase, predominantly due to the interaction of the quantum dot 
coating with the non-solvent ethanol. Nevertheless, based on the current results, 
nanoprecipitation can still be considered a promising method for the preparation of 
monodisperse quantum dot loaded polymeric nanoparticles. Application of quantum dot 
batches with initially higher optical quality would be a first step towards an improved 
fluorescence.  
However, keeping in mind the numerous impact factors and the limited stability of most of 
these nanocrystals, optimization of the system will still be a very empirical process, to find 
the ideal combination of QDs surface modification, matrix material and solvent system 
used for the precipitation. 
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Chapter 6 
Quantum Dots as fluorescent marker 
for microparticulate drug delivery 
systems 
 
 

Quantum Dot Loaded Microparticles 
1. Introduction 
Fluorescence imaging is a frequently used and well-established method to gain insight in 
the preparation and application of larger as well as smaller particulate drug delivery 
systems [DDS] (e.g. implants, micro- and nanoparticles) and thereby increase the 
knowledge of these systems with respect to their formation and fate at the application site, 
allowing further development and optimization. Compared to other imaging methods 
based for example on radioactivity [1; 2], radiocontrast [3] or magnetic properties [4; 5] 
fluorescence imaging enables a detection with relatively low technical effort and costs 
both in-vitro and in-vivo. Despite these advantages, the introduction of a fluorescent probe 
in the delivery system is essential to allow its detection and consequently the choice of an 
appropriate label strongly depends on the intended investigation. Labelling can commonly 
be achieved either by incorporation of small molecular weight organic fluorescence dyes, 
eventually also the fluorescently labelled drug molecule of interest, or by fluorescent 
modification of the used matrix material forming the particles. In the most studies labelling 
of a small molecules is preferred, since the interest is focused on the fate of the 
incorporated drug substance, investigation of the distribution within the particle [6; 7] and 
its behaviour during the release or the degradation of the carrier [8; 9]. In contrast, 
imaging of a whole system is useful either for the investigation of the composition and 
fabrication of so-called hybrid DDS, containing for example microparticles embedded in 
other carriers [10], or for the tracking of particles paths or drug release in-vitro or in-vivo 
[11; 12]. While the investigation of small molecular weight labels is characterized by a 
continuous loss of the marker substance in case of their release or particle degradation 
[13; 14], chemical and especially photochemical stability is by far the biggest hurdle for all 
applications, where a long term tracking of particles is intended. Possible strategies to 
fulfil these requirements could be a particle loading with increased amounts of the 
fluorophor or only slowly released fluorescent dyes. Alternatively, only the covalent 
attachment of the fluorophor to the matrix can yield a stable particle fluorescence, which 
just depends on the degradability of the matrix material [7; 15]. However, all these 
approaches struggle with the limited photostability of common organic fluorophores [16; 
17] and moreover, an extended loading or chemical alteration of the polymer structure 
could result in altered properties of the produced particles, probably hindering a transfer of 
the results to the investigated drug delivery system. 
With all these prerequisites for an ideal labelling procedure, quantum dots are an 
attractive alternative towards a more permanent labelling of drug delivery systems. 
Besides their well-known optical properties, including the tuneable emission wavelength 
and their high photostability, these inorganic fluorescent nanocrystals are expected to stay 
within the surrounding particle matrix as they are dispersed as solid crystals and very 
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unlikely to be degraded, dissolved or eluted, which would be essential for long-term 
imaging [17-19]. Introduced as fluorescence labels more than 10 years ago [20; 21], 
numerous works have been performed using them as probes in biomedical imaging [20; 
22; 23]. Surprisingly no reports are available about substituting common organic 
fluorophores during the development and investigation of new drug delivery systems. 
Various micro-scaled systems, containing quantum dots either in polystyrene or polylysine 
matrices, have been described in literature. However, their intended application was 
generally limited to bioassays or sensorics [24-28]. 
Therefore quantum dots were investigated as promising candidates to label 
microparticles, which could be either intended for parenteral use or also further processing 
in hybrid DDS. In combination with well-established degradable matrix materials and 
commonly applied encapsulation methods the microparticles should deal as satisfying 
models also for drug loaded derivatives possibly allowing a transfer of the obtained results 
to the later drug delivery application. In the here presented work lipophilic CdSe quantum 
dots containing microparticles have been prepared by loading lipophilic and amphiphilic 
matrix materials using a lab-scale emulsion based encapsulation method. Main interest 
was focused on the establishment of the microparticulate system, identification of potential 
impact factors and an evaluation of the applicability of the prepared labelled particles. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Preparation and characterization of microparticles 
PLGA 75:25 (Resomer® 756) was a kind gift of Boehringer Ingelheim 
(Boehringer Ingelheim AG, Biberach, Germany). The biodegradable diblock copolymer, 
PEG2PLA40, was custom made following an established method described in chapter 2. 
Glycerol tripalmitate (Dynasan 116) was obtained from Sasol (Sasol Germany GmbH, 
Witten, Germany). Oligo(poly(ethylene glycol)fumarate [OPF] 6K was custom made in the 
Department of Pharmaceutical Technology by Matthias Henke following an adapted 
method previously described by Jo et al. [29]. Uncoated and oleylamine-coated [OA-
coated] CdSe quantum dots were synthesized as described in chapter 4. Nile red 
(nile blue A oxazone), oxazine 170 perchlorate [oxazine], fluorescein, poly(vinylalcohol) 
[PVA] (Mowiol 40-88), Pluronic F68, Igepal® CA-630 (Octylphenyl-poly(ethylene glycol)), 
N,N,N′,N′-Tetramethylethylenediamine [TEMED] and ammonium persulfate [APS] were 
purchased from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (Lipoid® PC 16:0/16:0) was obtained from 
Lipoid (Lipoid GmbH, Ludwigshafen, Germany). Methylene chloride (p.a.) [CH2Cl2] and 
chloroform [CHCl3] were obtained from Acros (Acros Organics, Fischer scientific GmbH, 
Nidderau, Germany). Ethanol (p.a.), methanol (p.a.), isopropanol (p.a.) and nitric acid 
(65 %) [HNO3] were provided from Merck (Merck KGaA, Darmstadt, Germany). 
2.1.2 Cell culture 
The L929 mouse fibroblast cell line was a kind gift of the Department of Pharmaceutical 
Chemistry, University of Regensburg. Fetal bovine serum [FBS] was purchased from 
Biochrom (Biochrom KG, Berlin, Germany). Trypsin-EDTA 0.25 % and Dulbecco’s 
phosphate buffered saline [PBS] were obtained from Invitrogen (Invitrogen GmbH, 
Karlsruhe, Germany). 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide [MTT] 
was purchased from AppliChem (AppliChem GmbH, Darmstadt, Germany). Eagle’s 
minimum essential medium [EMEM], was obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemie GmbH, Taufkirchen, Germany). Triton-X (p.a.) was obtained from Merck (Merck 
KGaA, Darmstadt, Germany). 
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2.2 Methods 
2.2.1 Preparation and characterization of CdSe Quantum Dot stock 
dispersion 
Prior to encapsulation raw dispersions of the custom-made CdSe quantum dots were 
purified following a procedure established in chapter 4. Briefly an aliquot, usually 1 to 2 ml 
of the dispersion were mixed with a 30-fold excess of a mixture of ethanol and hexane 
(5:1), followed by centrifugation (10,000 g, 30 min, 10 °C; Avanti JE centrifuge; Beckman 
Coulter GmbH, Krefeld, Germany), discarding of the supernatant and subsequent re-
dispersion of the sediment in CH2Cl2. 
Photoluminescence [PL] properties and molar concentrations of nanocrystals were 
determined following methods described in chapter 4 (2.2.4 & 2.2.5). 
2.2.2 Standard preparation of polymeric microparticles 
Polymeric microparticles generally were prepared following an established emulsion 
based solvent evaporation method [30]. If not otherwise stated following standard 
procedure was used for encapsulation of lipophilic quantum dots dispersed in methylene 
chloride. 200 mg of the polymer (PLGA or Peg2PLA40) were dissolved in methylene 
chloride. After addition of an aliquot of the marker containing solution the final volume of 
the organic phase was adjusted to 4 ml (concentration of polymer in solution was 5 %). 
8 ml of an aqueous solution containing 0.5 % PVA were added and thereafter the mixture 
was homogenized via vortexing at maximum speed for either 10 s in the case of PLGA or 
30 s in the case of the copolymer. Subsequently, the as prepared primary emulsion was 
poured into 100 ml of an aqueous solution containing 0.1 % PVA and the organic solvent 
was allowed to evaporate over night under permanent stirring at 550 rpm.  
Plain microparticles were prepared in the same way, but without addition of the quantum 
dot dispersion. 
For particle recovery the microparticle dispersions were centrifuged (5,000 g, 15 min, 
10 °C), the supernatant was discarded and the particles were washed three times with a 
solution containing 0.1 % of Pluronic F68 in order to prevent their aggregation. Afterwards 
the particles were freeze-dried using a lab-scale freeze-dryer (Martin Christ 
Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) and dried particles were 
stored under vacuum or at -20 °C until further application.  
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2.2.3 Standard preparation of lipid microparticles 
The preparation of lipid microparticles followed an adapted melt dispersion method [31]. In 
a 50 ml round-bottom flask 500 mg of the triglyceride (Dynasan® 116) were dissolved in 
chloroform. In case of the quantum dot loaded particles the organic quantum dot 
dispersion was added, otherwise pure chloroform was added as control. Under reduced 
pressure the organic solvent was removed at 60 °C followed by complete melting of the 
left lipid or lipid/QD mixture at 70 °C. A pre-heated solution containing 0.1 % 
phosphatidylcholine (PC 16/16) in 70 % ethanol was added. Afterwards the mixture was 
homogenized via shaking and poured, under agitation, into 100 ml of ice-cooled water, for 
immediate hardening of the particles. Particles were collected by filtration, washed three 
times with water and subsequently dried under vacuum over night.  
2.2.4 Particle size determination 
Particle size distributions of the polymeric particles were determined based on laser 
diffraction using a Mastersizer 2000 equipped with the Hydro 2000µ dispersion unit (both 
Malvern Instruments, Herrenberg, Germany). Measurements were done in water 
containing Igepal® CA-630 as non-foaming surfactant under mild agitation at 300 rpm. 
Results are given as d10, d50 and d90 values describing the size distributions. All data 
were expressed as mean of quadruplicate measurements. 
Scanning electron microscopic images (2.2.5) were used to determine the mean diameter 
of the lipid particles. Size was determined by manual measuring the diameter of 100 
particles. Results are presented as mean and relative standard deviation. 
2.2.5 Imaging of particles surface morphology 
Scanning electron microscopy [SEM] was used for imaging of microparticles‘ surface 
morphology. Prior to the investigation the original material was mounted on aluminium 
stubs and sputtered with a thin gold film (4 x 20 s). Images were obtained using a 
JSM 840 scanning electron microscope (Jeol GmbH, Eching, Germany) with 3 kV 
operating voltage.  
2.2.6 Determination of loading with Quantum Dots 
Inductively coupled plasma optical emission spectrophotometry [ICP-OES] was used to 
determine the elemental concentrations of the quantum dot components Cd and Se. 
Sample preparation differed between polymeric and lipid microparticles. An aliquot, 
usually about 100 mg, of the lyophilisate of quantum dot containing polymeric 
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microparticles was degraded under increased temperatures in 2 ml, ethanol containing 
HNO3 (65 %) over 12 h. In the case of the lipid microparticles the particles were melted 
prior to the addition of HNO3 and ethanol. At least three melting and concealing cycles 
were performed to ensure quantitative isolation and disintegration of the quantum dots. 
Thereafter the remaining lipid phase was removed via filtration. 
50 to 100 µl of the organic quantum dot dispersion used in the respective experiment deal 
as reference for the determination of the initial amounts of Cd and Se. After drying at room 
temperature under atmospheric pressure nanocrystals were oxidatively disintegrated. 
Subsequently all samples were diluted up to 10 ml in a volumetric flask. The final 
concentration of HNO3 was about 2 to 3 %. Plain particles served as negative control.  
The standard solutions, prepared of cadmium chloride and selenium, contained 100 ppm, 
10 ppm and 1 ppm of Cd and Se in 2 to 3 % nitric acid. Measurements were performed 
using a Jobin Yvon 70 Plus (S+S) ICP-OE spectrophotometer (Horiba, Jobin Yvon, 
France) in the sequential analysis mode. Instrumental settings and element characteristics 
are given in chapter 4 (2.2.7).  
The CdSe loading of the microparticles was calculated based on the following equations: 
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with the real concentration of Se in the microparticles C(Se)real [nmol/mg], the molar 
amount of Se in degraded particles measured via ICP-OES M(Se)ICP-Sample [nmol], the 
weight of the particles used for the preparation of the ICP sample mICP-Sample [mg], the 
theoretically required concentration of Se in the microparticles given at 100 % 
encapsulation C(Se)Initial [nmol/mg], the molar amount of Se in the QD-reference 
measured with ICP-OES M(Se)QD-Reference [nmol], the multiple of the volume of the QD-
reference used for encapsulation fQD-Reference and the initial weight of polymer used for 
particle preparation mPolymer [mg]. 
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2.2.7 Confocal imaging of Quantum Dot loaded microparticles 
Spatial distribution of fluorescence within the polymeric and lipid microparticles loaded 
with quantum dots was determined by confocal laser scanning microscopy using a Zeiss 
Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss Co. 
Ltd., Germany). The inverted microscope was equipped with a C-Apochromat 40x and a 
Plan-Apochromate 63x objective. Particles were excited at 488 nm using an argon laser 
and fluorescence was detected using a long pass 560 nm filter. Unloaded microparticles 
served as negative control at same conditions and were used for determination of the auto 
fluorescence of the matrix materials. 
2.2.8 Fluorescence spectroscopic analyses 
The fluorescence properties were determined with respect to the fluorescence intensity 
and the maximum emission wavelength (λe). Microparticles were investigated in solid state 
using a custom made sample holder (Fig. 1) and after dissolving an aliquot of the particles 
(either 25 or 50 mg in 1 ml CHCl3) using quartz glass cuvettes (1 cm path length). 
 Aluminium holder  
Cover glass, quartz  
Mould for solid sample  
 
Fig. 1: Sample holder for fluorescence measurements of solid state samples 
All experiments were performed with a LS 55 spectrophotometer (PerkinElmer, Waltham, 
USA) equipped with the FL WinLab V4.00.03 software. After excitation with 488 nm 
fluorescence spectra were recorded over the range of 500 to 700 nm, with a 
photomultiplier voltage of either 775 or 900 V. 
2.2.9 Microparticles embedded in polymeric hydrogels 
The OPF 6k hydrogels were prepared via thermally induced free radical polymerization 
using TEMED and APS as initiator system. Quantum dot loaded microparticles were 
embedded prior to cross-linking by addition of the dry particles and subsequent stirring 
avoiding the incorporation of additional air bubbles.  
Spatial distribution of the microparticles within the hydrogels was imaged with z-stacks 
obtained with CLSM using a Zeiss Axiovert 200 M microscope, equipped with a Plan-
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Neofluar 10x and a Plan-Apochromate 40x objective, coupled to a Zeiss LSM 510 
scanning device (Carl Zeiss Co. Ltd., Germany). Samples were excited at 488 nm using 
an argon laser and fluorescence was detected using a long pass 560 nm filter. 
2.2.10 Cell culture 
The L929 cell line was cultured in EMEM medium supplemented with 10 % FBS at 
standard cell culture conditions (37 °C; 95 % relative humidity and 5 % CO2). Growth 
medium was changed every third day. 
2.2.11 Biocompatibility of polymeric microparticles 
Investigation of biocompatibility of the prepared particulate systems followed a procedure 
adapted from ISO 10993/EN 30993 [32] using the colorimetric MTT assay for quantitative 
assessment. Microparticles were investigated using an extraction procedure [33]. In brief, 
100 mg of each microparticle batch were incubated in 10 ml medium (without FBS) for 
24 h at 37°C. After removing the solid particles 10 % FBS were added and the stock 
extracts were diluted serially with medium (+ 10 % FBS) prior to addition to the cells. 
General parameters of the assay in detail have been given in chapter 2. However, in case 
of the microparticles incubation of cells with test extracts took 24 h. 
All data were expressed as mean (N=4) and relative standard deviation. Statistic 
significance was assessed by one-way analysis of variances (ANOVA) in conjunction with 
Tukey’s studentized range test using SigmaStat software. 
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3. Results 
3.1 Tailoring the particle size 
The easy controllable preparation step of the primary emulsion was investigated with 
respect to its effect on the resulting particle size distributions, which was also found to 
strongly depend on the used polymer type (Tab. 1). 
Tab. 1: Summary of characteristics of particle size distributions of PLGA and PEG2PLA40 microparticles 
depending on the pre-emulsification step 
 PLGA microparticles PEG2PLA40 microparticles 
Pre-emulsion d10 / µm d50 / µm d90 / µm d10 / µm d50 / µm d90 / µm 
Vortex 5 s 29.04 58.60 119.12 41.58 150.18 506.77 
Vortex 10 s 24.82 42.39 67.42 30.48 82.13 351.12 
Vortex 30 s 18.03 34.82 70.12 11.37 28.13 53.75 
Vortex 60 s 17.31 33.43 75.65 10.61 32.135 66.90 
Vortex 90 s 17.81 34.81 76.23 9.17 32.8 73.11 
Vortex 120 s 16.68 31.94 53.90 13.35 49.30 95.30 
Ultrasonic 10 s 1.44 4.53 24.51 4.40 27.00 283.30 
Ultrasonic 30 s 1.43 2.23 97.11 8.34 28.45 226.13 
Ultrasonic 60 s 1.27 2.64 83.95 4.06 16.32 117.06 
Ultrasonic 90 s 1.37 3.24 83.95 3.77 10.46 118.42 
 
Overall, changing the emulsification method (vortexing or sonication) showed the 
strongest impact on mean particle size in contrast to alterations of the treatment times. 
Comparing the results obtained with different agitation forces of the Vortex and the 
ultrasound treatment indicate that longer treatment times generally only led to a narrowing 
of size distribution for the particles without further significant reduction of the particle size. 
Additionally, the observed effects are only limited to a certain size range and no 
submicron particles were obtained, regardless of the applied emulsification time. 
The effects of similarly altered process parameters in case of lipid based microparticles 
was not investigated due to the hardly controllable time and especially strength of the 
shaking process in the round bottom flask. However, following the described standard 
preparation procedure a mean particle size was found of about 124 µm (±16 µm) as 
determined from SEM investigations. 
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3.2 Determination of encapsulation efficiency 
Encapsulation efficiency of the CdSe quantum dots generally was found to be very high 
(all above 75 %), indicated by the microparticles’ Se content as determined by ICP-OES 
(Tab. 2). In case of OA-coated quantum dots efficiency seems to slightly decrease with 
increasing initial loading independent of the used matrix material. 
Tab. 2: Encapsulation efficiencies of microparticles loaded either with uncoated or OA-coated Quantum Dots  
 uncoated CdSe Oleylamine-coated CdSe 
 
1 
nmol/200mg 
5 
nmol/200mg 
10 
nmol/200mg 
1 
nmol/200 mg 
5 
nmol/200mg 
10 
nmol/200mg 
PLGA 105.74 % 106.92 % 101.92 % 105.93 % 87.65 % 74.93 % 
PEG2PLA40 118.10 % 117.03 % 107.52 % 108.25 % 99.39 % 82.33 % 
Trigylceride 104.77 % 105.00 % 122.00 % 107.99 % 98.56 % 95.06 % 
 
3.3 Optical properties of Quantum Dot loaded microparticles 
Optical properties of quantum dot loaded particles were determined both in solid state and 
after dissolving of the particles in chloroform, and the evaluation was done with respect to 
the impact of quantum dots surface modification (either uncoated or OA-coated) and the 
initial loading.  
Fluorescence spectra of the microparticles loaded with uncoated CdSe quantum dots 
(Fig. 5) were slightly broadened when measured in solid state, with highest impact of the 
matrix material PEG2PLA40. However, the effect of the matrix state (solid or dissolved) on 
the maximum emission wavelength was almost negligible. 
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Fig. 5: Normalized fluorescence spectra of microparticles prepared of PLGA, PEG2PLA40 and glycerol 
tripalmitate, loaded with uncoated quantum dots; each measured both in solid state and after dissolving in 
CHCl3
After encapsulation of quantum dots with an initial quantum yield of 6 %, the solid matrix 
was found to lead to a pronounced loss in fluorescence intensity for all three types but 
with the highest impact for the lipid particles (Fig. 6, left). Indeed, despite the higher 
fluorescence quenching of the solid triglyceride, indicated by the measured fluorescence 
increase upon dissolving of the particles (Fig. 6, left), solid lipid microparticles were found 
to exhibit the best fluorescing properties of all matrix materials, followed by PLGA and 
PEG2PLA40 (Fig. 6, right). 
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Fig. 6: Normalized fluorescence intensities of microparticles loaded with uncoated CdSe quantum dots (initial 
loading of 6 nmol/200 mg) - (left) comparison of maximum fluorescence intensity in solid state and after 
dissolving same particle amounts in CHCl3, each material normalized on its maximum intensity; (right) 
comparison of maximum fluorescence intensities of solid particles measured; normalized on maximum 
intensity of all materials 
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Both, the effect of increasing initial loading of CdSe quantum dots and of modified 
quantum dots, were found to differ depending on the used matrix material (Fig. 7). In case 
of the polymeric particles increasing amounts of quantum dots generally resulted in 
improved optical properties (Fig. 7, left). In case of PLGA this was only detectable for the 
dissolved samples since none of the solid particles showed any detectable fluorescence. 
In contrary the PEG2PLA40 particles, although loaded with quantum dots of very poor initial 
quality, even a fluorescence of the solid particles could be detected. However, their overall 
fluorescence was very low, which certainly can be attributed to the bad quality of the here 
encapsulated quantum dots. 
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Fig. 7: Normalized fluorescence intensities of microparticles prepared of different materials loaded with 
increasing amounts of either (left) uncoated CdSe quantum dots or (right) OA-coated quantum dots; all 
normalized on overall maximum of all materials 
Glycerol tripalmitate again showed the highest impact of the solid matrix on the particles’ 
fluorescence intensity and moreover no detectable improvement in quality of the solid 
particles could be achieved by increasing the loading with quantum dots. 
Results obtained with the OA-coated quantum dots indicate dramatically improved 
fluorescence properties of polymer based microparticles despite the much lower initial 
quantum yield of the used quantum dots (Fig. 7, right). Lowest intensities, however, were 
obtained in case of the lipid matrix system, which also could not be detected in the solid 
state. No obvious effect of increasing quantum dot loadings could be determined. 
Interestingly, the quenching effect of the solid matrix was even levelled in case of 
PEG2PLA40 microparticles, if loaded with OA-coated quantum dots. 
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3.4 Morphologic characterization of Quantum Dot loaded 
microparticles 
Depending on the used matrix materials, quantum dot loaded microparticles differed 
significantly in their surface morphology and also in the spatial distribution of the 
detectable fluorescence, which could act as indicator of varying internal distributions of the 
nanocrystals in polymeric or lipid particles. In case of the uncoated quantum dots 
(Fig. 8, left) both lipophilic matrices PLGA and glycerol tripalmitate exhibit smooth particle 
surfaces (Fig. 8, A+C) and a homogeneous distribution of fluorescence (Fig. 8, a+c) over 
the whole cross section of the particles. In contrast, the particles prepared of the 
amphiphilic PEG2PLA40 (Fig. 8, B+b) is characterized by a spongy surface morphology 
and its fluorescence is only restricted to an inner area or core of the particle, which is 
surrounded by a non-fluorescing corona. 
Fig. 8: (left) Microparticles loaded with uncoated CdSe quantum dots prepared of (A/a) PLGA, (B/b) 
PEG2PLA40 and (C/c) glycerol tripalmitate; (right) microparticles loaded with OA-coated CdSe quantum dots 
prepared of (D/d) PLGA, (E/e) PEG2PLA40 and (F/f) glycerol tripalmitate; captial letters: SEM images; 
magnification 2,500x, scale bars correspond to 10 µm; lower case letters: corresponding grey-scale CLSM 
images, inserts represent coloured overlays of CLSM- and brightfield images; magnification 63x, scale bars 
correspond to 20 µm 
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After encapsulation of OA-coated quantum dots (Fig. 8, right) no changes could be 
observed in case of the lipid microparticles (Fig. 8, F/f). PEG2PLA40 based particles lost 
their rough surface morphology (Fig. 8, E) and in both polymeric matrices fluorescence 
appears to be restricted to individual, clearly defined small areas randomly distributed 
over the whole particle (Fig. 8, d+f). 
3.5 Biocompatibility of Quantum Dot loaded microparticles  
Biocompatibility of the polymeric microparticles was tested using a standard cell line for 
the evaluation of biomaterials (L929 mouse fibroblasts). There was no significant toxicity 
(tested against negative control) of either PLGA or PEG2PLA40 microparticles loaded with 
uncoated CdSe quantum dots even in case of the highest quantum dot loadings (Fig. 9). 
Measured cell viabilities were generally above 75 % for all investigated dilutions and 
quantum dot loadings. 
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Fig. 9: Viability of L929 cells after incubation (24 h) with extracts of microparticles prepared of (left) PLGA or 
(right) PEG2PLA40; both loaded with increasing amounts of uncoated CdSe quantum dots; star indicate 
significant toxicity compared to the respective negative control (p<0.05) 
In contrast, the particles loaded with the OA-coated quantum dots showed a significant 
toxicity (compared to negative control) if loading increased up to 10 nmol/200 mg 
independent of the used type of polymer (Fig. 10). The here obtained viabilities decreased 
down to about 50 % for the high quantum dot loading. 
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Fig. 10: Viability of L929 cells after incubation (24 h) with extracts of microparticles prepared of (left) PLGA or 
(right) PEG2PLA40; both loaded with increasing amounts of OA-coated CdSe quantum dots; star indicate 
significant toxicity compared to the respective negative control (p<0.05) 
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4. Discussion 
Various methods for the preparation of micro-scaled drug delivery systems have been 
described in literature [34-39], but the solvent evaporation methods are the most 
frequently used ones for encapsulation of both hydrophilic as well as lipophilic substances 
[40-43]. Therefore this method was chosen to be appropriate for an easy preparation of 
polymeric microparticles in the current work. Varying only a single process parameter, 
namely the preparation of the primary emulsion, allows the adaption of particles size 
within a certain range (Tab. 1). The desired particle sizes, between 50 and 75 µm, could 
be prepared by emulsification with 10 s vortexing in case of PLGA and respectively 30 s in 
case of PEG2PLA40. These standard conditions have been used for production of all 
further polymeric microparticles. Since the lipid based particle approach has been used 
primarily for the investigation of the potential impact of the differing processing and matrix 
material on the optical properties of the obtained particles and since particles were not 
intended for further applications, no optimization of the originally found particle size was 
performed. 
Quantum dots, which were identified as attractive alternative to label particulate systems, 
have been successfully encapsulated using a single emulsion method and generally 
behaved very similar to other lipophilic marker substances, if compared with commonly 
used organic fluorescence dyes, exemplarily shown for the PEG2PLA40 based particles 
(Fig. 11).  
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Fig. 11: CLSM Images of PEG2PLA40 microparticles loaded with (A) uncoated CdSe quantum dots 
(λex=488 nm/ LP 560 nm), (B) fluorescein (λex=488 nm/ BP 530-600 nm), (C) oxazine (λex=633 nm/ LP 650 nm) 
and (D) Nile red (λex=488 nm/ LP 650 nm); inserts show overlay of CLSM- and brightfield images, 
magnification 63x; scale bars correspond to 20 µm 
Encapsulation of the lipophilic particulate markers always resulted in high encapsulation 
efficiencies as shown in table 2, which is generally reported for lipophilic substances used 
in the emulsion based microencapsulation [44]. 
Since quantum dots are known to be very sensitive to different processing steps and it 
was the goal to reproducibly produce high quality fluorescing microparticles, an 
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investigation of potential impact factors on the resulting optical properties of the particles 
was essential. The prepared microparticles were evaluated focusing on the type of used 
matrix material, the quantum dot loading and the surface properties of the used quantum 
dots. 
Comparison of the finally obtained fluorescence intensities of the particles made from the 
three materials (Fig. 6, right) at the first glance suggests a protective effect of the 
triglyceride on the quantum dots PL. However, although assuming a higher stability in the 
lipophilic matrix material, this effect can also result from the slightly differing preparation 
process of lipid microparticles, where the emulsion was prepared only by manual shaking 
and not by vortexing at obviously higher frequency. The resulting lower agitation forces in 
combination with an increased viscosity of the melted pure lipid compared to the organic 
polymer solutions will lead to reduced shear forces on the quantum dot surfaces and 
therefore a much lower destruction of the surface coating, which proved to be beneficial 
for the particles’ fluorescence intensity. This positive effect of the triglyceride matrix is 
somewhat diminished by the materials higher optical density, obviously reducing the 
amount of penetrating and emitted light. The loss in the overall fluorescence intensity of 
the particles due to the matrix solidification for lipid matrices was found to be nearly twice 
as much as in case of both investigated polymer matrices (Fig. 6, left).  
Improvement of the particles’ optical properties was intended by both increasing the initial 
loading of quantum dots and also by encapsulation of OA-coated quantum dots. Such 
surface modified quantum dots were found to exhibit improved optical properties and were 
expected to show enhanced stability during encapsulation. Focusing on the mere 
fluorescence intensity of the solid particles the impact of the changed quantum dot type 
clearly exceeds the effect of an increased loading (Fig. 7), which is especially surprising, 
since the used batches of OA-coated quantum dots showed the overall lowest initial QY. 
The most significant improvement was found for the diblock copolymer, which suggests a 
contribution of the PEG-part. An interaction of the polymers PEG-blocks with the OA-
coated quantum dots could result in a further stabilization of their surface. The change in 
the microparticle morphology in the SEM (Fig. 8, B+E) could deal as an additional proof 
for this assumption. Following the solvent evaporation and freeze drying, the particles 
made of PEG containing block polymers are usually characterized by a very spongy 
structure, which can result from the predominant orientation of the PEG-chains towards 
the particle surface, due to an increased interaction with the surrounding aqueous 
environment in the emulsion [45]. Following encapsulation of OA-coated quantum dots, 
the microparticle surface appeared more ore less smooth due to a possible preferential 
orientation of the PEG chains to the inside of the particles. A consequent internal 
enrichment of the hydrophilic polymer compound may result in the development of a 
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porous internal structure, also found for other PEG containing block copolymers [46]. A 
subsequently resulting decrease in the materials’ optical density could furthermore explain 
the significantly reduced impact of the matrix state (solid or dissolved) on the particles’ 
fluorescence intensity (Fig. 7). 
In contrast, the effect of OA-coating appeared almost negligible in case of PLGA particles 
and was found to even impair the optical quality in case of lipid microparticles. No 
alteration in surface morphology could be observed for both of these lipophilic materials. 
However, there is a significant alteration of the internal fluorescence distribution using OA-
coated quantum dots. Originally the fluorescence is almost homogenously distributed in 
the lipophilic core, if particles are loaded with unmodified quantum dots (Fig. 8, a+b). For 
the OA-coated quantum dots the fluorescence, as indicator for the distribution of the 
nanocrystals, is now restricted to several small areas (Fig. 8, d+e), which were found to 
be comparable to the reports on the encapsulation of hydrophilic drug substances [47]. 
The distribution of an encapsulated material is usually a result of its interaction with the 
surrounding polymer matrix, which is especially apparent, when hydrophilic and lipophilic 
compounds are compared [48]. Although both types of used quantum dots (native and 
OA-coated) bear a lipophilic capping, these results suggest a reduced interaction of PLA 
and PLGA with oleylamine, which consequently leads to an accumulation of quantum dots 
in pores or hollows, instead of a homogeneous distribution within the polymer matrix. A 
resulting lower shear stress for the crystal surface could additionally account for the also 
improved optical properties. Due to these obvious differences in the internal distribution of 
the fluorescence, using the fluorescing area as indicator for the apparent particle size 
during imaging would only be possible in case of particles loaded with unmodified and 
consequently well dispersed quantum dots.  
However, a final concluding evaluation of the various impact factors on the particles’ 
quality could hardly be done as the fluorescence was also found to regenerate or restore 
during the extended storage of the particles. After 8 months, the fluorescence intensity of 
the solid particles again increased more than 900 % for some of the particles (Fig. 12), 
which indicate a still possible “healing” of the damaged quantum dot surfaces. 
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Fig. 12: Normalized fluorescence spectra of microparticles prepared of PLGA, PEG2PLA40 and glycerol 
tripalmitate loaded with OA-coated CdSe quantum dots (initial loading 5 nmol/200 mg) measured in solid 
state, directly after preparation and after storage for 8 months 
Indeed, independent of the used polymer material this regeneration was only observed in 
case of the particles loaded with OA-coated CdSe quantum dots, suggesting a 
participation of the primary amine ligand on the surface reconstitution of the nanocrystals. 
Although exhibiting the best intensities directly after preparation no superiority of the 
amphiphilic diblock copolymer could be determined after this “healing” period. 
Despite the diverse results and an originally only moderate optical quality, the prepared 
particles of both quantum dots types were successfully applied as fluorescent labels for 
the investigation of a hybrid drug delivery system. The above discussed differences in 
internal spatial arrangement of the fluorescing areas were found to be almost irrelevant in 
case of the imaging at lower magnifications, even using confocal microscopy. Therefore 
both types of labelled particles are suited for observations in a three-dimensional context. 
This is exemplarily demonstrated for PLGA microparticles (either loaded with uncoated or 
OA-coated QDs) embedded in transparent OPF hydrogels (Fig. 13). Despite very similar 
particle sizes and particle loadings the spatial distribution of the microparticles within the 
hydrogel differed, which already might affect the release characteristics in case of drug 
loaded delivery systems. 
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Fig. 13: CLSM images (z-stacks) of OPF 6k hydrogels loaded with PLGA microparticles fluorescently labelled 
with either (A) uncoated CdSe quantum dots or (B) OA-coated quantum dots; magnification 10x; stack size: 
x=y=824 µm, z=1210 µm 
The additionally envisioned application of quantum dot labels to track particulate systems 
in a cellular context or even during in-vivo applications requires biocompatibility of the 
used imaging system, which was tested using a common cell line used for biomaterial 
testing [32]. Independent of the used polymeric matrix no toxicity was found for particles 
loaded with uncoated CdSe quantum dots (Fig. 9), whereas particles containing 
increasing amounts of OA-coated quantum dots led to a statistical significant reduction in 
cell viability (Fig. 10). This may be due to a more likely leakage of quantum dots during 
extraction of microparticles, which could be enhanced due to the porous particle structure 
or an also possible solubilisation of released oleylamine, possibly acting as cell damaging 
surfactant. Further studies are necessary here to identify the cause of toxicity and take 
suitable counteractions. 
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5. Summary and Conclusion 
Fluorescence labelling of microparticulate systems using lipophilic quantum dots was 
successfully established using commonly available particle preparation methods and 
therefore could serve as an alternative to the commonly used organic fluorescence dyes 
(e.g. Nile red, Rhodamine dyes). The final characteristics of the obtained labelled particles 
strongly depend on the initial optical quality of the used quantum dots, but moreover on 
the interaction of the used matrix material and the quantum dot surface ligands. However, 
the obtained results could hardly be generalized, keeping in mind the numerous different 
synthesis routes to produce the fluorescing nanocrystals. As synthesis routes are usually 
differing in the composition of reaction solvents and added stabilizing ligands, the surface 
decoration of the prepared or even of different commercially obtained quantum dots will 
be highly variable. Focusing on one intended application it is therefore essential to choose 
an appropriate model system and to improve its encapsulation process with respect to the 
photoluminescence and quantum yield. Especially if the quantum dots should be used as 
model compounds for crystalline drug substances, which are similarly only dispersed 
within the microparticles, a careful adaption of their surface characteristics would be 
required to allow transferring the obtained results on their behaviour during encapsulation 
and particle degradation on the later applied drug substances. 
Besides the already presented investigations on hybrid drug delivery systems, the 
prepared microparticles could also be used as differently sized probes to investigate the 
macroporosity and interconnectivity of pores, which are of special interest in hydrogel 
foams or solid scaffolds applied in tissue engineering applications. 
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1. Overall summary 
Covering a wide range of different sizes and structures particulate drug carriers represent 
highly sophisticated systems, which are designed to enable control of the carriers’ 
biodistribution, its targeting abilities and also its release kinetics or mechanisms, thereby 
improving the overall performance in therapeutic or diagnostic issues. Despite the fact that 
particulate systems are in the focus of research since several decades, there is still a 
tremendous further development going on in order to get deeper insight in particle 
formation and distribution. In this context fluorescence based analyses offer an 
irreplaceable analytical tool to gain more insight into the characteristics and underlying 
mechanisms, which is essential for the adaption of the particle preparation and their 
further improvement. 
Main focus of this thesis was to provide a versatile pool of particulate systems, which 
proved to be applicable in different fluorescence imaging applications ranging from in-vitro 
investigations to cell culture testing or small animal applications. 
 
Based on a simple and very gentle phase separation method, the nanoprecipitation, a 
system for the reproducible production of polymeric nanoparticles within the size range of 
50 to 250 nm was established (Chapter 2). A thorough evaluation of several impact 
factors on particle formation, allowed to provide a toolbox, which was suitable to adjust the 
desired particle properties (i.e. size and surface characteristics) by choosing a certain 
biodegradable polymer (either PLGA, mPEG-PLA or NH2PEG-PLA) in combination with 
definite preparation parameters, e.g. the polymers’ molecular weight, polymer 
concentration, solvent and non-solvent system and the used solvents’ volume ratio. 
Generally, the influence of the different impact factors differed significantly for different 
polymers, which certainly requires similar investigations for every new polymer. In addition 
to the most commonly used aqueous preparation route (acetone/water) also a 
non-aqueous procedure (chloroform/ethanol) was established and thoroughly 
characterized, overcoming the limitations of nanoprecipitation for the encapsulation of 
lipophilic compounds. 
The as prepared polymeric nanoparticles were furthermore successfully applied for in-vitro 
as well as in-vivo imaging purposes, following an encapsulation of lipophilic fluorescence 
dyes, using either Nile Red or DiR as model compounds (Chapter 3). Interestingly, the 
impact of ‘drug’ loading on particles’ properties was found to be almost negligible, 
indicating a very homogenous distribution or even dissolution of the dye within the 
polymer matrix.  
A comparison of the imaging results obtained with these differing systems (Nile red vs. 
DiR loading), however, indicates the limitations of the Nile red loaded system (a “bleeding” 
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of dye into other surrounding lipophilic areas and the strong quenching of Nile reds’ in-vivo 
fluorescence by endogenous compounds). These dye inherent limitations were 
successfully overcome by exchanging Nile Red for the much more lipophilic near-infrared 
dye DiR. The DiR loaded nanoparticles proved to be an ideal tool, especially for in-vivo 
applications, allowing the imaging of whole body particle distributions as well as the 
imaging of deeper tissue regions due to the much higher tissue penetration of the near-
infrared light. 
The second part of the thesis was focused on the establishment of quantum dots as 
alternative solid crystalline marker substances for the fluorescence imaging of particulate 
drug delivery systems. 
At first, CdSe quantum dots with desirable maximum emission wavelengths of about 
610 nm were synthesized (Chapter 4). Their native optical properties as well as stability 
were successfully improved by adapting the synthesis duration, the purification methods 
or by addition of a post-synthesis surface coating of a lipophilic organic ligand. These 
improvements provided a bright fluorescing stable marker system, which should be 
applicable for further processing or encapsulation steps. Standardised synthesis methods 
were defined, which were dependent on the intended application of the respective 
quantum dots.  
The established non-aqueous nanoprecipitation process in general was found to be also 
an appropriate method for the preparation of small, monodisperse, quantum dot loaded 
nanoparticles (Chapter 5). Actually, their applicability as fluorescent imaging system was 
limited due to a high loss in their optical quality, like quantum yield and the subsequent 
fluorescence intensity. However, critical process steps could be identified and the 
problematic interference of the used solvents and matrix materials with the QD surface 
coatings was discussed, now allowing a constant further improvement of this promising 
system. Especially the application of quantum dot batches with initially much higher 
optical quality and different surface coating, as proven by commercially obtained 
nanocrystals, would be an initial step towards an enhanced fluorescence of the labelled 
nanoparticles.  
Finally, also the fluorescence labelling of microparticulate systems with custom-made 
lipophilic quantum dots was successfully established. Here the commonly available 
particle preparation methods, solvent evaporation and melt dispersion techniques, were 
investigated (Chapter 6). The characteristics of the labelled particles, especially the 
morphology and intraparticulate QD distribution, were found to strongly depend on the 
initial optical quality and coating of the used quantum dots, but moreover on the 
interaction of the used matrix material with the applied quantum dot surface ligands. 
Besides the application of QDs as a model compound for crystalline non-soluble drug 
 - 174 - 
 Summary and Conclusion 
compounds the accordingly labelled microparticles could be successfully used as stable 
fluorescence marker system for long-term investigations of hybrid drug delivery systems 
or eventually in-vivo applications of microparticulate carriers.  
2. Conclusions and Outlook 
In conclusion, the developed particulate drug delivery systems could be successfully 
applied for differing fluorescence imaging purposes. However, it also was demonstrated 
that the development and preparation of ideally monodisperse, fluorescently labelled 
particles for the investigation of in-vivo transport phenomena is a quite difficult task, which 
has to overcome several still persisting obstacles. 
Starting from the establishment of uniform nanoparticles and their loading with lipophilic 
dyes it became obvious that their permanent fixation within the small nanoparticles is 
especially challenging in cellular context and in-vivo environment. Once sufficiently 
optimized, the nanoparticulate systems established within this thesis, were successfully 
applied for investigation of passive drug targeting processes in small animals (Fig. 1).  
  
 
48 hours
 
Fig. 1: Co-localization fluorescence signal of a DsRed  expressing subcutaneous coloncarcinoma (green 
fluorescence) and DiR (red fluorescence) after 48 h following i.v. administration of DiR loaded NPs in mice  
2
An alternative set of particles (nano- and microscaled) was prepared, exchanging the low 
molecular weight dyes for inorganic fluorophores, the quantum dots. Quantum dots in 
general are known to be attractive alternatives for most commonly used organic 
fluorescence dyes and are already established in the field of diagnostics or diagnostical 
imaging. This work demonstrates their great potential also for future applications in the 
development of sophisticated and complex particulate drug delivery systems.  
However, despite their described advantages, like the optical properties and the 
particulate character, one has to keep in mind the still to overcome photolability during the 
performed encapsulation processes and their intrinsic toxicity, which certainly hampers 
in-vivo diagnostics. There is a tremendous need for “high-quality” quantum dots with 
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improved surface coatings to guarantee increased photostability and reduced or better 
eliminated toxicity, which certainly can be achieved by adapted synthesis parameters or 
additional post-synthesis treatments, as demonstrated in a recently finished PhD thesis 
[1].  
Adaption or even tailoring of the QDs surface properties would furthermore allow using 
them as a versatile model for different hydrophilic and lipophilic drug compounds to be 
incorporated in the particulate systems. At least the in-vitro investigation of low-soluble or 
in-solube compounds might provide a deeper insight in the formation and also the release 
of newly developed drug delivery systems. Thus the quantum dots can participate in the 
development of better drug delivery systems and more successful therapy, even during 
non-toxic in-vitro studies.  
Besides the potential perspectives of the established delivery systems, the obtained 
results point out the necessity for each researcher to pay special attention to the careful 
interpretation of experimental data and the choice of an appropriate set-up of analytical 
methods. It was found especially for the particulate DDS that they are quite sensitive to 
even slight changes in their preparation (e.g. within the preparation method or 
encapsulated compound). Therefore, once obtained results for the encapsulation of one 
specific drug compound could hardly be generalized, and need to verified with every 
change to a new system. Overall, the investigation of model compounds provide only a 
small assistance on the way to improved drug delivery systems, but certainly help to 
better visualize and understand the formation and performance of particulate delivery 
systems. 
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Characterization of biodegradable 
copolymers 
 
  
Polymer Characterization 
1. Methods 
1.1 1H-NMR Spectroscopy 
About 30 mg of each synthesized polymer were dissolved in 1 ml CDCl3. The 1H-NMR 
spectra were taken at 250.13 MHz with tetramethylsilane (TMS) as internal standard using 
a Bruker AC250 spectrometer with dual sample head and an autosampler (Bruker, 
Rheinstetten, Germany). For the detection of the primary amine group of the polymer 
spectra were taken after addition 100 µl TFA to allow acylation of the amine and hydroxyl 
end group. 
1.2 Gel permeation chromatography 
Gel permeation chromatography was used for estimation of the molecular weight of the 
synthesized polymers. Samples were prepared by dissolving about 10 mg of each 
polymer in 2 ml chloroform followed by filtration through a 0.2 µm chloroform resistant 
regenerated nitrocellulose membrane filter to remove particulate impurities. As stationary 
phase served a combination of a 5 µm particle size Phenogel® pre-colum (50 x 7.8 mm) 
with an analytical column Phenogel® Linear(5) (separation range 100 to 10.000 kDa; both 
Phenomenex, Torrance, CA). CHCl3 with a flow rate of 1.0 ml/min was used a mobile 
phase. Chromatograms were recorded on a 10AVP HPLC system (Shimadzu, Duisburg, 
Germany). The columns were kept at 35 °C using a CTO-10ACVP column oven 
(Shimadzu, Duisburg, Germany). After injection of 50 µl sample solution, signals were 
recorded by a RID 10A refractive index detector (Shimadzu, Duisburg, Germany).  
Molecular weight of the polymer sample were calculated from the retention time of 
polystyrene standards with narrow size distribution (Polymer laboratories, Darmstadt, 
Germany) using the Class VP software version 5.0. 
1.3 Modulated differential scanning calorimetry 
Thermal behaviour of all used polymers, expressed by their glass transition temperature 
(TG), was investigated by modulated differential scanning calorimetry [MDSC] on a 
DSC 2920 equipped with refrigerated cooling system and an autosampler (TA 
Instruments, Alzenau, Germany). Samples were prepared by weighing of about 3 mg of 
each polymer in aluminium sample pans, which were afterwards sealed using the TA 
Instruments sample encapsulating press. An empty sealed pan served as reference. 
For determination of TG the following protocol was used: first, both sample and reference 
were equilibrated at -45 °C for 5 min. Samples were heated up from -40 °C to 80 °C at a 
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heating rate of 2 °C/min, using a sinusoidal temperature modulation with a period of 60 s 
and temperature amplitude of 0.32 °C. After retaining the temperature at 80 °C for 5 min, 
the sample were cooled to -45 °C at a cooling rate of 2 °C/min. As relaxation phenomena 
are less pronounced after the first heating and cooling cycle, the TG was determined from 
a second heating run, which was carried out using the same sinusoidal temperature 
modulation. After 5 min isothermal phase the temperature was raised at a rate of 2 °C/min 
to heat sample and reference from -45 to 80 °C. Thermograms were analyzed for TG 
(obtained as half height of the transition) with the Thermal Advantage software provided 
with the MDSC system. 
2. Results 
2.1 1HNMR Spectroscopy 
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2.2 Gel permeation chromatography 
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Fig. 6: GPC chromatograms and retention times of custom-made diblock copolymers 
Tab. 1: Molecular weights of custom-made polymers – calculated based on retention times 
Polymer  Retention time / min expected MW / kDa calculated MW / kDa 
NH2PEG2000 10.272 2 2.07 
PEG2PLA20  8.744 22  23.77 
PEG2PLA40   8.632 42  45.33 
NH2PEG2PLA20  9.101 22  16.83 
NH2PEG2PLA40  8.955 42  23.16 
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2.3 Modulated differential scanning calorimetry 
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Fig. 7: Reversed heat flow thermograms of used/ synthesized polymers with calculated TG
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Characterization of dispersion media 
 
  
 
 Characterization of Dispersion Media  
1. Methods 
1.1 Preparation of dispersion media 
At first stock solutions of all stabilizing agents (sucrose, glucose, Pluronic F68 and PVA) in 
purified water were prepared. The media with exact concentrations over the intended 
concentration range were prepared by appropriate dilution with purified water. For all 
investigations media were pre-conditioned to 20 °C. 
1.2 Determination of refractive index 
Refractive indices n were determined at 20 °C using a temperature-controlled Abbé 
refractometer. Purified water, with a refractive index of 1.33 was used as control liquid. 
Results will be given at mean values of triplicate measurements. 
1.3 Determination of density 
Densities of solutions (at 20 °C) were determined using calibrated glass pynknometers. 
Calibration volumes Vc of the used pyknometers were given with 51.712 cm3 and 
51.870 cm3. Pyknometer weight was determined in empty (clean and dry) and filled state 
and density was calculated according to the following equation: 
 
 
c
nf
V
mm
cm
g −=][ 3ρ ;  
with density ρ [g/cm3], the pyknometers weight filled with the respective medium mf [g]; the 
pyknometers’ net weight mn [g] and its calibrated volume VC [cm3]. 
1.4 Dynamic viscosity  
Kinematic viscosity ν of solutions of sucrose, glucose and Pluronic F68 was measured 
using an Ubbelodhe capillary viscosimeter (PVS®; LAUDA DR. R. Wobser GmbH & CO. 
KG, Lauda-Königshofen, Germany), equipped with an capillary No. I (nominal capillary 
constant=0.01). During the measurement temperature was maintained at 20 °C using a 
temperature controlled water-bath (Lauda E 100; LAUDA DR. R. Wobser GmbH & CO. 
KG, Lauda-Königshofen, Germany). 
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Dynamic viscosity η of each solution was subsequently calculated according to the 
following equation: 
 
 ρνη ∗= ;  
with the dynamic viscosity η [cP=mPas], the kinematic viscosity ν [cSt=mm2/s] and the 
solutions’ density ρ [g/cm3]. The results will be given mean of quadruplicate 
measurements 
 
Dynamic viscosity of solutions of the high molecular weight polymer PVA (Mowiol® 
40-88)was calculated based on the following empirical equation [1]: 
 
 ; ce ∗∗= 8455.04197.1η  
with the dynamic viscosity η [cP=mPas] and the concentration of the PVA in solution c 
[%]. 
2. Results 
Dispersion medium 
 Concentration 
Refractive index n Density ρ / g/cm3 Dyn. viscosity η /cP 
Sucrose    
 0.5 % 1.330 0.999 (~1) 1.00 
 5.0 % 1.337 1.018 1.13 
 10 % 1.345 1.025 1.30 
 20 % 1.359 1.084 1.90 
Glucose    
 0.5 % 1.330 0.996 (~1) 1.00 
 5.0 % 1.336 1.014 1.12 
 10 % 1.343 1.033 1.27 
 20 % 1.357 1.069 1.69 
Pluronic F68    
 0.1 % 1.330 0.997 1.00 
 0.5 % 1.330 0.998 1.00 
 1.0 % 1.331 0.977 1.16 
 1.5 % 1.332 0.999 1.28 
PVA    
 1 % 1.331 - 3.31 
 1.5 % 1.332 - 5.05 
 2.5 % 1.333 - 11.75 
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